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ABSTRACT 
Decidual prolactin (PRL) is identical to pituitary PRL according to 
its chemical, biological, and immunological properties. The factors 
involved in the regulation of PRL production from pituitary and 
decidua, however, are different. Although much is known about the 
factors that modulate the pituitary production of PRL, very little is 
known about the control of decidual PRL synthesis and release. The 
studies in this thesis were undertaken to investigate the control of 
decidual PRL production during human pregnancy. 
When this study was carried out, the exact cellular origin of 
decidual PRL remained unclear. Using the in situ hybridization with a 
human pituitary PRL cDNA probe, validated by Northern blot analysis, 
together with immunocytochemistry to co- localize PRL mRNA and its 
protein product, decidual cells in the utero- placental unit were 
identified conclusively, for the first time, as the only source of PRL 
synthesis. 
As the decidual cells are one of the main targets of progesterone 
and estradiol action within the uterus, studies were carried out to 
examine the effect of these steroids on decidual PRL production. 
Firstly, the relationship between decidualization and PRL production at 
different stages of human pregnancy was examined using in situ 
hybridization and Northern blot to assess PRL mRNA level, 
immunocytochemistry to examine the PRL content inside the decidual 
cells and redioimmunoassay to measure PRL output in amniotic fluid. 
The results clearly show that PRL gene expression in human decidua 
paralleled the degree of decidualization which was resulted from the 
action of sex steroids. Further studies were performed to reveal how 
important the effect of progesterone on decidual PRL production was 
during early pregnancy by blocking the action of progesterone with the 
antiprogesterone (RU486) in vivo. Withdrawal of progesterone action in 
vivo only resulted in suppression of decidual PRL production associated 
with morphological de- decidualization in decidua parietalis free of 
trophoblast, while no such effect occurred in decidua capsularis which 
had trophoblast attached. The results indicated that decidual PRL 
production was not only dependent on progesterone, but also potentially 
on factors derived from the trophoblast. Finally, the effects of both 
oestrogen and progesterone, either alone or in combination on PRL 
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production by human term decidual cells, were investigated. This 
study clearly demonstrated that oestrogen and progesterone acted 
synergistically to maintain decidualization and consequent production 
of PRL by decidual cells which was further confirmed by studies of the 
immunolocalization of oestradiol and progesterone receptor. 
Progesterone induced and maintained PRL production via its receptor 
mechanism resulting in decidualization. Oestrogen modulated 
progesterone function at the progesterone receptor level, thus beeing 
indirectly involved in modulating PRL production. 
Because the blastocyst- induced decidualization probably 
augments that initiated by sex steroids in human pregnancy, the 
potential PRL releasing activity associated with placenta was explored 
by adding placenta- conditioned medium and hCG, one of the major 
placenta proteins, to the cultured decidua. The results supported the 
concept that a local regulatory mechanism for decidual PRL production 
might exist which was related to placenta, but not hCG. The adenyl 
cyclase system (abcAMP) failed to effect, while TPA, testing the DAG 
pathway, inhibited decidual PRL production by term decidual cells. 
Unlike pituitary PRL, dopamine had no effect on decidual PRL 
production. In situ hybridization appeared to indicate the presence of 
dopamine D2 receptors on decidual cells but Northern analysis and 
PCR of decidual mRNA with primers to both rat and human dopamine 
D2 receptors failed to confirm the presence of dopamine D2 receptors. 
Decidual cells transfected with the dopamine D2 construct aslo failed to 
response to dopamine (bromocriptin) suggesting the second messenger 
system associated with signal transduction of dopamine D2 receptor 
may not be functional. 
These results support the concept that decidual cells are the only 
source of PRL in the utero- placental unit. The major control of release 
is the rate synthesis of PRL and this is related to the degree and 
maintenance of decidualization, induced and maintained by a 
synergistic action of oestradiol and progesterone. Dopamine is not a 
controller of decidual PRL production. 
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CHAPTER 1 
The Background of This Thesis 
1.1. Introduction 
Prolactin (PRL) production is generally restricted to the anterior 
pituitary gland. Uniquely in human and primates, however, PRL is 
also produced by the decidualized uterine endometrium late in the 
luteal phase of the menstrual cycle and on through pregnancy should 
blastocyst implantation occur (Riddick et al., 1978; Maslar and Riddick, 
1979). Decidual PRL bears the striking homologies with the pituitary 
PRL with regards to its chemical, biological and immunologic 
properties. Although much less is presently known about the 
regulation and function of decidual PRL in contrast to the intensive 
effort directed to understanding of pituitary PRL, its regulation appears 
to be apparently different from PRL in the pituitary, to which the 
differently regulatory region of gene structure and subcellular storage 
sites might contribute. Decidual PRL probably serves different 
functions related to the fetus, amniotic fluid homeostasis and placenta. 
This review will deal with, first, the anatomical and histological 
structure of human endometrium, the process of decidualization and 
related factors, and then the tissue and cellular origin of decidual PRL, 
the regulatory mechanism and relevant molecular basis, and its 
function in the utero -feto- placental unit. 
1.2. H»man endometrium and decidualization 
1.2.1. The cellular elements in human endometrium 
There are four main tissues situated in the human endometrium, i.e. 
the luminal epithelium, glandular epithelium, stroma and vascular 
vessels (Findlay et al., 1990). The columnar epithelial cells on the 
uterine luminal surface, along with the epithelial cells of the glands, 
form a continuum over the luminal surface of the uterus. The glands 
grow further down into the stroma, their density depending on the 
1 
hormonal status. The extracellular matrix of the endometrium is 
composed of collagen fibres, in which are embedded smaller fibrocyte- 
like stromal cells which will undergo the dramatically morphological 
and biochemical changes during normal menstrual cycle and 
pregnancy. In addition, plasma cells, macrophages and lymphocytes 
have also been identified within the stroma. The blood vessels in the 
stroma area are mainly formed by smooth muscle cells lined with 
endothelial cells. 
The decidua is the endometrium of the uterus of pregnancy and is so 
named because much of it is shed after parturition. During pregnancy, 
the decidua thickens; eventually, a depth of 5 to 10 mm is attained. The 
portion of the decidua directly beneath the site of implantation forms the 
decidua basalis; that portion that overlies the developing ovum and 
separates it from the rest of the uterine cavity is the decidua capsularis. 
The remainder of the uterus is lined by decidua parietalis. During the 
early months of pregnancy, there is a space between the decidua 
capsularis and the decidua parietalis since the gestational sac does not 
fill the entire uterine cavity. By the fourth month, the enlarging sac fills 
the uterine cavity; and with fusion of the decidua capsularis and 
parietalis, the uterine cavity is obliterated. The decidua capsularis is 
most prominent at about the second month of pregnancy; at this time, it 
consists of decidual cells that are covered by a single layer of flattened 
epithelial cells without traces of glands; internally, it is in contact with 
the chorion laeve (Pritchard et al., 1985). 
1.2.2. The subcellular sites of action of progesterone and oestrogen 
The uterine cells undergo intense periods of proliferation, 
differentiation and then secretory activity during the normal menstrual 
cycle and pregnancy, initiated and modified by hormones, among which 
oestrogen and progesterone play specific roles. 
Oestrogen and progesterone are produced by the corpus luteum during 
the maternal menstrual cycle and corpus luteum/placenta during 
pregnancy. There is a general agreement that the sex steroids enter 
into cells by passive diffusion because of their lipophilic properties, 
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although it is difficult to rule out a facilitated transport of steroids into 
target cells through specific carrier molecules (Sakamoto et al., 1986). 
However, different suggestions regarding the mechanism of action of 
sex steroids within the cells have been put forward. 
The classic model was described as: steroid hormones interacted with 
cytosolic binding proteins. The hormone- receptor complex undergoes a 
process termed "activation" that resulted in an enhanced affinity of 
steroids for chromatin, followed by initiation of new nucleic acid and 
protein synthesis (Gorski and Gannon, 1976; Sakamoto et al., 1986). 
This classic theory was mainly based on the results from subcellular 
fraction studies. 
The study of steroid receptor biochemistry started with the pioneering 
works of Jensen and Jacobson (1962) with oestradiol. Soon identical 
studies were performed for both oestrogen and progesterone receptors by 
employing steroid binding assays (Bayard et al., 1978; Levy et al., 1980; 
Padayachi et al., 1987). All of the studies of oestrogen and progesterone 
receptors in the endometrium have analysed both cytosolic and nuclear 
receptors with high and specific affinity for their ligands (West and 
Brenner, 1985). 
It has been suggested that the ratio of cytoplasmic and nuclear 
receptors was under the influence of their ligands. When the 
circulating level of sex steroids increased, there was a rise of the 
respective receptors, but mainly in the nuclear compartment, as in the 
case of normal menstrual cycle (Bayard et al., 1978). In addition, the 
acute injection of oestrogen and progesterone resulted in the increase of 
the steroid -binding components in the nuclear fraction (King et al., 
1965; Gorski et al., 1968; O'Malley et al., 1971; Mueller et al., 1972; 
Jensen and DeSombre, 1973; Feil and Bardin, 1975; Gorodeski et al., 
1987). These results led to the conclusion that within the cell oestrogen 
and progesterone interacted with the unoccupied steroid hormone 
receptors forming a hormone -receptor complex upon hormone 
exposure. This process induced steroid receptor transformation to the 
actively biochemical form that was capable of penetrating the nucleus 
and binding to the specific region of chromatin, followed by a series 
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responses within the target cells (Gorski et al., 1968; Jensen and 
DeSombre, 1972). 
However, this classical view about the mechanism of steroid action has 
been challenged within the past few years. Initially using cellular 
enucleation method without the dilution/extraction artifacts, the 
receptor -DNA ratio was constant in all fractions, suggesting that 
unoccupied oestradiol receptors were loosely bound to the nucleus and 
only released into the cytosol during the extraction procedure (Welshons 
et al., 1984). Then, with the development of highly specific monoclonal 
antibodies of steroid receptors which were able to recognize both 
unoccupied and occupied steroid receptors (Press and Greene, 1988), it 
became possible to visualize the receptor proteins in situ in the intact 
cells. Most of the immunocytochemical procedures were performed on 
the frozen sections to avoid any procedures which could result in 
redistribution and extraction of steroid receptors (King and Greene, 
1984; Press and Greene, 1984; Bergeron et al., 1988b; Garcia et al., 1988). 
The results from the immunocytochemistry studies revealed that the 
specific staining of steroid receptors was only localized in the nucleus 
and no detectable cytoplasmic staining at the level of the light 
microscope has been reported yet. Furthermore, it has been 
demonstrated that the newly synthesized progesterone receptors in the 
cytoplasm in the absence of ligand rapidly entered the nucleus 
(Guiochon -Mantel et al., 1989). However, with electron microscopy, 
there were small amounts of progesterone receptor localized in the 
cytoplasm (Perrot- Applanat et al., 1986). 
Taken collectively, a new view of the mechanism of the steroid action 
has been proposed: steroid receptors were nuclear proteins which were 
synthesized in the cytoplasm in absence or presence of steroid hormones 
and rapidly entered the nucleus where they became loosely bound to the 
chromatin. Only occupied and transformed receptors were tightly 
bound to chromatin to induce the responses in the target cells. Their 
appearance in the cytosol in the subcellular fraction studies presumably 
reflected the fact that some nucleoplasmic proteins were released from 
the nuclei after tissue disruption during homoginization (Gorski et al., 
1986; Sakamoto et al., 1986; Savouret et al., 1988; Brenner et al., 1990). 
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1.2.3. The regulation of oestrogen and progesterone receptors 
Studies on the regulation of oestrogen and progesterone receptor 
contents in target tissue are fundamental to the understanding of 
steroid hormone action. Despite the drawback of the ligand binding 
assays as discussed above, they remain the standard quantitative 
methods for analysing steroid receptors. 
Progesterone receptor was controlled by oestradiol and its own ligands. 
This general model of double regulation (oestrogen and progesterone) of 
progesterone receptor has been confirmed in the studies on the 
endometrium of higher non -human primates and the human. In the 
follicular phase of normal menstrual cycle, the level of progesterone 
receptor was parallel to the oestradiol level in the serum, whereas 
during the luteal phase there was a decrease in progesterone receptor 
as the progesterone produced by corpus luteum increased (Bayard et al., 
1978; Kreitmann -Gimbal et al., 1980). Upon oestrogen administration, it 
has been further revealed that progesterone receptor was oestradiol 
induced and dependent (Gorodeski et al., 1988). However, this oestrogen 
induced increasing progesterone receptor was prevented by injection of 
progesterone in the artificially induced endometrial cycle in the women 
with gonadal dysgenesis or postmenopausal women (Kreitmann- 
Gimbal, et al., 1979; Lubbert et al., 1982). These observations reinforced 
results from an in vitro study where physiological concentration of 
oestrogen promoted the dose -dependent increases in progesterone 
receptor level in human endometrial cells (Eckert and 
Katzenellenbogen, 1981). 
In terms of the regulation of oestrogen receptor, the increase of 
oestrogen level in the plasma in normal menstrual cycle (Kreitmann- 
Gimbal et al., 1980; lubbert et al., 1982; Ghosh and Sengupta, 1988) and 
in the artificially induced cycle (Tseng and Gurpide, 1975; West and 
Brenner, 1985) resulted in an increase of oestrogen receptor, while 
progesterone appeared to down -regulate oestrogen receptor. Thus these 
results suggested the concept that oestrogen receptor was stimulated by 
its own ligands and inhibited by progesterone. 
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The steroid binding assay allows quantification of the receptor, but it 
can not identify variations of steroid receptors in different cell types. 
Nevertheless, the detailed investigation of the cellular change in both 
oestrogen and progesterone receptors using immunocytochemistry have 
confirmed the general regulation model of sex steroid receptors obtained 
from steroid binding assays, that is oestrogen upregulated both sex 
steroid receptors, while progesterone caused down -regulation of both 
oestrogen and progesterone receptors (West et al., 1987; Bergeron et al., 
1988a; Bergeron et al., 1988b). However, immunocytochemistry also 
showed that variations of steroid receptors existed in different cell types 
during the different stages of the menstrual cycle. Oestrogen receptor 
content changed synchronously in both glandular epithelia and stromal 
cells upon the different hormonal status of the menstrual cycle 
(Welshons et al., 1984; Lessey et al., 1988). The distribution of 
progesterone receptor in the endometrium seemed to be cell type 
dependent and had complex patterns. The depletion of progesterone 
receptor was most marked in glandular epithelium when progesterone 
levels rose during luteal phase, while stromal cells still maintained a 
significant progesterone receptor content (Lessey et al., 1988; Press et 
al., 1988). In ovariectomized monkeys progesterone receptor was 
restricted to the glandular epithelium, while, after oestrogen treatment, 
progesterone receptor was observed in luminal and glandular epithelia 
as well as stromal cells and oestrogen enhanced the staining intensity 
of oestrogen receptor in all cell types (Okulicz et al., 1989). Segregation 
of function through alteration of receptor content may be an important 
mechanism in steroid dependent growth and differentiation of target 
tissue. 
The presence of oestrogen and progesterone receptors was also observed 
by immunocytochemistry in the muscle cells of uterine arteries, but not 
in the endothelium of uterine arteries nor in uterine capillaries or veins 
(Perrot -Applanat et al., 1988). The intensity of progesterone receptor 
staining in the uterine vasculature was still under the control of 
oestrogen. These results suggested that sex steroid hormones may 
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regulate uterine blood flow through a direct effect on uterine arterial 
walls. 
Recently, a new concept of stromal- epithelial interaction has been put 
forward which was based on the study of the luteal -follicular transition 
period. In either natural or artificial luteal- follicular transition 
periods, oestrogen and progesterone receptors were only detectable in 
stromal but not epithelial cells, when the epithelial cells underwent 
various oestrogen and progesterone- dependent events (Brenner et al., 
1990). These results suggested the presence of soluble mediators that 
transmitted information between the stroma and epithelium in the 
endometrium. 
Although the regulation of steroid receptors of non -pregnant uterus has 
been extensively examined, there is little information about the control 
of sex steroid receptors during pregnancy. Oestrogen receptors in 
decidua could be increased by treatment with RU 486 implying that the 
inhibitory action of progesterone on oestrogen receptors still existed in 
the decidua during pregnancy (Haluska et al., 1990). This was further 
confirmed by in vitro decidual cell culture (Takeda and Leavitt,1986). 
The results from binding assays showed that the decidua in early 
pregnancy was characterized by a large concentration of progesterone 
receptor (Levy et aí.,1980) and both sex steroid receptors could be 
identified in term decidua (Khan- Dawood and Dawood. 1984). The latter 
study was disputed by the results from Padayachi (Padayachi et al., 
1987) in which oestrogen and progesterone receptors decreased to 
undetectable level at term pregnancy. During pregnancy the local 
factors derived from placenta might play an important role in the 
regulation of steroid receptors. 
1.2.4. Decidnali tion 
1.2.4.1. Morphological and biochemical changes in stromal cells 
associated with decidualization 
Decidualization begins in the human endometrium during the last 
week of normal ovulatory cycle, even in the absence of conception 
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(Maslar and Riddick, 1979). The transformation of stromal cell into 
decidual cell was characterized by the increased cell proliferation, 
morphological changes and an alteration with biochemical features of 
all cells. 
In the of follicular phase of menstrual cycle, before decidualization, 
there is an active proliferation of stromal cells in the endometrium. 
These stromal cells then differentiate in the late luteal phase and 
pregnancy into decidualized cells. The stromal cells enlarged when 
they started to decidualize and continued to increase in size as they 
gradually differentiated into the large epithelium -like polyhedral 
decidual cells (DeFeo, 1967). Decidualization first appeared in the 
vicinity of the spiral arterioles at day 22 -23 of the menstrual cycle. By 
day 25, the decidual reaction has spread from the periarteriolar region 
into the subcapsular region, and during the final 2 days of the cycle the 
upper two -thirds of endometrium are composed of the decidualized cells 
(Finn, 1977). If pregnancy occurred, the decidual reaction persisted. 
The ultrastructural changes induced by decidualization in the stromal 
cells consisted of an increase in rough endoplasmic reticulum, 
filaments (Enders et al., 1985) and development of gap junctions which 
were considered as ultrastructural marker of decidual differentiation 
(Lawn et al., 1971). 
Decidual cells rich in glycogen and lipid (Glasser, 1986) were 
surrounded by basement membrane components that contained 
laminin, fibronectin, type IV collagen and heparan sulfate proteoglycan 
(Wewer et al., 1985). Of these substances, laminin and fibronectin were 
derived from decidua tissue (Irwin et al., 1989). The changes associated 
with enzymatic activities, such as alkaline phosphatase, sulfatase and 
cell proliferation, have been used as markers of decidualization (Bell, 
1983; Irwin et a..,1989; Benedetto et al., 1990). 
1.2.4.2. The control of decidualization 
It is widely accepted that in the human endometrium the induction of 
decidualization is solely under the influence of ovarian steroid 
hormones. Extensive histological studies have confirmed that during 
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natural ovulatory cycle or artificially induced cycle with sequential 
treatment of oestrogen and oestrogen with progesterone, decidualization 
occurred in the late luteal phase (Dallenbach- Hellweg, 1988). Moreover, 
during ectopic pregnancy stromal cells also underwent decidual 
reaction. This in vivo model emphasized that decidualization in 
human, in contrast to animals, was a spontaneous phenomena that 
occurred in the presence of functional corpus luteum and did not 
require the local presence of an embryo. Studies in vitro confirmed that 
decidualization was induced by treatment of proliferative endometrium 
with progesterone alone during in vitro culture, and maintenance of 
decidualization was dependent on progesterone (Daly et al., 1983a; 
Maslar and Ansbacher, 1986). 
While the role of oestrogen on decidualization is less defined, Daly et al 
(1983a) reported that oestrogen slowed the rate of progression of 
progesterone induced decidualization assessed histologically. In 
contrast, Irwin et al (1989) observed that concurrent oestrogen 
treatment could enhance progesterone induced -decidualization upon 
cell culture, which was consistent with the known induction of 
progesterone receptor by oestrogen in human endometrial cells as 
discussed before. Moreover, oestrogen was clearly the major stimulator 
of cell growth and proliferation in uterus (Pavlik and Katzenellenbogen, 
1978), which was a direct prerequisite for decidualization (Bell, 1983). 
Furthermore, oestrogen priming was important for the subsequent 
protein secretion by decidua (Seppala et al., 1988). Thus, oestrogen 
might be indirectly involved in the control of decidualization. 
During pregnancy, the factors from feto- placental unit may augment 
and maintain the decidualization initiated by steroid hormones. Firstly, 
large amounts of progesterone and oestrogen derived from placenta 
replace that produced by corpus luteum to maintain decidualization 
during pregnancy. Insulin -like growth factor (IGF) which is involved 
in proliferation of a number of cell types and its binding protein have 
been localized in decidual cells (Bell, 1989), implying potential role of 
IGF in regulating decidual cell differentiation. 
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In addition, a number of other proteins, such as pregnancy- associated 
endometrial a2- globulin (a2 -PEa), and epidermal growth factor, have 
also been suggested as possible factors in the induction of 
decidualization (Waites, et al., 1988, Yamamoto et al., 1989). 
1.2.4.3. The physiological and endocrine role of decidua 
Decidual cells contain high concentrations of glycogen and lipid 
implying a potential role for supplying nutrition to the blastocyst 
(Kearns and Lala, 1983). In vitro studies of interaction between human 
trophoblast and endometrium, showed that the trophoblast invasion 
was under the control of decidua (Kishimoto et al., 1987). Decidual cells 
were also believed to play a role in the protection of the embryo from 
maternal immune rejection (Golander et al., 1984). After 
decidualization, decidual cells were of functional secretory activity, and 
a variety of proteins have been isolated from human endometrium 
(Table 1). The exact role of these proteins remains to be clarified but 
some of them, especially PRL, have generally been accepted as the 
markers of decidualization (Yamamoto et al., 1989; Irwin et al., 1989). 
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Table 1.1. Human endometrial proteins 
Proteins 
Prolactin 
Placental protein 12 
Endometrial protein 14 
a -1 pregnancy -associated 
endometrial globulin 
Insulin -like growth factor - 
binding protein 
Placenta protein 14 
Progesterone- dependent 
endometrial protein 
Endometrial protein 15 
a -2 pregnancy- associated 
endometrial globulin 
Pregnsncy -associated 
plasma protein -A 
Placental protein 5 
Endometrial protein 1 -17 
Epidermal growth factor 




Tyson et al., 1972 
Whalstrom & Seppla, 1984 
Bell, 1986 
Bell, 1986 
Koistinen et al., 1986 
Julkunen et al., 1986 
Joshi et al., 1980 
Bell, 1986 
Bell, 1986 
Sjoberg et al., 1984 




Pihoker et al., 1991 
1.3. Identi.fica.tion of Decidual Prolactin 
In the early 1970's, high levels of PRL were found in amniotic fluid 
throughout gestation ( Tyson et al., 1972). Since then, extensive studies 
have been carried out to identify the similarities and dissimilarities 
between pituitary PRL and PRL derived from amniotic fluid. On the 
basis of molecular size, net charge and isoelectric point upon 
polycrylamide gel electrophoresis and isoelectric focusing, human PRL 
from amniotic fluid is indistinguishable from pituitary PRL (Ben -David 
et al., 1973). Again this PRL was identical to pituitary PRL according to 
its chromatographic (Frame et al., 1979a), immunologic, biologic 
(Tornita et al., 1982a; 1982b), and receptor binding properties (Golander 
et al., 1978). In addition, cDNA for decidual PRL has been prepared 
and the amino acid sequence predicted from the nucleotide sequence of 
its cDNA was identical to pituitary PRL (Takahashi et al., 1984). 
1.4. The source of decidual PRL 
Initially the major source of PRL in amniotic fluid was thought to be 
from either maternal pituitary since the concentrations of PRL in 
maternal plasma was positively correlated with amniotic fluid PRL 
concentration and radiolablled PRL could pass from the mother to the 
amniotic cavity (Josimovich et al., 1974), or fetal origin since the 
molecular size heterogeneity of PRL in amniotic fluid differed from 
maternal PRL to a greater degree than fetal PRL (Fang and Kim, 1975). 
An extra -pituitary origin of amniotic fluid PRL was suggested as result 
of experiments in monkeys in which neither maternal hypophysectomy 
nor fetal death decreased the concentration of PRL in amniotic fluid 
(Walsh et al., 1977). This indicated that neither the maternal pituitary 
gland nor a live fetus was necessary for the PRL accumulation in 
amniotic fluid. An extra -pituitary source of amniotic fluid PRL in 
women was further suggested since suppression of maternal and fetal 
pituitary PRL to very low levels with bromocriptine throughout 
pregnancy was not associated with any decline in the level of amniotic 
fluid PRL (Bigazzi et al., 1979a). Furthermore the changes in amniotic 
fluid PRL were not closely related in many cases with the changes in 
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plasma concentrations of PRL in either the mother or the fetus 
(Rosenberg et al., 1980). 
The precise tissue origin of amniotic fluid PRL remained to be defined 
until Riddick and Kusmik (1977) reported that among the tissues of the 
amniotic membrane, i.e. the chorion, placenta and decidua, the 
amount of PRL contained solely in decidua was significant enough to 
explain the origin of PRL in amniotic fluid. Moreover, neither the 
initial PRL content in the decidua nor the amount of PRL accumulated 
in the medium during in vitro tissue culture was significantly different 
when the tissues from normal and ectopic pregnancies were compared 
(Maslar et al., 1980). Therefore, it was suggested that the presence of 
cells of fetal origin within uterus was not essential for the production of 
PRL by the decidua of early pregnancy. Amniotic fluid PRL levels in 
early pregnancy were much higher than those of maternal serum in 
normal pregnancy (Schenker et al., 1975). However amniotic fluid PRL 
levels obtained from the ectopic pregnancy were found to be essentially 
within the normal serum range (Rosenberg, 1984), providing further 
support for an essential role of decidual tissue as the source of amniotic 
fluid PRL in vivo. PRL was then shown to be synthesized and secreted 
in the endometrium during the normal menstrual cycle (Maslar and 
Riddick, 1979) and during cycles artificially induced by sequential 
administration of sex steroid hormones (Taga et al., 1982), confirming 
that the production of PRL by the endometrium did not depend upon 
either conception or implantation. This concept was confirmed by 
experiments in vitro in which endometrium from the proliferative 
phase of the cycle was treated with progesterone and underwent 
decidualization and then secreted PRL. In this system, the initiation of 
PRL secretion in vitro corresponded to the onset on histologically 
apparent decidualization (Daly et al., 1983a; Maslar et al., 1986) and the 
degree of decidualization of stromal cells was proportional to the 
increase of PRL produced by endometrium (Morimoto, 1988). 
Confirmation was achieved by identification of a specific mRNA for 
decidual PRL by Northern Blot analysis using [32P]- labelled cDNA 
probes (Clements et al., 1983) and an in vitro translation system (Taii et 
al., 1984). Only decidua contained PRL mRNA: no PRL mRNA was 
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found in amnion, chorion or trophoblast confirming that the PRL gene 
was indeed expressed in human decidua. 
While these studies suggested that decidua in the utero -feto- placental 
unit was the only source of PRL in amniotic fluid, PRL had also been 
localized by immunocytochemistry in the amnion (Healy et al., 1977), 
chorion (Fram et al., 1979b; Bryant- Greenwood et al., 1987), the 
trophoblast (Al- Timimi and Fox, 1986) and in the cytoplasm of decidual 
cell (Meuris et al., 1980; Pileri et al., 1982; Kauma and Shapiro, 1986). 
As immunocytochemistry can not distinguish the sites of the synthesis 
from the sites of accumulation, it was not clear whether PRL was 
synthesized in all the PRL immunopositive cells or whether it is 
sequestered from an extracellular source. 
The exact cell type which is responsible for PRL production in decidua 
has not been conclusively localized. Several groups have attempted to 
isolate the PRL producing cells by a number of different methods. 
DeZeigler and Gurpide (1982) reported that PRL producing cells could 
be selected by taking advantage of slowness of their attachment to the 
culture dishes. Similarly PRL producing cells could be obtained from 
term decidua employing isopycnic centrifugation (Markoff et al., 1983a). 
Later, Bravermen et al. (1984) isolated purified decidual cells, 
distinguishable from epithelial cells, from early and mid pregnancy 
decidua which possessed immunocytochemically localized PRL and 
secreted PRL. According to different size of cells, PRL producing cells 
could be separated from fibroblast cells by selective filtration (Hochner- 
Celnikier et al., 1984). Results from these studies showed that PRL 
producing -cells were morphologically similar to decidual cells. 
1.5 Biochemical fate of decidual PRL 
The relatively low tissue contents of PRL measured in decidua 
(Golander et al., 1978) and in isolated decidual cells (Markoff, 1983a) 
and the finding of inhibition of PRL synthesis by cycloheximide 
treatment in expiants of decidua (Riddick et al., 1978) suggested that 
there was only limited storage of PRL in decidual cells. Further 
evidences were obtained by the studies that different subcellular storage 
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sites existed in decidua- and pituitary- derived PRL following 
differential and density gradient centrifugations (Handwerger et al., 
1984). Almost all of the PRL in the pituitary was contained in 
mitochondrial and microsomal particulate fractions. Following 
centrifugation on sucrose density gradients, they sedimented in a 
fraction associated with secretory granules. In contrast, decidual PRL 
was detected in the post- microsomal supernatant, and was distributed 
diffusely throughout the gradients, suggesting that the PRL in decidua 
was not stored in secretory granules. Moreover, no chromogranin, a 
major protein component of secretory vesicles, was localized in the 
decidual cells by immunocytochemical techniques, in contrast again to 
the strongly positive staining in pituitary cells ( Handwerger and Capel, 
1985). It is therefore concluded that decidual PRL is not stored in the 
tissue and it is secreted soon after its synthesis. 
After PRL is released from decidua, it will be accumulated in the 
amniotic fluid by passing through the amniotic membrane. This 
assumption has been confirmed by in vitro study employing a double 
chamber system divided by amniotic membrane. The large quantities 
of PRL produced by the decidua crossed the fetal membrane to the 
amniotic side readily (Riddick and Maslar, 1981). This study was 
extended to demonstrate that the newly synthesized human decidual 
PRL was transported from the maternal to the fetal surface of the 
membrane within 4 hours and the biologic activity of decidual PRL 
determined by bioassay was retained after its transport (McCoshen and 
Barc, 1985). However, such transport required the intimate adhesion of 
decidua to amniochorion (McCoshen et al., 1982a). 
During the normal menstrual cycle, no PRL was detectable in the 
proliferative phase upon in vitro tissue culture. After day 22 to 24 days 
of the cycle, PRL could be measured in the medium of cultured decidua 
(Maslar and Riddick, 1979). Generally, most of endometrium dated 25 
to 28 days contained measurable amounts of PRL. During very early 
pregnancy, a significantly higher concentration of decidual PRL 
accumulated in the cultured medium was associated with those tissues 
in which definitive villi were identified ( >2 weeks post conception) 
compared to those in which the syncytiotrophoblast had not yet 
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differentiated extensively ( <2 weeks post conception) (Maslar et al., 
1980). The concentration of PRL in amniotic fluid appeared to peak 
between 16 to 20 weeks, and then decreased to a plateau around week 36 
(Kletzky et al., 1985). This decrease was probably due to the dilution by 
the continually increasing volume of amniotic fluid, while PRL 
production by decidua was still constant (McNeilly et al., 1977). 
1.6. The regulation of synthesis and release of decidual prolactin 
1.6.1. Dopamine and thyrotropin- releasing hormone (TRH) 
Although decidual PRL is indistinguishable from pituitary PRL, a 
diversity of studies have shown that factors regulating the synthesis 
and release of decidual and pituitary PRL were distinct. The first 
striking difference in control of PRL production was that dopamine and 
dopamine agonist drugs given in vivo (Bigazzi et al., 1979a) or in vitro 
(Golander et al., 1979) had no inhibitory effect on decidual PRL 
secretion. Similarly, Thyrotropin -releasing hormone, the potent 
stimulator of pituitary PRL, failed to affect PRL secretion from decidual 
in in vitro studies (Golander et al., 1979), the mechanism for which 
might be related to the lack of the corresponding receptors in decidual 
cells (Bigazzi et al., 1979a). 
1.6.2. Oestrogen and progesterone 
As the decidual cell is one of the main targets of oestrogen and 
progesterone, extensive studies have been carried out to examine the 
effect of these steroid hormones on decidual PRL production. 
Progesterone appeared to be essential for the initiation and 
maintenance of decidual PRL production in the endometrium from the 
normal menstrual cycle (Maslar and Ansbacher, 1986; Maslar et al., 
1986; Maslar and Ansbacher, 1988). Decidual PRL production 
increased in response to progesterone in a dose and time dependent way 
(Casslen et al., 1990), with inhibition by the antiprogesterone RU 486 
(Bischof et a1., 1986; Chen et al., 1989). The induction and maintenance 
of decidual PRL production was related to the mechanisms causing the 
decidualization (Maslar and Ansbacher, 1986) and the ability of 
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endometrium to produce PRL corresponded to the degree of 
decidualization (Maslar and Riddick, 1979). 
The potential regulatory role of oestrogen is contradictory. Some 
studies showed that oestrogen alone had either no effect or decreased 
the rate of decidual PRL production (Daly et al., 1983a; Huang et al., 
1987), while others demonstrated that oestrogen, especially in 
combination with progesterone, was able to stimulate or modify 
decidual PRL production (Randolph et al., 1990; Casslen et al., 1990). 
The modified effect of oestrogen on progesterone- induced decidual PRL 
production might be due to its action of increasing progesterone 
receptors in vivo and in vitro as stated before. 
During pregnancy, the regulatory role of oestrogen and progesterone is 
less defined. Oestradiol alone was without effect on decidual PRL 
production (Daly et al., 1983b), while in combination with progesterone 
had the effect of maintaining PRL production observed in early 
pregnancy (Maslar et al.,1988). Progesterone alone seemed to have little 
or no effect on PRL production by decidua obtained from either early 
(Maslar et al.,1988; Ren and Braunstein, 1990) or term pregnancy 
(Rosenberg and Bhatnagar, 1984). However, in short -term cultured 
explants of decidua obtained at Caesarean section, progesterone was 
capable of stimulating decidual PRL secretion, which was abolished in 
labour -exposed decidua (Daly et al., 1983b). Thus the effect of 
progesterone may only be facilitative, maintaining decidual 
differentiation, and PRL production is only associated with the presence 
of progesterone - dependent differentiated decidual cells. 
By examining decidual PRL mRNA levels in steroid hormone 
stimulated endometrium, it was shown that the increase in PRL 
production rate elicited by these sex steroids was accompanied by an 
increase of PRL mRNA in decidual cells (Huang et al., 1987). However, 
it is still not clear whether the accumulation of PRL mRNA in decidua 
was due to facilitated PRL gene transcription or PRL mRNA 
stabilization, or an overall increase in cellular metabolism, protein 
synthesis and cell differentiation. 
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1.63. Factors derived from the Utero- placental unit 
It has been suggested that decidual PRL production is controlled by 
complex regulatory mechanism, operating at the local level. Insulin 
stimulated both acute secretion and de novo synthesis of decidual PRL 
(Thraikill et al., 1989). Insulin -like growth factor I (IGF -I) was also a 
potent stimulator, with marked effects on decidual PRL release, 
mediated through specific insulin -like growth factor I receptors 
(Thraikill et al., 1988). Human chorionic gonadotropin (hCG), a major 
protein produced by placenta, given repeatedly, failed to induce and 
stimulate PRL production from the endometrium of normal menstrual 
cycle (Ying et al., 1988), early pregnancy (Ren and Braunstein 1990) or 
term pregnancy (Handwerger et al., 1983). However, a single study 
reported a stimulating effect of hCG at a specific dose on decidual PRL 
secretion (Rosenberg and Bhatnagar, 1984). 
A decidual PRL- releasing factor has been semi -purified from placenta 
and the conditioned medium from human placental explants 
(Handwerger et al., 1987a). This PRL releasing factor was heat (56 °C 
for 30 minutes) and pH (pH 3.0 -10.0) stable, unaffected by lipid 
extraction and sensitive to proteolytic digestion, with a molecular 
weight of 23.5 kilodalton . It was able to induce biphasic stimulation of 
synthesis and secretion of decidual PRL (Handwerger et al., 1983; 
Golander et al., 1988). In contrast, an inhibitory effect associated with a 
factor from decidua on decidual PRL secretion has been reported 
(Markoff et al., 1983b). Again, arachidonic acid, a precursor of 
prostaglandins, appeared to inhibit decidual PRL production in a dose 
dependent manner, although prostaglandins applied directly had no 
effect on PRL production by decidua (Handwerger et al., 1981), which 
suggested that arachidonic acid did not appear to be mediated by a 
cyclooxygenase product of arachidonic metabolism. Lipocortin -I, a 
family of calcium -dependent phospholipid- binding proteins present in 
the local environment derived from decidua and placenta inhibited 
decidual PRL production and blocked the stimulating effect of PRL 
production by decidual PRL -releasing factor (Pihoker et al., 1991). All 
these results demonstrated that local factors from utero- fetal -placental 
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unit played important roles in regulating decidual PRL production, 
although the relative importance of each of the factor remains unclear. 
1.6.4. Intracellular signsilling systems 
A number of studies have investigated the relationship between 
decidual PRL production and the environment of the extracellular 
osmolality. In a longer term exposure of decidual explants to a 
hyperosmotic environment produced by sodium chloride within a range 
of 351 mmol/kg to 457 mmol/kg, decidual PRL production was 
significantly increased (Andersen et al., 1982). This effect was not 
specific to sodium chloride and also occurred at the specific 
hyperosmolality of 387 mmol/kg, with potassium chloride, mannitol, 
sucrose or choline chloride (Andersen et al., 1984). This 
hyperosmolality -affected PRL secretion from human decidua was 
prevented by ouabain, a cardiac glycoside blocking the Na +/K+ pump 
(Andersen et al., 1986). In addition, hyposmolality had an opposite, 
inhibitory effect on decidual PRL production (Andersen et al., 1982). All 
these results indicated that intracellular ionic concentrations were of 
importance in the regulation of the synthesis and secretion of decidual 
PRL in vitro. This concept has, however, been disputed by Markoff et al. 
(Markoff et al., 1982), who had shown no effect of changes in osmolality 
up to 336 mOsm/kg on decidual PRL production. Extracellular calcium 
was required for basal secretion of decidual PRL, although the calcium - 
calmodulin complex inhibitor trifluoperazine had no inhibitory effect on 
decidual PRL secretion (Richards et al., 1982). 
Activation of the adenylate cyclase- cyclic AMP system and protein 
kinase C by 12- O- tetradecanoylphorbol -13- acetate (TPA), testing 
diacylglycerol/inositol triphosphate system, inhibited acute release of 
PRL production from decidua (Handwerger et al., 1987b; Harman et al., 
1986), but it is still uncertain of the long term action of TPA on decidual 
PRL production. Gellersen et al. (1989b) reported that, in long term, 
TPA reduced PRL mRNA in the human B- lymphoblastoid cell line IM- 
9-P3, which ectopically produced PRL resembling decidual PRL with 
regard to its similar molecular size of PRL mRNA and identical 5' 
untranslated gene structure (DiMattia et al., 1990), very small 
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intracellular PRL pool and the unresponsiveness of those cells to many 
secretagogues controlling pituitary PRL secretion. These observation 
that both cAMP and protein kinase C activation inhibited the release of 
decidual PRL clearly indicated that there were striking differences in 
the intracellular mechanisms involved in the synthesis and release of 
decidual PRL from those of most other peptide hormones, including 
pituitary PRL. 
Unlike pituitary PRL, decidual PRL was not stored in the secretory 
granules as discussed above, explaining perhaps the different 
mechanisms of control of PRL synthesis and secretion operation in 
these tissues. In addition, the different gene structure in the DNA 
regulatory region as discussed later in this review might be the main 
reason that resulted in the marked regulatory difference between 
decidua and pituitary PRL. Furthermore, decidual cells did not possess 
the cell surface gangliosides A2B5 and 3G5, which were features 
shared by all anterior pituitary and other endocrine cells that 
synthesize and release protein hormones (Handwerger and 
Cape1,1985). The decidual cells thus appear to represent a unique 
protein hormone -producing cells different from the classical protein 
hormone -secreting cells. 
1.7. The physiological function of decidual PRL 
1.7.1. The localization of PRL receptors in utero-feto-placental unit 
Since interaction with receptors is assumed to be the first step in the 
mechanism of action of protein hormones, a mandatory prerequisite for 
any biological action of decidual PRL would be the demonstration of 
PRL receptor. PRL receptors have been identified in human chorion- 
decidua (McWey et al., 1982), chorion laeve (Herington et al., 1980) and 
amnion (McCoshen et al., 1982b; Jayatilak and Gibori, 1986). The 
binding parameters of PRL receptor in these tissues were similar to 
those of other recognised PRL target tissues. Similarly, 
immunocytochemistry techniques have revealed PRL in amnion (Healy 
et al., 1977), chorionic cytotrophoblast (Bryant- Greenwood et al., 1987) 
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1987) and placenta (Pileri et al., 1982). These studies suggested an 
auto /paracrine role of decidual PRL. 
1.7.2. Effect of PRL on water and minerals across the fetal membrane 
It has been suggested that decidual PRL might function as an osmo- 
regulator, modulating water and electrolyte transport across the fetal 
membrane in a manner similar to the effects of PRL on water and ion 
transport in lower vertebrates. Several investigators have displayed a 
role for decidual PRL in the regulation of amniotic fluid volume and 
mineral content (Tyson et al., 1984; Raabe and McCoshen,1986), as PRL 
altered the permeability of human chorioamnion to these materials 
(Holt and Perks, 1975; Leontic and Tyson, 1977; Stray- Pedersen, 1982). 
These findings were supported by an in vivo study in which the 
injection of PRL into the amniotic fluid of rhesus monkeys reduced and 
prevented the rapid changes in the movement of sodium, potassium 
and water across the fetal membrane following the alteration in tonicity 
of the amniotic fluid (Josimovich et al., 1977). Regardless of the 
experimental design, it appeared that the fetal membrane response was 
specific to the presence of PRL, since addition of anti -prolactin or anti - 
prolactin receptor antibodies completely negated the effect of PRL 
(Leontic and Tyson,1977). Furthermore, a clinical study in the women 
with chronic polyhydramnios has shown there were a reduced number 
of PRL receptors in the chorion laeve of these patients (Healy, 1982; 
1985). It was suggested that this chronic PRL receptor defect might 
cause the development of chronic polyhydramnios. Hence, there seems 
little doubt that PRL affects the water and minerals transport across the 
amniotic membrane and in human it may also protect the extracellular 
fluid volume of the fetus. However, decidual PRL only increased water 
flow from the fetal to the maternal compartment and when PRL was 
added to the maternal side of the amniotic membrane, no effect on 
water volume rate was noted (Andersen, 1982). Thus both the 
mechanism and the physiological role and importance of these effect of 
PRL on fluid balance remain to be established conclusively. 
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1.7.3. Effect on fetal lung maturation 
Decidual PRL has also been implicated in the regulation of fetal lung 
maturation, through activation of surfactant synthesis in the basis of 
both experimental and clinical evidences (Hamosh and Hamosh, 1977; 
Grosso et al., 1980). PRL receptors appeared to exist in the fetal lung 
and PRL stimulated phosphatidycholine generation in explant cultures 
of fetal lung (Mendelson et al., 1981). Large quantities of decidual PRL 
are present in the amniotic fluid allowing decidual PRL gain access to 
the fetal tracheobronchial tree. However, such a role for decidual PRL 
on fetal lung maturation was disputed by a study showing an absence of 
a positive relationship between amniotic fluid PRL level and other 
indices of fetal lung maturity, such as, the ratio of 
lecthin/sphingomyelin and the palmitic /stearic acid (Diani and 
Perdelli, 1981). 
1.7.4. Other effects of decidual PRL 
In women, periarteriolar decidualization began from day 23 of the 
menstrual cycle and was exclusively under the control of oestrogen and 
progesterone. PRL was detected in endometrium after day 23 of the 
cycle and its production increased as decidualization spread through 
the endometrial stroma (Maslar and Riddick, 1979). Obviously this 
process proceeded precisely at the time when implantation normally 
occurs. Moreover, decidual PRL generation was low in infertile women 
with a luteal phase defect endometrium (Daly et al., 1981). These 
findings suggested a role for endometrial PRL in implantation. 
Furthermore, PRL receptors were apparently present in the decidual 
cells as discussed above, producing the basis for PRL interaction with 
decidual cells. 
It has also been suggested that decidual PRL may be involved in the 
control of parturition through the mechanism of the modulation of 
prostaglandin synthesis in the fetal membrane (Healy, 1984; Tyson et 
al., 1985), the stimulation of oestrogen sulfatase activity of decidual cells 
to increase the level of oestrogen (Braverman and Gurpide, 1986), the 
regulation of the uterine contractility (Horrobin, 1973) and prevention of 
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the immunological rejection of the blastocyst and fetus (Karmali et al., 
1974). However, conclusive support for many of these proposed roles 
remains to be investigated. 
1.8. Decidual PRIA gene expression 
Under normal physiological conditions expression of the human PRL 
gene is tissue specific, restricted to the anterior pituitary and the 
decidua. Comparing the understanding of the regulatory mechanism 
of controlling PRL gene expression in pituitary with decidua, much 
less is known about the regulation of the gene expression in decidua. 
Decidual PRL was first localized in the term decidua -chorion by 
Northern blot hybridization, with a demonstration of a similar sized 
PRL mRNA coding for PRL in decidua and pituitary when comparing 
PRL mRNA from human decidua -chorion with PRL mRNA from ovine 
pituitary (Clements et al., 1983). The existence of PRL gene expression 
in decidua was further confirmed by an in vitro translation system, in 
which only decidua contained detectable amounts of PRL mRNA 
among amnion, chorion and decidua (Taii et al., 1984). 
Further work was carried out to determine the similarities and 
dissimilarities between the PRL gene sequence in the pituitary and 
decidua in order to understand the regulation of PRL gene expression 
in decidua. The nucleotide sequence of decidual PRL mRNA was 
determined from a 807 base pair cDNA clone that contained a coding 
region corresponding to 18 amino acid residues of the signal peptide, 
199 amino acids of the mature protein, and 157 nucleotides of the 
3'untranslated region (Takahashi et al., 1984). This was very similar to 
the full structure of the pituitary PRL deduced from a 914 base pair 
cDNA clone of pituitary adenomas, consisting of a 28 amino acid signal 
peptide and 199 amino acids of the secreted protein (Cooke et al., 1981). 
It was therefore assumed that, since there was only a single copy of the 
human PRL gene, the human pituitary and decidual genes were 
identical in structure. 
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In contrast to the PRL protein coding sequence in decidua being 
identical to that in the pituitary, a recent study has revealed that 
decidual PRL mRNA was approximately 150 nucleotides longer than 
the transcript from the pituitary. The size difference to pituitary PRL 
mRNA persisted after RNase H digestion of Poly(A) tails, excluding the 
possibility the the elongation was due to a longer poly(A) tract 
(Gellersen et al., 1989a). The elongation was therefore not attributed to 
differences in the protein coding region or in the degree of 
polyadenylation and was suggested to reside in the 5' untranslated 
region of the molecule, which implied the usage of a transcription 
initiation site different from that in the pituitary PRL gene. 
More direct evidence for the presence of elongated 5' untranslated 
regions of decidual PRL mRNA was obtained from the sequence of 
isolated decidual PRL cDNA. It has now been demonstrated that 
decidual PRL mRNA similar to the PRL mRNA from a human B- 
lymphoblast cell line IM -9 -P3 and possessed identical 5' ends having 5'- 
untranslated sequence of 83 -263 nucleotides longer than that of the 
pituitary PRL mRNA, located as a new 5'- noncoding exon 5 -7 kilobase 
pairs upstream of the human pituitary PRL gene, exon 1 (DiMattia et 
al., 1990). A similar finding was obtained by Hiraoka et al. (1991), in 
which it was shown that the placental PRL mRNA was encoded by six 
exons including the placenta -specific exon, named as exon 0, which 
was located 5.3 kilobase upstream of exon 1 of the pituitary mRNA. In 
addition, the PRL gene in the decidua contained a placenta -specific 
promoter other than the pituitary -specific promoter, since the 
transcription of the PRL gene in decidua started at a site located 87 
nucleotides or more upstream from the previously determined start site 
in pituitary. 
The molecular mechanism underlying the pituitary- specific 
transcription of the PRL gene is the presence of a DNA -binding 
transcription factor (trans- acting factor), Pit- 1/GHF1. This interacts 
with cis- acting elements located in the pituitary PRL gene regulatory 
region which was divided into the proximal and distal parts, each of 
which contained four binding sites for Pit -1 to direct transcription from 
PRL promoter in rat pituitary. In human pituitary, at least three 
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nuclear protein binding sites located in hPRL gene appear to bind with 
pit -1 (Davis, 1990). However, no Pit -1 binding consensus sequence was 
found within the 250 base pair sequence upstream of exon 0 (Hiraoka et 
al. 1991). Furthermore, no Pit -1 mRNA was expressed in decidua as 
revealed by polymerase chain reaction (PCR) (DiMattia et al., 1990) and 
Northern blot analysis (J. Brooks, J.R.G., Davis and A. McNeilly, 
unpublished observation, 1991). Thus, the mechanism of the different 
regulators controlling the synthesis and secretion of PRL from pituitary 
and decidua probably resides in the different regulatory structure of the 
PRL gene. Because cis - acting elements responsible for transducing 
regulatory signals from the cell membrane to the pituitary PRL gene 
are located in the immediate vicinity of the transcription initiation site 
associated with Pit -1 response elements (Elsholtz et al., 1986; Jackson 
and Bancroft, 1988), but this is not apparently the case for decidual PRL. 
1.9. The aims of this thesis 
The studies in this thesis were to investigate, in detail, the control of 
decidual PRL production by human decidua during pregnancy. Firstly, 
in Chapter 2, the exact cellular origin of decidual PRL was localized by 
co- localization of PRL and its mRNA in the utero- placental unit, as this 
was essential for the further determination of the relevant regulators of 
decidual PRL synthesis and release. 
In Chapter 3, the relationship between decidualization and PRL 
production at the different stages of pregnancy was examined using in 
situ hybridization and Northern blot to assess PRL mRNA level, 
immunocytochemistry to examine the PRL content inside the decidual 
cells and radioimmunoassay to measure PRL in amniotic fluid. 
Further studies in Chapter 4 were carried out to reveal how important 
the effect of progesterone on decidual PRL production was during early 
pregnancy by blocking the action of progesterone with mefipristone 
(RU486) in vivo, and to examine the effect of both oestradiol and 
progesterone on PRL production by human term decidual cells. In 
Chapter 5, the potential cells involved in mediating the effects of 
oestradiol and progesterone on decidual PRL production were 
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determined by immunochemical localization of receptors for both 
steroids in human decidua. 
In Chapter 6, the potential PRL releasing activity associated with the 
placenta and the intracellular signal transduction factors, cAMP and 
TPA, affecting PRL production, were investigated. Finally, in Chapter 
7, the potential reasons for the failure of dopamine to affect decidual 
PRL secretion were examined by, firstly, determing whether dopamine 
receptors were expressed in decidual cells and, secondly, by 
determining whether introduction of the dopamine D2 receptors into 




Localization of the Sites of Synthesis and Action of Prolactin by 
Immunocytochemistry and In Situ Hybridization within the 
Human Utero-placental Unit 
Part L Development of an in situ hybridization method to localize PRL 
mRNA in utero -placental unit 
2.1.1. Introduction 
In situ hybridization enables the precise localization and identification 
of individual cells that contain a specific nucleic acid sequence. When 
used together with immunocytochemistry, both mRNA transcribed 
from the gene itself and the gene product translated from mRNA can be 
identified. The aim of the study described in part I of this chapter was 
to develop an in situ hybridization technique, using a cDNA probe to 
human pituitary PRL, for precise anatomical localization of PRL 
mRNA within human utero- placental unit. Thus detection of both PRL 
and its mRNA in a particular cell type, which gave strong evidence for 
the site of synthesis, would be obtained by combining in situ 
hybridization with immunocytochemistry. 
To optimize in situ hybridization methodology with respect to 
morphology, sensitivity, and retention of target RNA, the following 
procedures were taken into account during developing this method: 
1. Fixation; 
2. Pretreatment of the tissue section; 
3. Composition of hybridization buffer; 
4. Temperature and duration of the hybridization; 
5. The degree of washing after hybridization. 
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2.1.2. Materials and methods 
2.1.2.1. Tissue collection and fixation 
The studies in these thesis were approved by the 
Paediatric /Reproductive Medicine Ethics of Medical Research 
Subcommittee of the Lothian Health Board, and all patients gave 
informed consent. 
Human early pregnancy tissue, calculated from the last menstrual 
period, was obtained by curettage during therapeutic abortions under 
normal anaesthesia. Tissue from term pregnancy was collected from 
patients with uncomplicated deliveries at 37 -40 weeks. Fresh tissue 
was received at theatre/labour ward and put on ice immediately where 
early pregnancy tissue was isolated into decidua or trophoblast, while 
several small pieces of placenta and membrane including amnion, 
chorion and decidua were cut from placenta and fetal membrane. 
Tissue was then fixed in the following fixative: 
1. 4% paraformaldehyde in 0.01 M Phosphate Buffer Saline (PBS), pH 
7.4 for 24 h at room temperature (RT); 
2. 0.25% and 2.5% glutaraldehyde in 0.01 M PBS, pH 7.4 for 24 h at 4°C. 
The fixed tissue was then processed on a standard tissue processor and 
embedded in paraffin wax. The sections were cut at 5 µM, floated onto 
poly -L- lysine coated slides (See Appendix 1 for preparation of poly -L- 
lysine coated slides), and dried at 55 °C overnight. 
Frozen sections were assessed for comparing with the paraffin 
sections (See Chapter 5 for the method of preparation of frozen tissue). 
51.1.M frozen sections were fixed in 4% paraformaldehyde for 10 min. 
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2.1.2.2. Pretreatment of the sections 
For paraffin sections, the following schedules of pretreatment were 
tried (The method of preparation of all solutions used for in situ 
hybridization are detailed in Appendix 2): 
1. Sections were pretreated with 0.2 M HC1 for 20 min at RT and 2XSSC 
at 70°C for 10 min; 
2. Pretreated with 0.2 M HC1 for 20 min at RT and with prewarmed 
2XSSC at 70 °C for 10 min, followed by 1, 5 or 10 µg/m1 proteinase K in 
0.1M Tris/HC1, pH7.5, 2 mM CaC12 for 30 min at 37 °C; 
3. Pretreated with or without acetic anhydride. 
2.12.3. Preparation of radiolabelled cDNA probe 
The human PRL cDNA (0.96 Kb, ID p06715) was kindly donated by the 
Repository of Human DNA Probes and Libraries American Type 
Culture Collection, Rockville, MD, USA. It was labelled with [35S] 
dCTP for in situ hybridization and with a[32P] dCTP for Northern 
blotting by the method of Feinberg and Vogelstein (1983) using a 
random primed DNA labelling kit (Boehringer Mannheim, Lewes, 
Sussex, UK; the detailed labelling method is shown in Appendix 3). 
2.1.2.4. Composition of hybridization buffer 
By considering the factors affecting the stability of hybrids, such as salt 
strength, temperature, probe concentration and hybridization time, the 
following composition of hybridization solution was chosen 
(Preparation of stock hybridization solution is described in Appendix 2): 
50% deionised formamide 
5X SSPE 
4% dextran sulphate 
0.1% denhart's 
200 µg/ml tRNA 
200 gg/ml stDNA 
0.1% SDS 
10 mM DTI' 
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Prehybridization buffer was prepared using DEPC treated water 
instead of dextran sulphate because it made the buffer too viscous and 
consequently was difficult to be removed prior to application of the 
hybridization buffer. The sections were incubated in 70 p.1 of 
prehybridization buffer at 42 °C for 1 h. In the meantime, the labelled 
probe was thawed and denatured in boiling water for 10 min, then 
transferred immediately to ice for 5 min to prevent reannealing of the 
probe, and added directly to prewarmed hybridization buffer. The 
buffer and probe were then maintained at 42 °C in the oven until use. 
The hybridization was carried out at 42 °C in hybridization buffer 
containing heat denatured [35S] -PRL -DNA probe at a concentration of 
15x106 cpm/ml. Each slide containing 60 -70 pl hybridization buffer with 
probe was covered by an acetone cleaned coverslip, and kept in the 
humified boxes. Different probe concentrations (1x106 cpm/slide and 
1.5x106 cpm/slide) and hybridization time (18 h or 36 h) were tried to 
increase the signal -to -noise ratio. 
Sections were treated with pancreatic RNAse (20 µg/ml) (Sigma) as a 
negative control in RNAse buffer (20 mM Tris/HCl pH7.6, 1mM EDTA) 
for 30 min at room temperature before the hybridization procedure. 
The slides were then rinsed in 3 changes of 2XSSC (5 min each). The 
hybridization with probe was performed exactly as described above. 
2.1.2.5. Washes 
The following different washing steps were compared to assess the 
effect on background levels: 
Solutions Schedule 1 schedule 2 Schedule 3 
2XSSC (RT) 4 X 30 min 2Xlh 1X2h 
1XSSC (RT) 4 X 30 min 2Xlh 1X2h 
0.5XSSC (RT) 1 X i h 2 X 30 min iXih 
0.5XSSC (370C) 1 X 1 h iX1h 1Xih 
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Following the washes, the slides were dehydrated by passing for three 
min each through an alcohol series ( 50 %, 85 %) containing 300 mM 
amonium acetate to stabilize the hybrids, and then one change of 100% 
alcohol. After air drying, the slides were stored with cover at room 
temperature until ready to dip in emulsion. After coating with 
emulsion (Kodak), the slides were exposed at 4 °C for 8 to 14 days, and 
then developed and stained with haemotoxylin and eosin within 2 hours 
(See Appendix 4 for the detailed autoradiography). 
2.1.3. Results 
2.1.3.1. Fixation 
In this study, two different cross- linking fixatives were compared 
(plate 2.1.). The decidua fixed in 2.5% glutaraldehyde (2.1.B) gave a 
reduced hybridization signal compared to that fixed in 4% 
paraformaldehyde (2.1.A). The tissue (decidua or trophoblast) was not 
fixed properly in 0.25% glutaraldehyde at 4 °C for 24 h, so the tissue was 
not used for in situ hybridization. 
2.1.3.2. Pretreatments 
As shown in plate 2.1.C, without proteinase K pretreatment for paraffin 
sections in this study, no specific silver grains were observed over the 
sections. However, by comparing different concentrations of proteinase 
K (1, 5, and 10 µg /ml), the 5 µg /ml proteinase K treatment was the 
optimised concentration (2.1.A) because 1µg /ml proteinase K gave a 
lower signal, whereas no further increase in signal was observed on 
the sections when digested with 10 gg /ml proteinase K. For frozen 
sections, the hybridization signal was decreased dramatically by 
proteinase K treatment at all concentrations used above. 
2.1.3.3. Probe concentration and duration of hybridization 
After increasing the probe concentration from 1x106 cpm/slide to 
1.5x106 cpm/slide, there was no further increment in signal (2.1.A and 
D). There was a prominent rise in signal after hybridization for 36 h 
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when compared with 18 h, although the background noise was also 
enhanced (2.1.E). 
2.1.3.4. Washes 
The best washing step developed in this study was the Schedule 3 which 
gave the best signal -to -noise ratio (2.1.A) compared with other two 
washing schedules. By using wash schedule 1 as shown in 2.1.F, there 
were no apparent grains observed over the section, with lower 
background noise indicating too high wash stringency used. 
2.1.4. Discussion 
The successful application of in situ hybridization depends on the 
quality of fixation of the tissue. Several aspects must be considered 
when preparing of tissue for in situ hybridization: target RNA 
retention, probe penetration, and preservation of morphology. 
Two cross -linking fixatives, glutaraldehyde (0.25 %, 2.5 %) and 4% 
paraformaldehyde were used in this study. The results confirmed that 
glutaraldehyde fixation resulted in a lower hybridization signal even 
with proteinase K digestion than similarly treated paraformaldehyde 
fixed tissue. This apparently occurs because of a greater degree of 
crosslinking of proteins after fixation with glutaraldehyde than that 
with paraformaldehyde (Lawrence and Singer, 1985). It has been 
reported previously that at the same concentration, glutaraldehyde 
could preserve 20% more RNA than paraformaldehyde, but the 
accessibility for probes was decreased to 40% compared with 
paraformaldehyde (Singer et al., 1984). To compromise between RNA 
retention and probe penetration, 4% paraformaldehyde was therefore 
used as fixative for in situ hybridization throughout this study, since 















































The development of an in situ hybridization method to localize decidual 
PRL mRNA using [35S] -hPRL cDNA probe in utero -placental unit. The 
scale bar is 20 µm. 
(2.1.A.) In situ hybridization of PRL mRNA in human decidua fixed in 
4% paraformaldehyde for 24 h with 5 µg /ml proteinase K 
pretreatment. The probe concentration used was 1x106 
cpm/slide and the hybridization was carried out at 42 °C for 18 h 
followed by optimum posthybridization wash (Wash schedule 3). 
(2.1.B.) In situ hybridization of PRL mRNA in human decidua fixed in 
2.5% glutaraldehyde for 24 h with identical pretreatment, 
hybridization and wash condition to 2.1.A. Note lower level of 
grains over the decidual cells than that shown in 2.1.A. 
(2.1.C.) In situ hybridization of PRL mRNA in human decidua under 
the same conditions as 2.1.A, but without treatment of 
proteinase K before applying the probe onto the sections. Note 
that grains were absent over the section. 
(2.1.D.) In situ hybridization of PRL mRNA in human decidua with 
increased amount of PRL cDNA probe (1.5x106 cpm/slide). Note 
no further increment of grains over the section compared with 
2.1.A. 
(2.1.E.) In situ hybridization of PRL mRNA in human decidua with 
longer hybridization time (36 h). Note a prominent rise in the 
level of grains, but with enhancement of the background 
staining. 
(2.1.F.) In situ hybridization of PRL mRNA on the section of human 
decidua postwashed by schedule 1. Note grains were not 
apparent in the decidual cells indicating too high wash 
stringency used. 
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However proper tissue fixation varies with the physical property of the 
tissue, probe size, and the concentration of fixative used. This may 
explain why some investigators obtained better signal -to -noise ratio 
when glutaraldehyde fixative was used (Fox et al., 1985). 
The aim of treatment of tissue after fixation, which is one of the more 
variable elements of in situ hybridization protocols, is to reduce non- 
specific binding and increase of probe penetration. The reduction of 
background in this study was attempted by inclusion of 10 mM DTT in 
the hybridization buffer to prevent the formation of disulphide bonds, 
prehybridization to block non - specific protein and nucleic acid 
interaction with probe, and acetylation with acetic anhydride to reduce 
non -specific electrostatic binding of the probe. Because acetylation was 
not effective in reducing the background in this study, this step was 
omitted in the routine procedure carried out in this study. This may be 
explained by the observation that the acetylation treatment may only 
reduce the background for the probe of more than 1500 bp, but not for 
smaller probes (Lawrence and Singer, 1985). 
The need to facilitate probe diffusion depends on the type and extent of 
fixation, the particular tissue used, the length of probe, and section 
thickness. A permeabilization was required following 
paraformaldehyde fixation to allow access of the probe to mRNA in this 
study. This permeabilization included incubation of slides at high 
temperature (700C), in diluted HCL (0.2 N), and with enzyme digestion 
(proteinase K). Increased signals were only obtained by combining 
these three treatments together. It appeared that enzyme digestion 
was an essential step of deproteination because no specific signal was 
observed without application of proteinase k. 
Since the routine paraffin sections were suitable for the retrospective 
study of PRL mRNA, and serial sections could be easily obtained for in 
situ hybridization and immunocytochemistry study, no further work 
was carried out on frozen sections. 
The intention of the previous steps was to provide optimal conditions for 
the hybridization reaction. Many factors, which must be taken into 
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account in planning this step, have important effects on hybridization 
including the composition of the hybridization buffer, probe 
concentration, and preservation of tissue morphology. Although many 
studies have investigated the effect of hybridization conditions on in situ 
hybridization, the basic conditions were reinvestigated to optimize the 
method for the tissue, i.e. decidua, amnion, chorion, trophoblast and 
placenta used in subsequent studies in this thesis. 
Formamide which is capable of disrupting hydrogen bonds decreases 
the melting temperature of hybrids by 0.7 °C per 1% of formamide for 
DNA hybrids, and 0.4 °C for RNA hybrids, and so allows the use of 
lower hybridization temperatures resulting in better tissue morphology 
(Angerer et al., 1987). By keeping the hybridization temperature 
constant and varying the formamide, the most effective temperature 
could be determined. Inclusion of dextran sulphate and other polymers 
accelerates the rate of hybridization by volume exclusion, which 
increases effective probe concentration. Increased ionic strength 
(sodium ion concentration) has a stabilizing effect on nucleic acid 
duplexes. However increasing ionic strength above 0.4 M NaC1 has 
little effect on hybridization or hybrids stability (Meinkoth and Wahl, 
1984). 
By considering the factors discussed above, the experiment in this study 
were carried out at 42 °C by using a hybridization buffer containing 50% 
formamide and followed by a series of posthybridization washes at 
increasing stringencies, i.e. decreasing the salt concentration. All of 
the conditions used favoured the detection of well matched hybrids. 
The appropriate probe concentration for in situ hybridization is that 
which produces the greatest signal -to -noise ratio. Less probe would 
result in a decreased signal and more would only increase the 
background. The desired probe concentration in this study seemed to be 
1x106 cpm/slide because there was no further increment of the signal 
when the probe concentration was increased to 1.5x106 cpm/slide. 
The final protocol of in situ hybridization used in this study was as 
follows: 
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Paraffin sections were dewaxed in 2 changes of xylene for 10 min, 
rehydrated in 100 %, 80 %, 50% alcohol and rinsed in DEPC water for 5 
min prior to the Step 1. 
1. The sections were incubated in 0.2 M HC1 for 20 min at RT; 
2. Transferred to preheated 2X SSC for 10 min at 70 °C; 
3. Washed in DEPC water for 5 min at RT; 
4. Washed in 100 mM Tris/HC1, pH7.5 for 5 min at RT; 
5. Digested with 5 µg /ml proteinase K in 100 mM Tris/HCl pH7.5, 2 
mM CaC12 for 30 min at 37 °C; 
6. Immersed in 0.2% glycine in PBS for 30 sec to stop the proteinase K 
action, followed by rinsing in PBS for 5 min; 
7. Rinsed in PBS and post fixed in 4% paraformaldehyde for 20 min at 
RT; 
8. Washed in PBS twice for 10 min; 
9. Prehybridization: the sections were incubated in 70 µ1 of 
prehybridization buffer at 42 °C for 1 h; 
10. Hybridization: the hybridization was carried out for 18 -36 h at 42 °C 
in hybridization buffer containing heat denatured [35S] -PRL -DNA 
probe at a concentration of 1x106 cpm/slide; 
11. Washes: after hybridization, the slides were immersed in 4XSSC 
for 15 min to remove coverslip, and then washed in the following 
solutions: 
2XSSC for 2 h at RT; 
1XSSC for 2 h at RT; 
0.5XSSC for 1 hat RT; 
Finally, 0.5XSSC for i h at 37 °C. 
12. Following washes, the slides were dehydrated by passing, for three 
min each, through an alcohol series (50 %, 85 %) containing 300 mM 
amonium acetate to stabilize the hybrids and one change of 100% 
alcohol. The slides coated with emulsion were then exposed at 4 °C 
for 7 to 14 days before autoradiography. 
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Part II. Modification of the immunostaining method for 
immunolocalization of decidual PRL in utero -placental unit 
2.2.1. Introduction 
The initial intention in this chapter was to use the avidin- biotin 
immunostaining method set up in our histology laboratory to localize 
the decidual PRL. However the achievement of optimal specific 
staining is related to the proper antibody dilution, incubation time and 
temperature, appropriate tissue fixation, as well as the minimal 
background staining. These factors affect the quality of 
immunostaining in a complementary fashion, but vary according to the 
antigen to be localized and the primary antibody. These conditions 
were, therefore, investigated to determine the best protocol for the 
immunolocalization of decidual PRL. 
2.2.2. Materials and methods 
2.2.2.1. Fixation 
The tissue from early and term pregnancies was collected and 
embedded in paraffin and sectioned exactly as described in Part I. 
Three cross -linking fixatives were evaluated for proper fixation: 
1. 4% neutral buffered formalin at RT for 24 h; 
2. 4% paraformaldehyde at RT for 24 h; 
3. 2.5% glutaraldehyde at 4 °C for 24 h. 
After fixation, tissue was pretreated with or without 0.1% (w /v) trypsin 
(BDH Chemicals Ltd., Poole, England) and 0.5% (v /v) Triton -X 100 
before the application of primary antibody (See Appendix 5 for 
preparation of immunostaining solutions). 
38 
2.2.2.2. Antibodies 
The following checkboard was used to determine the optimal dilution of 
primary and secondary antibodies, as well as incubation time. 
Secondary antibody Primary antibody Time & temperature 
(incubation) 
1:200 1:100 1:200 30 min at RT 
1:500 1:1000 24 h at 4°C 
1:500 1:100 1:200 30 min at RT 
1:500 1:1000 24 h at 4°C 
The primary antibody was an anti -human PRL antibody raised in a 
rabbit (Lot no. 068, Dako Corporation, Santa Barbara, CA, USA) and 
biotinylated swine anti -rabbit immunoglobulin G (Dako, Lot no. 129) 
was used as the secondary antibody. The avidin -biotin complex (Dako, 
Lot no. 067) was used at the concentration recommended by the 
manufacturer. 
2.2.2.3. Background staining 
The major problem in performing immunocytochemistry is 
background staining. The following efforts were taken to decrease 
background staining according to the main cause of this problem: 
1. Suppression of endogenous peroxidase activity by incubating the 
sections with 3% (v /v) H2O2 in 100% methanol for 30 min; 
2. Reduction of ionic interaction of tissue with antibody by addition of 
0.9% NaC1 in 0.05 M Tris/HC1 buffer (Tris Buffered Saline; TBS); 
3. Involvement of 5% (w /v) bovine serum albumin (BSA) in blocking 
reagent (normal swine serum 1.4 diluted in TBS); 
4. The protein concentration of the normal rabbit serum was adjusted 
to be the same as that of primary anti serum. 
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2.2.2.4. Control 
Controls of the method and specificity of the antisera were: 1) sections of 
human anterior pituitary gland as positive and human tonsil as 
negative controls (tissue sections supplied by Dr K. Grigor, Department 
of Pathology, Royal Infirmary, Edinburgh); 2) substitution of normal 
rabbit serum and normal sheep serum for the specific serum; 3) 
omission of primary antiserum. 
2.2.3. Results and discussion 
Formaldehyde is the most popular fixative employed for 
immunocytochemistry study on paraffin- embedded sections. It 
generally preserves good morphology and maintains the 
immunoactivity as well provided that tissue is fixed under suitable 
conditions and for the optimal time (Farmilo and Stead, 1990). 
Therefore a phosphate buffer with neutral salt was used to make up 4% 
formaldehyde to maintain tonicity and pH (7.4) in this study to optimize 
the conditions for tissue fixation. Early and term pregnancy tissues 
were fixed for 8, 24, or 72 h respectively followed by digestion with or 
without trypsin. Since formaldehyde forms cross -linkages with basic 
amino acids, mainly lysine and arginine, there is a relatively low 
permeability to antibody. However trypsin digestion compensates for 
the impermeable nature of the fixative by cleaving adjacent to lysine 
and arginine to promote antibody penetration (Farmilo and Stead, 
1990). As illustrated in Plate 2.2.B, without trypsin digestion, no 
specific PRL staining was localized over the sections after fixed in 4% 
neutral buffered formalin for 24 h. Staining was seen after addition of 
trypsin digestion and, of the three different time of fixation, 24 h gave 
the strongest specific staining and least background (2.2.A). When the 
tissue was fixed for 72 h which was beyond the optimal fixation time, 
the antigenic site appeared to be masked probably due to excessive 
cross -linking of tissue proteins and increased hydrophobicity of the 
tissue, which consequently resulted in very weak staining as shown in 
(2.2.C). In contrast insufficient fixation (8 h in this case) made tissue 
too soft to be sectioned and destroyed the morphological integrity of the 
specimen. Although PRL staining intensity was slightly less in 4% 
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paraformaldehyde fixed tissue than that fixed in 4% neutral buffered 
formalin when applied at same concentration and incubation duration 
of the primary antibody (2.2. D), it was still used for those studies in this 
thesis in which in situ hybridization and immunocytochemistry was 
carried out on serial sections of the same tissue. Because 
glutaraldehyde is most effective at cross -linking and causes loss of 
more immunological activity, very weak PRL staining was observed on 
sections fixed with 2.5% glutaraldehyde (2.2. E). 
Apart from trypsin digestion, a further attempt to improve antibody 
penetration was tried using pretreatment of sections with 0.5% (v /v) 
Triton -X 100 to remove the lipid across the cell membrane (Hartman, 
1973). After Triton -X 100 treatment, the background staining was not 
increased , while the intensity of staining was improved. Thus 
pretreatment with Triton -X 100 was adopted as a routine procedure for 
the immunocytochemistry study in this thesis. 
The determination of the optimal antibody dilution and incubation 
duration is one of the most critical steps in immunocytochemistry 
study. For each new batch of reagents these parameters were always 
checked by using the checkboard shown before. A primary antibody 
dilution between 1:500 and 1:1000 in combination with secondary 
antibody at a dilution of 1:500 at room temperature for 0.5 h incubation 
was the optimal protocol for localization of PRL in utero- placental unit 
(2.2.A). The increase or decrease of antibody concentration or 
incubation duration enhanced background staining or attenuated 
specific staining. 
Further efforts to improve the quality of immunostaining was designed 
to decrease the background staining which is the most common 
problem encountered in immunostaining. Besides including 0.9% 
NaCl in the Tris buffer to reduce the ionic interaction with opposite net 
charged antibody (Boenisch, 1990) and adopting normal swine serum 
as blocking serum, it was found that the addition of 5% BSA in the 
blocking serum and the diluent of antibody diminished the background 
staining to the greatest extent (2.2.A and F). In addition, the 
endogenous peroxidase activity was quenched by using 3% H2O2 
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without exception since the tissue always contained many red blood 
cells with high endogenous peroxidase activity. 
There was no specific staining when normal rabbit serum was 
substituted for primary antibody, in which the normal rabbit serum 
was diluted to a protein concentration identical to that in the primary 
antibody. In addition no positive staining for prolactin was observed in 
sections of human tonsil. These results confirm that the 
immunostaining for PRL was specific. 
The optimal immunostaining method for PRL in utero -placental unit is 
shown in following: 
Sections were deparaffinised in xylene and brought to alcohol. Unless 
otherwise specified all the sections were sequentially incubated for 
various time at room temperature with each of following reagents: 
1. 3% (v /v) hydrogen peroxide in methanol to block endogenous 
peroxidase activity for 30 min; 
2. 0.1% (w /v) trypsin and CaC12, pH 7.4, 370C for 30 min; 
3. 25% (v /v) normal swine serum and 5% (w /v) bovine serum albumin 
(BSA) in 0.05 M Tris/HC1 with 0.15 M NaC1, pH 7.6 (TBS), for 30 min; 
4. Rabbit anti-hPRL serum (1:500, 1:1000) for 30 min; 
5. Biotinylated swine anti -rabbit immunoglobulin G diluted (1:500) in 
'l'BS for 30 min; 
6. Avidin- biotin complex: 40 µl of each in 5 ml 0.05 M Tris/HC1 (pH 7.6) 
for 30 min. 
After each incubation the slides were washed with TBS for 10 min 
except after incubation with normal swine serum. Hormone 
localization was determined by detection of peroxidase activity, effected 
by 5 min incubation of the slides with a freshly prepared solution 
containing DAB (4 mg/10 ml 0.05 M Tris/HC1 to which was added 0.2 ml 
3% (v /v) hydrogen peroxide). Sections were counterstained with 
haematoxylin, dehydrated and mounted in DPX mounting medium 




The development of the immunocytochemistry method to localize 
decidual PRL in utero -placental unit. The scale bar is 20 µm. 
(2.2.A.) Immunolocalization of PRL in human decidua fixed with 4% 
neutral buffered formalin for 24 h. Predigestion using 0.1 % 
(w /v) trypsin was performed on the sections and the primary 
and secondary antibodies were both used at a dilution of 1:500. 
5% BSA was added to the blocking serum. 
(2.2.B.) Immunolocalization of PRL in human decidua performed 
under the same condition as 2.1.A., but without trypsin 
digestion. Note very faint PRL immunostaining observed over 
the decidual cells. 
(2.2.C.) Immunolocalization of PRL in human decidua fixed in 4% 
neutral buffered formalin for 72 h. Note apparently decreased 
staining intensity of PRL over the decidual cells compared with 
2.2. A. 
(2.2.D.) Immunolocalization of PRL in human decidua fixed in 4% 
paraformaldehyde for 24 h. Note slightly reduced staining 
intensity of PRL in the decidual cells compared with 2.2.A. 
(2 2 E) Immunolocalization of PRL in human decidua fixed in 2.5% 
glutaraldehyde for 24 h. Note very faint PRL immunostaining 
observed over the decidual cells. 
(2.2.F.) Immunolocalization of PRL in human decidua performed 
under same conditions as 2.2.A, but without involvement of 5% 
BSA in the blocking serum. Note much higher nonspecific 
background staining over the section than that in 2.2.A. 
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Part DI Localization of the sites of synthesis and action of prolactin by 
immunocytochemistry and in situ hybridization within the human 
Utero- placental unit 
2.3.1. Introduction 
Many studies support the concept that the high concentration of PRL 
found in amniotic fluid during human pregnancy originates from the 
decidualized endometrium (Bigazzi et al., 1979b; Healy et al., 1979). 
This PRL appears to be identical to pituitary PRL (Golander et al., 1978). 
However the definitive cell type which is responsible for PRL production 
in decidua has not been localized. 
Several groups have attempted to isolate these PRL producing cells by a 
number of different methods, including isopycnic centrifugation 
(Markoff et al., 1983a), immunocytochemistry (Braverman et al., 1984) 
and fibroblast -free decidual cell culture (Hochner -Celnikier et al., 1984). 
Results from these studies have suggested that the PRL -producing cells 
are morphologically similar to decidual cells. 
While these studies suggest that only the decidua is the source of PRL 
in the utero- placental unit, high concentrations of PRL have also been 
localised by immunocytochemistry in the amnion (Healy et al., 1977) 
and the trophoblast (Al- Timimi and Fox, 1986). It is not clear whether 
this PRL is synthesized in these PRL immunopositive cells or whether 
it is sequestered from the extracellular space. In addition, the role of 
decidual PRL within the feto -utero- placental unit is still obscure. 
The aim of the study in this part of the thesis was to determine the 
specific cell type which synthesizes PRL together with a precise 
localization of the tissues which accumulates PRL by using the 
combined methods of immunocytochemistry and in situ hybridization 
as developed and described in the previous parts of this Chapter. Thus 
a positive identification of the site of synthesis of PRL together with a 
precise localization of the cell types which accumulates PRL should 
provide evidence for the potential site of action of decidual PRL. In 
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addition, localization of the specific PRL- producing cells is essential for 
further determination of the relevant regulators of decidual PRL 
synthesis and release. 
2.3.2. Materials and methods 
Immunocytochemistry and in situ hybridization to localize PRL and its 
mRNA in utero- placental unit were performed as described in Part I 
and II of this Chapter. Tissues from three patients at both early (8 -11 
weeks) and term pregnancies (37 -40 weeks) were used in this study. 
2.3.2.1. Northern blot Analysis 
The localization of decidual PRL mRNA was cross -checked by Northern 
blot analysis which was performed according to the routine method 
used in our laboratory (Preparation of solutions for Northern blot 
analysis is shown in Appendix 6). 
A. RNA extraction procedure 
Total RNA was extracted from the frozen term decidua according to the 
method of Chomozynski and Sacchi (1987). Ovine pituitary RNA was 
also extracted for comparison with the decidual PRL mRNA. This 
pituitary was collected from an anoestrous ewe within 3 min of death 
induced by an overdose of sodium pentobarbitone. 
The collected tissue samples stored in liquid nitrogen until RNA 
extraction were placed onto aluminium foil on dry ice, weighed and 
dropped into solution D (1 ml solution D /100 mg tissue), which had been 
chilled on ice for no more than 5 min, and then homogenized 
immediately using a polytron homogenizer for 30 sec at speed 8. The 
homogenate was transferred to a sterile polypropylene tube (Falcon 12 
ml) and the following solutions were sequentially added (quantities /1 
ml solution D): 
0.1 ml sodium acetate (2 M, pH 4.0) 
1 ml water saturated phenol 
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0.2 ml cholorofor,u/isoamyl alcohol (49:1) 
The final mixture was shaken vigorously for at least 10 sec, and 
centrifuged at 10,000 g for 20 min at 4 °C. The aqueous phase containing 
RNA was removed to a new tube, mixed with an equal volume of cold 
isopropanol which was stored in a -20 °C freezer and added immediately 
after removal from freezer, and placed at -20 °C for at least 1 h to 
precipitate RNA. The solution was then centrifuged at 10,000 g for 20 
min at 4 °C to pellet RNA. After dissolving the pelleted RNA in 1 ml 
solution D, the RNA was reprecipitated as described above. The pellet 
was dried under nitrogen and then redissolved in 200 p.1 pure water 
containing 0.1% (w /v) sodium dodecyl sulphate (SDS) by warming up to 
65 °C for 10 min, and then stored at -70 °C. The concentration and purity 
of RNA were determined at 260 nM and 280 nM in a Spectrophotometer. 
The ratio of readings at 260 /280 gives the purity and the concentration of 
RNA is determined from the 260 nM reading (40 p.g/ml RNA =1.0) 
B. Separation of RNA and hybridization 
If the volume of the samples containing the required amount of RNA 
(15 µg) was more or less than 5 µl, the samples were concentrated by 
precipitating with ethanol or diluted with sterile water to bring the 
required concentration of RNA to 5 pl. 
RNA (15 µg) was denatured in 16 p.1 of sample buffer containing 17.4% 
formaldehyde, 50% formamide, 20 mM 3 -[N - 
morpholino]propanesulphonic acid (MOPS), 5 mM sodium acetate and 
1 mM EDTA at 60 °C for 5 min. RNA was then fractionated on a 1.5% 
agarose /0.66 M formaldehyde mini -gel running at 100 voltage for 2.5 h 
and transferred to a nylon membrane (Hybond -N, Amersham, UK). 
After air - drying and crosslinking with UV light for 2 min, the 
membrane was prehybridized at 65 °C for 5 h with 20 ml hybridization 
buffer containing 5XSSC (1XSSC being 0.03 M NaCl, 0.003 M sodium 
citrate), 0.1% (w /v) SDS, 0.1% (w /v) sodium pyrophosphate, 0.05% (w /v) 
ficoll 400, 0.05% (w /v) polyvinylpyrrolidone (PVP), 0.05% (w /v) BSA and 
100 µg/ml sheared herring sperm DNA. Hybridization was carried out 
in 20 ml fresh hybridization buffer containing 1 -2 x 106 cpm/ml [3213]- 
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radiolabelled cDNA probe (See Appendix 3 for cDNA probe labelling 
method) overnight at 650C. After washing twice in 40 mM sodium 
phosphate (pH 7.2), 1 mM EDTA and 1% SDS at 650C for 1 h, the blot 
was exposed to Kodak X -OMAT AR film at -700C with two intensifying 
screens for 1- 4 days. 
2.3.3. Results 
2.3.3.1. Northern Blot Analysis 
Hybridization occurring between the [32P] -cDNA PRL probe, and 
mRNA from ovine pituitary (lanes 1 to 3) and two separate preparations 
of term decidua (lanes 4 to 5) are shown in Plate 2.3. The mRNA for the 
human decidual PRL appeared to be larger than that of the ovine 
pituitary PRL mRNA. 
2.3.3.2. Immunocytochemistry and in situ hybridization 
PRL immunocytochemical staining and in situ localization of PRL 
mRNA in the utero -placental unit in early and term pregnancy tissue 
is illustrated in Plate 2.4. 
A. Early Pregnancy 
Specific PRL staining was seen both in the trophoblast (2.4.A) and 
decidua (2.4.C). The staining in the decidua was more intense, and 
was apparent not only in the decidualized cells but was also in 
endometrial glands. The immunostaining appeared to be uniform 
throughout the cytoplasm of all positive staining cells. The in situ 
hybridizations revealed that all of the silver grains were only associated 
with decidualized cells, whereas no specific grains were observed over 
the endometrial glands and trophoblast (2.4.D and 2.4.B). 
B. Term pregnancy 
Although PRL was detected in cells in the amnion (2.4.E), syncytio- and 
cytotrophoblast of the placenta (2.4.G) and decidua (2.4.I), it was not 
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Plate 2.3. Autoradiograph of a Northern blot showing the hybridization 
of [32P] -hPRL cDNA with RNA extracted from ovine pituitary (lanes 1 
to 3; 5 p.g, 1µg and 0.5 µg respectively) and from human term decidua 
(lanes 4 and 5; 15 µg). The position of the 18S ribosomal RNA is shown 






Immunocytochemical staining of PRL and in situ localization of PRL 
mRNA in human utero -placental tissues from early and term 
pregnancies. The scale bar is 20 µm 
(2.4.A) Immunostaining for PRL in early trophoblast. Note faint but 
positive staining for PRL. 
(2.4.B) In situ localisation for PRL in early trophoblast. Grains are not 
readily apparent indicating the absence of specific localization 
of probe to tissue. 
(2.4.C) Immunostaining for PRL in early decidua. Note intense 
specific staining for PRL in decidualized cells and endometrial 
glands. 
(2.4.D) In situ localization for PRL in early decidua. Note abundant 
black grains over decidualized cells only. 
(2.4.E) Immunostaining for PRL in term amnion. Note positive 
staining for PRL. 
(2.4.F) In situ localization for PRL in term amnion. Note only 
background grains present. 
(2.4.G) Immunostaining for PRL in term placenta. Positive staining 
for PRL again seen. 
(2.4.H) In situ localization for PRL in term placenta. Note presence of 
background grains only. 
(2.4.I) Immunostaining for PRL in term decidua (D) and chorion (C). 
Note intense positive staining for PRL in the decidua, but not in 
the chorion. 
(2.4.J) In situ localization for PRL in term decidua. Note abundant 
black grains over decidual cells. 
(2.4.K) In situ localization for PRL in term chorion. Note only 
background grains present. 
(2.4.L) Dark -field photomicrograph of in situ localization for PRL in 
early decidua. Note abundant white grains. 
(2.4.M) Dark -field photomicrograph of in situ localization for PRL in 
early decidua treated with RNAse. Note only background white 
grains. 
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found in the chorion (2.4.I). As in early pregnancy, the only cell types 
containing PRL mRNA was the decidualized cells (2.4.J) and no PRL 
mRNA was identified in amnion (2.4.F), in chorion (2.4.K) and placenta 
(2.4.H). 
Pretreatment of tissue sections with RNAse before hybridization 
completely prevented specific labelling of decidualized cells by the [35S] 
labelled probe (2.4.M), confirming that the labelled probe had hybridized 
specifically with PRL mRNA (2.4.L). 
2.3.4. Discussion 
This is the first study to localise the specific cell type for synthesis of 
PRL by co- localization PRL and its mRNA within the utero- placental 
unit. Using in situ hybridization, we have identified the mRNA 
encoding for PRL within decidualized cells. No other cell types within 
the utero- placental unit in early or term pregnant tissue were found to 
contain PRL mRNA. While some previous studies identified only the 
placenta as the source of PRL (Kasai et al., 1982; Al- Timimi and Fox, 
1986), this is not confirmed in this study and the present results are in 
accord with other reports (Pileri et al., 1982; Bryant- Greenwood et al., 
1987) identifying PRL in amnion, trophoblast and decidua. However, 
we could not confirm a further report identifying PRL in the chorion 
(Frame et al., 1979b), but showed conclusively that PRL is present in 
both early and term trophoblast in contrast to a previous report (Bryant - 
Greenwood et al, 1987). 
The synthesis and secretion of PRL by decidualized endometrium at 
term was first shown by Riddick and Kusmik (1977). This finding was 
then extended to early pregnant endometrial tissue and uterine 
endometrium obtained from ectopic tubal pregnancies (Maslar et al., 
1980). This latter observation suggests that the presence of cells of fetal 
origin within the uterus is not essential for the production of PRL by the 
uterine endometrium. Furthermore, Daly et al. (1983a) using an in 
vitro system showed that proliferative endometrium obtained during 
the menstrual cycle underwent progesterone -dependent differentiation 
and synthesized PRL. The initiation of PRL secretion in vitro 
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corresponded to the onset of histologically apparent decidualization. In 
addition, when morphological de- decidualization of decidual cells was 
induced by blocking progesterone action in vivo with the anti 
progesterone, mifepristone, decidual PRL synthesis was shown to be 
suppressed (Chapter 4). These results suggested that PRL production 
is entirely dependent on the decidualization of endometrium. 
The present study is the first to localize PRL raRNA within the decidua 
by in situ hybridization. The use of a human pituitary PRL cDNA probe 
for in situ hybridization was validated by Northern hybridization, 
showing that the probe hybridized to a single RNA species. It appeared 
that the decidual PRL mRNA was longer than that of the ovine 
pituitary PRL mRNA. 
However an early study using Northern blot analysis has reported that 
the decidual PRL mRNA was of a similar size to ovine pituitary PRL 
mRNA (Clements et al., 1983). Further support for the concept that 
decidual PRL gene structure might be similar to that of pituitary PRL 
was obtained when it was shown that cDNA synthesized from the 
decidual PRL mRNA had almost precisely the same sequence as 
pituitary -derived PRL cDNA, suggesting that only one copy of the PRL 
gene is present in the haploid genome and the same PRL gene is 
expressed in both pituitary and decidua (Takahashi et al., 1984). 
In contrast to those reports that the PRL protein coding sequence in 
decidua was identical to that in pituitary, it has now been reported that 
the decidual PRL mRNA is about 150 nucleotides larger than the 
human pituitary transcript, in accord with the present study, due to an 
elongation of the mRNA located in the 5' untranslated region of the 
gene (Gellersen et al., 1989; DiMattia et al., 1990; Hiraoka et al., 1991) 
implying a different transcription initiation site in decidual PRL gene 
from the PRL gene in the pituitary. These results might underlie an 
important mechanism which specifically controls PRL gene expression 
in decidua. 
The results of the present study strongly suggest that only decidualized 
cells are capable of PRL biosynthesis. Cells of fetal origin, namely 
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amnion and trophoblast, only accumulate PRL. It may be anticipated 
that the sites of PRL action may be the amnion and trophoblast where 
PRL receptors have been identified (Healy et al., 1982; 1985; McCoshen 
et al., 1982b) and amniotic fluid, a compartment into which decidual 
PRL is secreted. Indeed, studies have suggested that decidual PRL 
may play a role in maintaining amniotic fluid volume (Healy et al., 
1982; 1985; McCoshen et. al., 1982b), in fetal lung maturation (Johnson 
et a., 1985) and possibly in modulating fetal membrane prostaglandin 
production (Tyson et al., 1985) to control parturition (Healy et al., 1984). 
In summary, these results identify conclusively for the first time that 
decidual cells within the endometrium are the only major source of 
PRL synthesis. The fact that other cell types within the trophoblast and 
the amnion contain PRL suggests that it may play an important 
paracrine role within the utero- placental unit. 
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CHAFER 3 
The Relationship between the Decidualization and PRL 
Production at the Different Stages of Human Pregnancy 
3.1. Introduction 
It is clear now that the high level of PRL in amniotic fluid is 
specifically produced by the decidual cells. However the control of 
decidual PRL secretion is still poorly understood. Previous studies have 
suggested that the decidualization of the stromal cells in the 
endometrium is essential for the initiation of PRL production (Maslar 
and Riddick, 1979; Daly et al., 1983a). Because progesterone is the main 
hormone involved in differentiating the oestrogen -primed stromal cells 
into decidual cells, the regulatory effect of both sex steroids on PRL 
production in the endometrium of normal menstrual cycle has been 
extensively studied. However, their potential role in PRL production 
during pregnancy and the relationship between decidualization and 
PRL production throughout pregnancy remain obscure. Furthermore 
most studies have not distinguished between regulation of de novo 
synthesis and regulation of secretion of PRL. Unlike pituitary PRL, 
decidual PRL is not packaged into secretory granules (Handwerger et 
al., 1984), so it is important to examine the regulation of PRL at the level 
of synthesis . 
In this chapter, the relationship between decidualization and PRL 
production at different stage of human pregnancy was studied at the 
level of synthesis and secretion by means of in situ hybridization and 
Northern blot to reveal the PRL mRNA level, immunocytochemistry to 
examine PRL content inside the decidual cells as well as 
radioimmunoassay to measure PRL output in amniotic fluid. 
3.2. Materials and methods 
Immunocytochemistry, in situ hybridization and Northern blot 
analysis were performed exactly as described in Chapter 2. Tissue 
from two patients in each stage of early, mid and term pregnancy was 
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used in this study. Tissue fixed in 4% paraformaldehyde was used for 
both immunostaining and in situ hybridization. Eight serial sections 
from each block (one patient) were cut and floated onto the previously 
cleaned and poly -L- lysine coated slides for in situ hybridization and 
immunocytochemistry. Amniotic fluid samples were collected at 
amniocentesis by Dr. W. Ledger, Department of Obstetrics and 
Gynaecology, University of Edinburgh, in 3 early, 14 mid and 16 term 
pregnancies and PRL was assayed using a two -site 
immunoradiometric assay (IRMA). 
3.2.1. Quantitative analysis of in situ hybridization 
All in situ hybridization sections were counterstained with 
haematoxylin and eosin. Once dehydrated and mounted, sections were 
examined and photographed using an Olympus photomicroscope 
under both light and dark field. 
In situ hybridization signals from each stage of pregnancy were 
quantified with a computer -assisted image analysis system. Five areas 
from each section were randomly chosen for grain counts. This system 
consisted of a Charge- Coupled Device camera, microscope, and camera 
monitor linked to an IBM PC /AT microcomputer. The software 
program (Cue -2) for densitometry was provided by Olympus Optical 
Company. An optimum threshold and filter combination were set to 
select only the silver grains. Because in some cells at different stages of 
pregnancy the density of grains was large, these grains collected into a 
single large area within the cell preventing accurate counts of 
individual grains. Therefore, the grain area per cell from five areas 
per section was calculated as a mean. By combining the means 
obtained from two sections, an overall mean representing one patient 
was averaged (n =1). 
3.2.2. PRL radioimmunoassay procedure 
PRL in the amniotic fluid was assayed using a two -site 
immunoradiometric assay (IRMA) as described in the following: 
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Amniotic fluid samples (1:10 diluted in assay buffer defined as below) 
were assayed in duplicate in a volume of 450 pl. 50 µl of standard or 
samples were added to 400 p.1 assay buffer (1% (w /v) BSA (Sigma RIA 
grade, fraction V) in 0.05 M phosphate buffer plus 5% (v /v) Tween 20, 
pH 7.4 ). 50 pl of a sheep anti -prolactin linked to a solid phase was 
added to all tubes except total counts and incubated with the sample or 
standard buffer at room temperature on a rotary mixer for 3 h. 
Following washing twice with washing buffer (0.05 M phosphate buffer 
with 5% (v /v) Tween 20), 50 p.1 of the radioiodinated mouse monoclonal 
anti -prolactin antibody, diluted in assay buffer to give 100,000 counts /50 
µ1/100 seconds, and 400 p.1 of assay buffer, were added to all tubes and 
the reaction continued overnight on a rotary mixer, followed by 
washing and centrifugation twice with washing buffer, and then 
counting. The detection limit of this assay was 50 mU/L. Intra- and 
inter- coefficients of variation were 2.5% and 12% respectively. 
All the reagents, i.e. standards, solid phase, and radioiodinated second 
antibody, were purchased from NETRIA ( NETRIA, St Bartholomews 
Hospital, London, U.K.). 
3.2.3. Data reduction 
The two -site PRL (IRMA) was counted in a Multigamma Counter (1261 
Multigamma, LKB Wallac OY, Turku, Finland), from which the 
output of the raw counts was recorded by a digital data logger (Data 
grabber, Mutek, Box, Wiltshire) onto a 3.s5 inch floppy disc. The data 
were then transferred from the data grabber disc into an Apple 
Macintosh computer where raw counts were analysed by the AssayZap 
universal assay calculator program (Elsevier, Biosoft, UK). Briefly, a 
four -parameter weighted -regression model of displacement curve was 
utilized for this program. This begins with the two -parameter Logit -log 
model as a first estimate but then adjusts the asymptotes, slope and 
point of inflection (the four parameters) of model curve reiteratively, in 
order to give more weight to the standard points with smaller variance, 
until optimum squares fit is obtained. Assayzap also preserves the 
previous information of assay history in order to compare with previous 
standard curves, quality control and binding level. 
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3.2.4. Statistical analysis 
All statistical analyses were performed on a Apple Macintosh 
computer. The linear regression and correlation between the cell size 
and grain area were conducted using Statworks (Data Metrics Inc., 
USA) program. The difference in PRL concentration of the different 
stage of pregnancy in amniotic fluid was assessed by analysis of 
variance using a statistics program written for the Apple Macintosh 
computer (CLR Anova, Clear Lake Research, Houston, TX, USA). 
3.3. Results 
3.3.1. Immunocytochemistry, in situ hybridization and Northern Blot 
PRL immunostaining and PRL mRNA localization by in situ 
hybridization are shown in Plate 3.1. In early pregnancy 
decidualization was not uniform throughout the specimen, and the 
intensity of immuno- and in situ localization of PRL and its mRNA 
corresponded very well with the decidualization, i.e. the better 
decidualized the cells, the more PRL mRNA and PRL were contained 
in the cells as shown in Plate 3.1. B, C, E and F. Plate 3.1.A and D are 
the dark field photomicrograph of in situ localization of PRL mRNA in 
early pregnancy decidua. From early to mid pregnancy, more stromal 
cells were decidualized indicated by the enlargement of the cell size and 
nuclei. The grain density and the content of PRL in each individual 
cell were dramatically increased as illustrated in Plate 3.1. G (dark 
field), H and I. However, when the decidualization still progressed in 
term decidua, there was no obvious increment in the average grain 
area and PRL content in term decidual cells (Plate 3.1. J (dark field), K 
and L). Both grain area and PRL content were still much higher than 
that in early pregnancy. This was reconfirmed by Northern Blot 
analysis (Plate 3.2.), in which the hybridization signals in term 





In situ localization of PRL mRNA and immunocytochemical staining 
of PRL in human decidua from early, mid and teiul pregnancies. The 
scale bar is 20 ulm 
(3.1.A & B) Dark field (A) and light field (B) micrographs of in situ 
localization of PRL mRNA in the decidua of early 
pregnancy. Note the decidual cells are still like fibroblast 
cells and a low level of black grains overlay the cytoplasm 
of the cells. 
(3.1.C) Immunolocalization of PRL in the decidua of early 
pregnancy. Note the shape of the decidual cells is same as 
that observed in 3.1.B and very faint staining for PRL in the 
cytoplasm of the cells. 
(3.1.D &E) Dark field (D) and light field (E) micrographs of in situ 
localization of PRL mRNA in the decidua of early 
pregnancy. The picture was taken from the same section 
as shown in 3.1. A, B and C, but from a different area. 
Note the increase in the cell size indicating the more 
decidualization and apparently increased level of black 
grains over the decidual cells. 
(3.1.F) Immunolocalization of PRL in the decidua of early 
pregnancy from the same section as 3.1.C, but from a 
different area. Note the decidual cells become more 
decidualized indicated by the enlargement in cell size with 
obviously increased intensity of the immunostaining. 
(3.1.G & H) Dark field (G) and light field (H) micrographs of in situ 
localization of PRL mRNA in the decidua of mid 
pregnancy. Note the decidual cells have increased 
dramatically in size and much higher level of black grains 
overlays the individual cells than that in early pregnancy. 




(3.1.I) Immunolocalization of PRL in the decidua of mid 
pregnancy. Note the increase in cell size with more 
intense staining of PRL in the cytoplasm. 
(3.1.J & K) Dark field (J) and light field (K) micrograph of in situ 
localization of PRL mRNA in the decidua of term 
pregnancy. Note decidual cells continue to increase in the 
cell size, but without an apparent increase in the level of 
black grains in the individual cells. 
(3.1.L) Immunolocalization of PRL in the decidua of term 
pregnancy. Note the intensity of immunostaining of PRL 
in the decidual cells is similar to that in the mid 




Plate 3.2. Autoradiograph of a Northern blot displaying the 
hybridization of [32P] -hPRL cDNA with RNA (15 µg/lane) extracted 
from one term decidua (lanes 1) and one early decidua (lane 2). The 
position of the 18S and 28S ribosomal RNA is shown on the right. 
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The quantitative results of in situ hybridization are presented in 
Fig.3.1. The average cell size (3.1.A) and grain area (3.1.B) from early 
to mid pregnancy both increased dramatically. However, cell size 
continued to increase in term decidua, PRL mRNA concentration in 
the individual cells did not increase further from mid to term 
pregnancy. All these quantitative results were in good agreement with 
the results of the morphological overview. 
The percentage of cells containing PRL mRNA localized by in situ 
hybridization at the different stages of pregnancy is demonstrated in 
Fig. 3.1. C. Again, the number of positive cells increased dramatically 
from early to mid pregnancy (from 9.8% to 47.3 %), and then slightly 
increased towards term pregnancy (57.8 %). 
3.3.2. Correlation between cell size and its mRNA 
There was a significant correlation (p<0.0001) between the cell size and 
PRL mRNA level in early, mid and term decidua as shown in Fig. 3.2. 
A, B and C, although no additional increment was noted in PRL mRNA 
level in term decidua. 
3.3.3. PRL concentration in amniotic fluid 
The PRL concentration in amniotic fluid in early, mid and term 
pregnancy is shown in Fig. 3.3. PRL in amniotic fluid increased 
dramatically (p <0.01) from early (12.7 mU/L ± 3.4 sem) to mid 
pregnancy (2755 mU/L ± 1269 sem ) and then decreased significantly 
(p <0.01) towards term pregnancy (668 mU/L ± 423 sem), which was still 
significantly higher than that in early pregnancy (p<0.05). 
3.4. Discussion 
These results clearly show that PRL production in human decidua is 
entirely dependent on decidualization in vivo. This confirms the 
previous in vitro studies that the commencement of decidual PRL 
synthesis coincided with the onset of morphological changes indicative 
of decidualization, and the capacity of the endometrium to produce PRL 
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Early Mid Term 
Stage of Pregnancy 
Fig. 3.1. Changes in average cell area (A), average grain area per cell 
(B) and percentage of cells showing PRL gene expression by in situ 
hybridization (C) in samples of decidualized endometrium from early 
(n =2), mid (n =2) and term (n =2) pregnancy. Note the dramatically 
increase in the average cell size and PRL mRNA levels represented by 
grain area in the individual cells from early to mid pregnancy, while 
from mid to term pregnancy only the continuance increase in cell size 
was observed with maintenance of grain area in the individual cells. 
The number of positive in situ cells increases, again, markedly from 
early to mid pregnancy and then slightly increases towards the term 
pregnancy. 
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Fig. 3.2. The relationship between the decidual cell size and PRL 
mRNA level is demonstrated in A (early pregnancy), B (mid 
pregnancy) and C (term pregnancy). The close correlation between the 
decidual cell size and the grain area in the individual cells exists in 













Early Mid Term 
n =3 n =14 n =16 
Stage of pregnancy 
Fig. 3.3. Changes in PRL concentration in the amniotic fluid in early 
(n =3), mid (n =14) and term (n =16) pregnancies. From early to mid 
pregnancy PRL concentration increased dramatically (P <0.01) and then 
decreased significantly (P <0.01) from mid to term pregnancy, which 
was still significantly higher (p<0.05) than that of early pregnancy. 
66 
in vitro increased when decidualization spread throughout the 
endometrial stroma (Maslar and Riddick, 1979; Maslar et al., 1980). 
However the present results extend these previous study by 
demonstrating decidualization has affected not only on PRL secretion 
but also on PRL gene expression in decidual cells, that is 
decidualization acted on PRL gene expression which in turn increased 
PRL mRNA level in decidual cells. Thus the ability of an individual 
decidual cell to make PRL was magnified, which was very obvious from 
early to mid pregnancy. 
In the human endometrium decidualization starts at day 22 -23 of the 
normal menstrual cycle. In contrast to other species, it is triggered by 
sex steroid hormones only. The stromal cells of the endometrium show 
enlargement in size when they decidualize, which starts with the cells 
round the spiral arterioles. If implantation occurs the decidua reaction 
persists throughout pregnancy during which decidual cells continue to 
increase in size involving in the upper two thirds of whole 
endometrium as pregnancy progresses (Finn, 1977). 
Since progesterone has been considered as the main hormone to 
trigger and maintain decidualization of oestrogen primed 
endometrium in human, a large number of studies have been carried 
out to examine the regulatory effects of oestradiol and progesterone on 
decidual PRL production. Several studies on endometrium in the 
normal menstrual cycle demonstrated that progesterone alone was 
capable of generating the decidualization of the stromal cells and 
stimulating and maintaining synthesis of decidual PRL (Daly et al., 
1983a; Huang et al., 1987; Ying et al., 1988; Randolph et al., 1990). 
However this is not the case in either early or term human pregnancy, 
because several studies could not confirm that progesterone alone was 
able to stimulate PRL production in pregnancy decidua upon in vitro 
culture system (Rosenberg and Bhatnagar, 1984; Bischof et al., 1986; 
Ren et al., 1990). Therefore, it is unlikely that the effect of progesterone 
alone can explain the dramatic increase of PRL produced by human 
decidua during pregnancy. 
The direct role of oestradiol alone in decidualization and consequent 
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PRL production by decidualized cells is less defined even in normal 
menstrual cycle, but it is generally acceptable that oestrogen priming 
enhances the decidualization induced by progesterone (Irwin et al,. 
1989). Although a number of studies have shown that progesterone 
alone was capable of inducing decidualization and PRL production in 
vitro as discussed above, these experiments were performed either on 
proliferative phase or on early luteal phase endometrium which 
already had oestrogen priming in vivo. Thus oestrogen might be 
indirectly involved in the control of decidualization and subsequent PRL 
production in the endometrium. 
As the stimulating effect of progesterone on PRL production was 
attenuated during pregnancy according to the results of in vitro culture 
as discussed above, it would be logical to ask whether progesterone is 
still a regulator of decidual PRL production during pregnancy. Since 
decidualization keeps progressing throughout pregnancy, to reveal the 
relationship between decidualization and PRL production in decidua 
throughout pregnancy will indirectly unveil the regulatory effect of the 
sex steroid hormones on decidual PRL production during pregnancy. 
The present study is the first to examine PRL gene expression and the 
translated product of PRL gene in the decidua from the different stages 
of pregnancy, representing the different degree of decidualization 
observed throughout pregnancy. The results clearly show that PRL 
mRNA level, revealed by in situ and Northern hybridization, and PRL 
content inside individual cell, exhibited by immunocytochemistry, and 
PRL output in amniotic fluid, measured by radioimmunoassay, were in 
good agreement with the degree of decidualization. 
In early pregnancy, decidualization was not uniform over the cells of 
the decidua, in which case the better decidualized cells indicated by the 
bigger cell size had the stronger immuno- and in situ staining of PRL 
and its mRNA. From early to mid pregnancy, decidual cells continued 
to increase in size and decidualization has spread over the decidua. 
Correspondingly, the marked increment in PRL content and its mRNA 
level was found in the individual cells which was consistent over the 
specimen of decidualized endometrium examined. Additionally, 
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compared with the early pregnancy, the proportion of positive in situ 
cells in sections increased dramatically in mid pregnancy. 
Furthermore, the close correlation between decidual cell size and grain 
density in each cell further supports the hypothesis that PRL gene 
transcription was switched on by decidualization in vivo, which 
continued throughout pregnancy. Nevertheless the present findings 
could not distinguish at this stage whether the factors modulating 
decidualization have an indirect or direct effect on activation of PRL 
gene expression in decidua during pregnancy. 
In contrast, the decidual PRL content and its mRNA level in individual 
cells from mid to term pregnancy showed no obvious increase 
according to the overview of immuno- and in situ staining on the 
sections and grain density obtained by the quantitative analysis of in 
situ hybridization. In addition, the numbers of positive immuno- and in 
situ staining cells from mid to term pregnancy were constant as well, 
but the decidual cells continued to increase in size. The present results 
at this stage can not disclose the mechanism by which continuance of 
decidualization is not accompanied by a further increment of PRL 
production by term decidua. However, PRL gene expression in 
individual term decidual cell still paralleled the degree of 
decidualization, since the bigger decidual cells contained the more PRL 
mRNA signals, shown by in situ hybridization, and there was a close 
correlation between the decidual cell size and PRL mRNA level (Fig. 
3.2.C). 
The changes of PRL in amniotic fluid found in the present study are in 
consistent with those of the previous studies (McNeilly et al., 1977; 
Kletzky et al., 1985). There was a minor increase in PRL concentration 
in early pregnancy. During mid pregnancy the concentration of PRL 
increased dramatically to reach its maximum around 16 -20 weeks of 
pregnancy, after which PRL concentration gradually decreased until 
delivery. However little information is available to explain the 
mechanism of the PRL pattern in amniotic fluid which will give a clue 
to understand the control of PRL synthesis. Thus the PRL 
concentrations in amniotic fluid during early, mid and term pregnancy 
were reexamined, in combination with the investigation of de novo 
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synthesis of PRL in decidua. By consideration of the volume increment 
of amniotic fluid (Ganong, 1984) and the net increasing rate of PRL 
synthesis shown by the immunocytochemistry and in situ 
hybridization, it can be concluded from the present results that the 
large increase in concentration of PRL in amniotic fluid from early to 
mid pregnancy must be from active synthesis by decidual cells to 
overcome the increment in the volume of amniotic fluid. From mid to 
term pregnancy, PRL production is still constant, since the numbers of 
positive immuno- and in situ staining cells and intensity of immuno- 
and in situ staining within these cells were maintained as revealed by 
immunocytochemistry and in situ hybridization. Hence, the 
decreasing PRL concentration measured in amniotic fluid probably 
resulted from the dilution by the increasing amount of amniotic fluid 
occurring in the third trimester pregnancy as suggested previously by 
McNeilly et al. (1977). 
The present results clearly show that PRL production during human 
pregnancy corresponded to the degree of decidualization. This suggests 
that PRL production by the pregnant decidua is still, at least partly, 
under the control of the sex steroids, since it is well established that 
decidual cells are the main targets of the sex steroids, under which 
influence decidual cells undergo further decidualization. 
Progesterone alone failed to stimulate PRL production by pregnant 
decidua as discussed above indicating that the decidualization process 
might be more complex during pregnancy. Whether both oestrogen 
and progesterone are required for maintaining the decidualization and 
consequent PRL production or other factors derived from placenta 
(Handwerger et al., 1987a) augment the decidualization initiated by the 
sex steroid hormones need to be further investigated. 
Conclusions: this is the first study to examine decidual PRL regulatory 
mechanism at the level of both synthesis and secretion, by combining in 
situ and Northern hybridization to estimate gene expression with the 
immunocytochemistry to qualify intracellular PRL synthesis and 
measurement of secreted PRL by radioimmunoassay of PRL in 
amniotic fluid. The present striking finding was that there was a close 
correlation between PRL gene expression and decidualization in vivo. 
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Further studies will be carried out to examine the effect of the factors 
involved in decidualization on the control of decidual PRL production. 
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CHAPTER 4 
Sex Steroid Modulation of Prolactin Production by Human 
Early and Term Decidua 
Part L The effects of the anti progestin, mifepristone, in vivo, 
and progesterone in vitro on prolactin production by the 
human decidua in early pregnancy 
4.1.1. Introduction 
PRL production by endometrium from the normal menstrual cycle can 
be induced and stimulated by progesterone in vivo (Ying et al., 1988) 
and in vitro (Daly et al., 1983a). This PRL production is related to 
histological decidualization of endometrium (Maslar and Riddick, 
1979). The previous chapter has shown the close relationship between 
decidualization, PRL production and PRL gene expression throughout 
pregnancy. Since progesterone alone had little effect on PRL 
production of pregnant decidua as demonstrated by earlier studies 
using in vitro culture (Rosenberg and Bhatnagar, 1984; Ren and 
Brausterin, 1990), it is not clear how important the effects of 
progesterone on PRL production are during early pregnancy. The 
study in Part I of this Chapter was designed to investigate the effects of 
blocking the action of progesterone with the anti progestin mifepristone 
(RU 486 ) in vivo on PRL production in decidua parietalis, free of 
trophoblast, and decidua capsularis, with attached trophoblast. 
4.1.2. Materials and methods 
This study was approved by the Paediatric/Reproductive Medicine 
Ethics of Medical Research Subcommittee of the Lothian Health Board 
and the clinical management of the patients and collection of tissue 
was undertaken by Dr. J. Norman and Professor D. T. Baird, 
Department of Obstetrics and Gynaecology, University of Edinburgh. 
All patients gave informed consent and were treated in ward 54 of 
Simpson Maternity Pavilion (SMMP) of the Royal Infirmary, 
Edinburgh. 
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4.1.2.1. Tissues collection 
Human decidua from early pregnancy (42 -56 days), calculated from the 
last menstrual period, was obtained by curettage during therapeutic 
abortions. Decidua was obtained from 7 women who had been treated 
with a single oral dose of 600 mg of mifepristone (kindly supplied by Dr 
D. Philibert, Roussell Uclaf, Paris, France) 24 to 36 h before tissue 
collection and from a further 8 women without any treatment in vivo as 
the control group. At the time of surgery, the decidual tissue was 
immediately placed in a sterile bottle that contained RPMI 1640 
Medium (Gibco Limited, Paisley, Scotland, UK) supplemented with 200 
gg /ml gentamycin (Sigma Chemical Co., St. Louis, MO, U.S.A.), 2 
µg/ml amphotericin B (Sigma) for transportation. 
4.1.22. Development of the organ culture method 
The organ culture was chosen for this study based on the following 
major advantages: 
1. Maintenance of histological and biochemical integrity which was 
essential for investigating the tissue received in vivo treatment; 
2. Preservation of cell and matrix interaction, especially when the cell 
interaction between trophoblast and decidual cells needed to be 
preserved to mimic the in vivo status in decidua capsularis; 
3. Ease of performance. 
Several parameters i.e. selection of medium, gas phase, substrates, 
and sterilization were investigated to ensure that the organ culture 
system was satisfactory for this study. 
As the choice of medium is empirical, RPMI -1640 medium (Gibco) was 
selected for this study since this was used in the previous studies on 
organ culture carried out in the laboratory of MRC Reproductive 
Biology Unit, Edinburgh, UK (Dr R. Kelly). For better tissue 
maintenance in vitro, 5% (v /v) calf serum (Gibco) previously stripped 
with 1 mg/ml charcoal was added to the culture medium. 
The equipment involved in dissection procedure was autoclaved and the 
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stripped calf serum were sterilized by passing through a 0.2 µm filter. 
Furthermore, all dissection was performed in a laminar -flow hood. 
Initially the decidua was incubated on a piece of sponge (12x10x10 mm3) 
sterilized with 10% Shield surrounded by 1 ml of culture medium, so 
that the tissue was placed at the inter -phase of air and medium to 
prompt the oxygen to penetrate into the tissue. However, tissue death 
during culture was noted on several occasions. This was related to 
trace amount of the detergent used for sterilization which could not be 
completely removed from the sponge. Thus, in subsequent experiments 
the sponge was not utilized and the tissue was incubated in suspension 
culture. The tissue was cultured in 24 well plates under 95% air with 
5% carbon dioxide. 
Sterile 24 -well disposable plastics plates (Nunclon, Nunc, Denmark) 
treated to give a net negative charge were used throughout the organ 
culture. As the medium in this study was changed daily, the amount 
of tissue in each well was optimized (4 pieces per well; approximately 2 
mm3 each) to prevent the fall of pH to below 7.0 which would indicate a 
shortage of nutrients. 
The tissue viability was examined histologically on cryostat sections (5 
p.m) after 3 or 6 days in culture in three separate tissues. After in vitro 
culture for 3 days, the integrity of cell and tissue architecture was 
maintained. However, after 6 days culture, some central necrosis 
could be identified in the tissue. Thus, all the studies were terminated 
on day 5. 
The final procedure for the organ culture was as follows: 
The medium, RPMI 1640, used for long term organ cultures was 
supplemented with previously stripped 5% (v /v) calf serum, 50 µg /ml 
gentamycin and 2 µg /ml amphotericin B. The final pH of complete 
medium was 7.3 to 7.4. All dissection was performed in a laminar flow 
hood where the tissue was rinsed twice in fresh medium, divided into 
decidua parietalis which was free of fetal tissues and decidua 
capsularis in which trophoblast cells were attached to the decidua. The 
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tissues were then minced into small pieces approximately 2 mm3 and 
four pieces of decidua parietalis or capsularis (each weighing about 2 
mg) were selected and placed in each well of 24 well plates and 1 ml of 
culture medium was added to all wells. Control cultures received 
complete RPMI 1640 medium only. Test cultures containing decidua 
parietalis received medium containing 0, 50 or 500 ng/ml progesterone, 
or 50 ng /ml progesterone and 175 ng /ml mifepristone. Decidua 
capsularis received either complete RPMI 1640 medium or 500 ng /ml 
progesterone. Tissue cultures from the group which received the 
mefipristone in vivo were treated in exactly the same way as the control 
group. There were 4 replicates for each treatment. The plates were 
maintained at 37.0 in an incubator gassed with 95% air and 5% CO2. 
The culture medium was changed daily. The spent medium was 
frozen and stored at -20 °C prior to assay for human PRL. 
4.1.2.3. Radioimmunometric assay of decidual prolactin 
Samples of culture medium were assayed for decidual PRL using a 2- 
site immunoradiometric assay (IRMA) for human PRL (NETRIA, St 
Bartholomews Hospital, London, U.K.) as described in chapter 3. 
4.1.2.4. Avidin- biotin immunoperoxidase staining 
At the time of tissue collection, a portion of each tissue was fixed in 4% 
(w /v) buffered formalin, pH 7.4, for histological examination and 
avidin- biotin immunoperoxidase staining. After embedding in paraffin 
wax, sections (3µm) were cut and stained with hematoxylin and eosin 
(HE) or immunostained for PRL by avidin- biotin immunoperoxidase 
staining methods using rabbit anti -human PRL serum (Lot No. 068, 
DAKO Corporation, Santa Barbara, CA, U.S.A.). The cells size in HE 
sections was measured by an Imagan 2 programme. The 
immunostaining was performed as described in Chapter 3. 
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4.1.2.4. Analysis of Data 
The amount of PRL accumulated in the medium removed from 
cultures that were prepared from the same sample of decidua and 
received the same treatment in vitro were averaged to provide a single 
representative value for an individual patient (n =1). These means were 
then combined to provide an overall mean ± s.e.m. for each day of 
culture in the various treatment groups. The data were then analysed 
by paired Student's t test for the same treatment on different days. The 
effect of different treatments on the same day was analysed using 
unpaired Student's t -test, which was also used to analyse the effect of 
mefipristone on cell size from decidua parietalis and capsularis. 
4.1.3 Results 
4.1.3.1. Pattern of PRL production by decidua 
A. Control 
As shown in Fig 4.1. PRL production by decidua parietalis during the 
five days of organ culture in vitro in the absence of progesterone 
decreased significantly (P <0.05) on each day. Addition of 50 and 500 
ng /ml progesterone in vitro slightly increased decidual PRL production 
compared with control tissue receiving medium alone but this was not 
significant (P >0.05). The addition of mefipristone with 50 ng /ml 
progesterone in vitro had no effect on PRL production by decidua 
parietalis. 
In contrast, for decidua capsularis there was no significant (P >0.05) 
decrease in PRL production during the five days in organ culture, 
regardless of the presence or absence of progesterone (Fig. 4.2.). 
During the first two days in culture decidua parietalis produced more 
PRL than the decidua capsularis, while in the last two days decidua 
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Fig.4.1. Production of PRL by decidua parietalis in vitro during a 5 day 
incubation period (D1 to D5). Tissue was collected from women between 
days 42 and 56 of pregnancy after treatment with or without (control) 
mifepristone (RU 486). Tissue was then cultured in the presence of 0, 
50 or 500 ng progesterone or 50 ng progesterone and 175 ng 
mefipristone. The amounts of decidual PRL accumulated in the 
medium removed from cultures that were prepared from the same 
sample of decidua and received the same treatment in vitro (n =4 
replicates per treatment) were averaged to provide a single 
representative value for an individual patient (n =1). These means were 
then combined to provide an overall mean ± s.e.m. for each day of 
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Fig. 4.2. Production of prolactin by decidua capsularis in vitro during a 
5 day incubation period (D1 to D5). Tissue was collected from women 
between days 42 and 56 of pregnancy after treatment with or without 
(control) mifepristone. Tissue was then cultured in the presence of 0, 
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Fig. 4.3. Comparison of prolactin production by decidua parietalis and 
capsularis in vitro during a 5 day incubation period (D1 to D5). Tissue 
was collected from women between days 42 and 56 of pregnancy after 
treatment with or without (control) mifepristone. Results are mean ± 
s.e.m. as described in Fig. 4.1. 
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B. Mifepristone 
Decidua parietalis from patients treated with mifepristone in vivo for 24 
to 36 h, produced significantly (P<0.01) less PRL than the control group 
and addition of progesterone had no significant effect on PRL 
production (Fig. 4.1.). In contrast, mifepristone in vivo had no 
significant (P >0.05) effect on PRL production by decidua capsularis 
(Fig. 4.2.). Moreover, decidua capsularis produced significantly 
(P <0.05) more PRL than that of decidua parietalis on each day (Fig. 
4.3.). 
4.1.32. Histology and avidin - biotin immunoperoxidase staining 
Decidua parietalis only contained maternal tissue with typical decidual 
cells located around the hypersecretory glands, and some fibroblast 
cells and lymphocytes were present throughout the section. Both 
decidual and trophoblast cells were found in decidua capsularis. There 
was a greater abundance of blood vessels in the decidua parietalis than 
decidua capsularis. Cells in decidua parietalis from the women 
pretreated with mifepristone in vivo were significantly (p <0.001) 
smaller when compared with the control group, while mifepristone in 
vivo had no effect on decidual cell size in decidua capsularis (Fig. 4.4. 
and Plate 4.1.). 
The cytoplasm of the decidual cells in both decidua parietalis and 
decidua capsularis was stained positively for prolactin (Plate 4.1. C and 
A). This positive staining for PRL in decidua parietalis from the 
control group was much stronger and more intense than in the 
mifepristone in vivo group where there was often no immunostaining 
for PRL (Plate 4.1. C and D). In decidua capsularis the 
immunostaining for PRL was similar to decidua parietalis but was not 
affected by pretreatment in vivo with mifepristone (Plate 4.1. A and B). 
Glands were only observed in the decidua parietalis in the sections used 
for immunostaining. While these glands showed intense staining for 
PRL in the controls, this was greatly reduced in the mifepristone in vivo 
group. 
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Fig. 4.4. Comparison of the area of decidual cells in sections (HE stain) 
of decidua parietalis and decidua capsularis taken from women treated 
with or without (control) mifepristone. Results are mean ± s.e.m. n = 
no. of cells measured per treatment. * p <0.001 compared with control. 
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Plate 4.1. Avidin- biotin immunostaining of PRL and HE stain in 
sections of decidua parietalis (c,d), (e,f -HE stain) and decidua 
capsularis (a,b) from women treated without (a,c,e) or with (b,d,f) 
mefipristone for 24 to 36 h before collection of tissue. Note that 
pretreatment with mefipristone resulted in complete absence of PRL 
staining only in decidual cells of decidua parietalis and the presence of 
pycnotic nuclei in these cells. 
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4.1.4 Discussion 
The present results suggest that PRL production by decidua parietalis 
in vivo in early pregnancy was dependent on progesterone. The 
morphology and results of immunostaining for PRL suggest that 
blockade of progesterone action in vivo results in a reduction in 
decidual cell size, PRL cell content and the degree of decidualization. 
These results support the concept that PRL production by decidual cells 
occurred as a consequence of decidualization which was induced by 
progesterone (as described in Chapter 3). In addition these results 
extend previous study in vitro of effect of progesterone on PRL 
production from early pregnancy (Maslar et al., 1988). In spite of the 
apparent dependence of PRL secretion on progesterone in vivo, it is of 
interest that addition of progesterone in vitro could not stimulate 
decidual PRL secretion, confirming previous reports on decidual PRL 
production by decidua in vitro from early human pregnancies (Bischof 
et al.,1986; Ren and Braustein, 1990). It has been observed that 
decidua capsularis released between 3 and 5 fold more progesterone 
than decidua parietalis during the incubation period (Chapter 5), but 
the concentration of progesterone was 10 to 90 times less than the 
maximum amount of progesterone added in vitro. Thus it is unlikely 
that endogenous production of progesterone could explain the 
difference in the release of PRL between decidua capsularis and 
parietalis. Additionally, It is well known that oestrogen priming is 
necessary for demonstration of a progestational effect (Tamaya et al. 
1985; Irwin et al., 1989). This may explain the absence of an effect of 
progesterone on decidual PRL production, since oestradiol was not 
added to the culture medium. 
The observations in early pregnancy are the first where mifepristone 
has been given in vivo but the results complement previous in vitro 
studies which showed that addition of mefipristone to decidualized 
tissues from the late luteal phase and early pregnancy prevented 
progesterone induction of decidual PRL production (Bischof et al.,1986; 
Huang et al., 1987). In the present study addition of mifepristone to the 
cultures in vitro, in the presence of progesterone, did not affect decidual 
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PRL production. It is possible that this local of effect of mifepristone is 
due to an inadequate concentration to displace all the progesterone 
bound to receptors and will need further investigation. 
It is well documented that during the luteal phase of the human 
menstrual cycle, the onset of prolactin secretion by proliferating 
endometrium in culture corresponded to the onset of histologically 
apparent decidualization in response to progesterone- induced 
differentiation in vitro (Daly et al., 1983a). Similarly, decidualized 
endometrium from non - pregnant women in vitro maintained prolactin 
secretion and histological integrity only in the continued presence of 
progesterone (Maslar et al., 1986). However, little information is 
available to elucidate the relationship between decidualization and 
progesterone on PRL production during early human pregnancy. The 
present results are the first from biological and morphological features 
where the inhibition of PRL production resulted from de- 
decidualization of decidual parietalis by mifepristone in vivo, which 
indicated an indirect effect of progesterone on regulation PRL 
production during pregnancy. 
Of considerable interest is the observation in the present study that the 
secretion of PRL by decidual cells of the decidua capsularis did not 
decline over the 5 days in culture period, in contrast to the decidua 
parietalis. In addition, mifepristone in vivo did not affect PRL 
production by decidua capsularis. These results suggest that the 
trophoblast tissue attached to the capsularis may produce a factor(s), 
steroids or non -steroids, which maintained decidualization and, hence, 
decidual PRL production, in spite of progesterone withdrawal. There 
was evidence to imply that decidua parietalis and capsularis were 
under progesterone control, because progesterone receptors have been 
localized in both decidual parietalis and capsularis (Chapter 5). It was 
also possible that the greater abundance of blood vessels in the decidua 
parietalis than decidua capsularis increased the exposure of decidual 
cells of the parietalis to mefipristone. 
On the other hand, potential PRL releasing factors have been identified 
in the utero -placental unit. These factors include insulin (Thraikill et 
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al., 1989), insulin -like growth factor I (IGF -1) (Thraikill et al., 1988), 
human chorionic gonadotrophin (hCG) (Rosenberg and Bhatnagar, 
1984) and a placental- derived PRL releasing factor (Handwerger et al., 
1987a). Moreover, it has been observed that significantly higher 
concentrations of PRL were associated with these tissues in which 
definitive villi containing cyto- and syncytio- trophoblast cells were 
identified more than 2 weeks post conception, compared to those less 
than 2 weeks post conception in which the syncytial trophoblast had not 
yet differentiated extensively (Maslar et al., 1980). These results 
indicate that progesterone plays a central role in switching on PRL 
production as a result of decidualization of the endometrium. Apart 
from progesterone, a factor(s) produced by fetal tissues (trophoblast 
cells), steroids or non - steroids may be required for maintaining 
decidualization and PRL production throughout pregnancy. 
Summary the present results show for the first time that blockade of 
progesterone action in vivo by the anti progestin mifepristone in early 
human pregnancy results in a suppression of decidual PRL production 
associated with morphological de- decidualization of decidual cells in 
the decidua parietalis. In contrast, withdrawal of progesterone did not 
affect either decidualization or PRL production by decidual cells of the 
decidua capsularis. These results suggest a local control of PRL 
derived from the trophoblast is associated with stimulating and 
maintaining PRL production during pregnancy. 
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Part II. The combined effect of progesterone and oestrogen on 
prolactin production by human term decidual cells 
4.2.1. Introduction 
Prolactin production by decidua capsularis to which trophoblast cells 
attached was sustained for up to 5 day in in vitro culture with 
morphological maintenance of decidualization even under the 
condition of progesterone withdrawal in vivo. This suggests that a 
factor(s) from the trophoblast prevent de- decidualization even when 
progesterone action is blocked by anti progesterone. Furthermore, PRL 
production was correlated with decidualization in either normal 
menstrual cycle (Daly et al., 1981) or pregnancy (Chapter 3). It is 
generally accepted that progesterone is required for the induction of 
decidualization and the role of progesterone is constant throughout the 
lifespan of decidualized endometrium, i.e. that of the stimulation and 
maintenance of the decidual reaction. In contrast, the role of oestrogen 
is less defined and has not yet been clearly elucidated. The previous 
results in Part I showed that progesterone alone could not stimulate 
PRL production, while a factor(s) derived from trophoblast could 
maintain decidualization, and thus maintain PRL production. During 
pregnancy, large quantities of progesterone and oestrogen are produced 
by syncytio -trophoblast cells. Presumably progesterone receptors in 
decidua depend on oestrogen stimulation, hence, there may be an 
indirect association between oestrogen and decidualization (Tamaya et 
al., 1985), which is in turn related to PRL production. To determine 
whether both steroids are required for the continued release of PRL, the 
pattern of PRL production produced by the cultured term decidual cells 
in vitro treated with or without progesterone and oestrogen, either 
alone or in combination, was investigated in this part of study. 
While organ culture has been employed in some studies in this thesis, 
the present studies were undertaken using cell culture. An in vitro cell 
culture system was chosen because, firstly, it is possible to select the 
cell population for study using cell separation techniques; secondly, 
tissue viability appears better during in vitro term cell culture; finally, 
the system showed less variation in response. 
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4.2.2. Materials and methods 
4.2.2.1. The development of cell culture method 
Because of the limited availability of tissue from other stage of 
pregnancy, only term decidua was used in these studies. Several 
aspects of the preparation of the term decidual cells and the subsequent 
culture conditions were investigated before the methods was utilized, 
which include: 
1. Enzyme treatment for cell dispersion; 
2. Plating efficiency on uncoated or collagen- coated culture plates; 
3. Semi -purification of decidual cells. 
A. Enzymatic digestion of tissue and culture 
The term placenta with membranes from uncomplicated pregnancies 
between 37 -40 week of gestation were received in the labour ward 
immediately after delivery. When the decidua was separated using a 
scalpel, the areas with obvious attachment of trophoblast were avoided. 
The separated decidua was collected into PBS supplemented with 50 
µg /ml gentamycin and 5 amphotericin B and then transported to 
the laboratory for further processing. 
Decidual cells were dispersed according to the method of Markoff et al. 
(1983a) with some modification as described below: 
Because collagen and hyaluronic acid are the natural substrates upon 
which decidual cells migrate in vivo, collagenase and hyaluronidase 
were chosen for digesting decidual tissue. Two different types of 
collagenase (type III, Lot no. C -0255; type I, Lot no. C -0130; Sigma) were 
compared for the yield and viability of the dispersed cells. The yield of 
the dispersed decidual cells obtained from two different collagenases 
was similar, but the viability of the dispersed decidual cells using 
collagenase III was often less than 50 %. Thus the collagenase I was 
selected in the subsequent experiments carried out in this study. 
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However, individual batches of collagenase, even of same type and from 
the same source, varied greatly in their activity and ability to digest 
decidual tissue is in agreement with other workers (Findlay et al., 
1990). Therefore, optimum digestion times, were tested in order to 
choose the most suitable preparation for producing an acceptable 
decidual cell yield and cell viability. In a previous study (Markoff et 
al.,1983a), 0.1% (w /v) collagenase of 120 -150 U digesting activity /mg and 
0.1% (w /v) hyaluronidase with a digesting activity of 255 U /mg were 
used. Thus in the present study, in which different preparation with 
different digesting activity of the enzymes were employed, the 
percentage of both collagenase and hyaluronidase were varied to 
maintain a similar unitage of activity. When the digesting activity of 
collagenase purchased was at 120 -150 U /mg, 0.1% (w /v) collagenase 
was used in the culture system. If the collagenase digestion activity 
was higher than 150 U /mg, the concentration of collagenase used for 
dispersing decidual cells was decreased correspondingly, which was 
the essential step to obtain the better cell viability in this cell culture 
system. The concentration of 0.1% (w /v) hyaluronidase (type I -S, Lot 
no. H -3506, Sigma) was used in this study with the digesting activity 
around 200 -250 U /mg. 
After the concentrations of the enzymes were decided, different 
digestion times, i.e. 1 h, 1.5 h and 2 h, were compared to obtain the best 
cell viability and cell yield. 
Table 4.1. 
Time Cell yield (cells /g. tissue) Cell viability 
1 h 1.5x106 >98% 
1.5 h 4x106 80-90% 
2 h 4.5-5x106 60-80% 
To compromise between cell viability and cell yield, all the enzymatic 
digestion of decidua was carried out for 1.5 h at 37 °C with the gentle 
stirring. It was essential in this culture system to disperse cells by 
trituration through a 50 ml eppendorf, otherwise only a few decidual 
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cells could be collected from the enzyme solution. 
B. The plating efficiency using uncoated or collagen coated plates 
In order to increase the plating efficiency of the cells, multiwell plates 
were coated with collagen (type I, Sigma) which is the main component 
of the extracellular matrix in decidua (see Appendix 7 for the detailed 
coating method). However, no significant difference in PRL production 
between plates coated with or without collagen was found under this 
culture conditions. Thus uncoated plates were used during the 
subsequent culture procedure. 
C. Cell separation using Percoll 
When the same density of cells was plated into wells, the yield of PRL 
produced by cells with 40% Percoll purification (the detailed method for 
preparating 40% Percoll shown in Appendix 8) was almost twice as 
much (1245 ± 279 s.e.m. mU/L) as that without applying Percoll 
purification (741± 83 s.e.m. mU/L). So 40% Percoll purification was the 
ordinary procedure undertaken in this culture procedure. After 
centrifugation of the dispersed cell suspention through 40% Percoll 
gradients, decidual cells were banded at the density between 1.019 -1.033 
g /ml calibrated by Density Marker Beans, which was in accordance 
with the previous report (Markoff et al., 1983a). 
D. Immunocytochemistry and in situ hybridization 
The proportion of PRL producing cells after Percoll separation, was 
determined using both immunostaining for PRL using anti -human 
PRL serum, and localization of PRL mRNA using human PRL cDNA 
probe by in situ hybridization. Dispersed cells were plated in tissue 
culture chamber slides (Nunclon) at a density of 5 x 104 cells /ml in 5 ml 
RPMI -1640 medium supplemented with 10% fetal calf serum, 50 µg /ml 
gentamycin, 25 U /ml penicillin, 25 µg /ml streptomycin, and 5 µg /m1 
amphotericin B. The cells were then incubated for 48 h at 370C in a 




Plate 4.2. Immunocytochemical staining of PRL and in situ localization 
of PRL mRNA in dispersed decidual cells from human term decidua. 
(4.LA) The specific immunostaining of PRL in dispersed term decidual 
cells grown in culture for 48 h. 
(4.1.B) In situ localization of PRL mRNA in dispersed term decidual 
cells grown in culture for 48 h. Note highly specific localization 
of black grains within the cytoplasm of decidual cells. 
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cells to the slides. The culture medium was then aspirated from the 
chambers, the cells were washed twice with RPMI -1640 medium and 
the slides were stored at -70 °C until processing for 
immunocytochemistry or in situ hybridization. 
The immunocytochemistry and in situ hybridization were performed as 
described in Chapter 2 except that cells were only fixed in 4% 
paraformaldehyde in PBS for 10 min followed by two washes in PBS for 
10 min before adding prehybridization buffer or normal swine serum as 
blocking reagent for in situ hybridization and immunocytochemistry. 
Thereafter the methods were identical to those described in Chapter 2. 
When the positive immuno- and in situ staining cells were counted 
throughout the slides, 50 -60% cells were positively immunostaining 
with anti -PRL antibody, and 80% cells contained PRL mRNA localized 
by in situ hybridization (Plate 4.2. A and B). 
The final protocol of decidual cell culture was as follows: 
Decidual tissue from term pregnancies stripped from the chorion was 
washed thoroughly in PBS (Gibco) supplemented with 50 µg /ml 
gentamycin and 5 µg /ml amphotericin B. The tissue was then minced 
into small pieces (5 mm3) and placed in a stirrer flask (1 g tissue /5 ml 
medium) and digested for 1.5 h at 37 °C with gentle stirring in buffered 
RPMI -1640 medium containing 0.1% collagenase (type I, 120 -150 
units /ml, Sigma), 0.1% hyaluronidase (type I -S, 200 -250 units /mg, 
Sigma), and 1% fetal calf serum (Flow Laboratories, Rickmansworth, 
Herts, UK). Cells were then dispersed by trituration through a 50 ml 
eppendorf sterile combitip, passed through nylon cloth (Lockertex, 
Warrington, Cheshire, UK; mesh size 150 µm) and then collected by 
centrifugation (100 x g, for 10 min). The cell pellet was washed twice 
and resuspended in the medium at a density 6 -8 x 106 cells /ml. 
One ml of dispersed cells was carefully layered on the top of the 
performed 40% Percoll (Pharmacia Ltd, Milton Keynes, Bucks, UK) 
gradients and cells were separated by centrifugation at 800 g for 20 min 
at room temperature. Those with densities of 1.019- 1.033, calibrated 
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with Density Marker Beans (Pharmacia LKB, Biotechnology AB, 
Uppsala, Sweden), were accumulated by aspiration, and washed twice 
in medium. Cells were counted and assessed for viability by trypan 
blue exclusion. Only those cells with viability more than 80% were 
plated in 24 -well plates (Nunclon) at a density of 0.5 -1 x106 /ml in 1 ml 
RPMI -1640 medium supplemented with 10% stripped fetal calf serum, 
50 µg/ml gentamycin, 25 U /ml penicillin, 25 µg /ml streptomycin, and 5 
p.g /ml amphotericin B. and treated as experimental design. 
4.2.2.2. Steroid hormone treatment 
After plating, the cells were incubated for 48 h at 37 °C in a humidified 
atmosphere of 95% air:5% CO2 to allow attachment of the cells to the 
wells. The culture medium was aspirated from the wells, cells were 
then treated as experimental design, with medium changed daily for 3 
days and frozen for later assay of PRL. 
In order to add oestradiol and progesterone to the medium, 
concentrated stock solution were firstly prepared by dissolving 2 mg of 
each steroid in 2 ml of absolute ethanol. These stock solutions were 
further diluted in RPMI -1640 medium to the desired working 
concentrations. 
Nine different steroid treatments were investigated in this study, with 
triplicates for each treatment. This was repeated using 3 separate 
tissues. Control cultures received RPMI -1640 culture medium only, but 
with same concentration of ethanol as test cultures and test cultures 
received RPMI -1640 medium containing 1 or 100 ng/ml of progesterone 
or 1 or 10 ng /ml of oestradiol, either alone or in combination as shown 
in Fig 4.5. The steroids were added to the culture medium when cells 
were being added to the plates at the start of the culture. 
4.2.2.3. Radioimmunoassay and statistical analysis 
PRL radioimmunoassay was performed as described in Chapter 3. The 
PRL values prepared from same sample and receiving the same 
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treatment in vitro were averaged to provide a single representative 
mean for each patient. These means were then combined to provide an 
overall mean of different patients for each day of culture in the various 
treatment groups. Statistical analysis was performed by using analysis 
of variance and Duncan's multiple range test with significance defined 
as P <0.05. 
4.2.3. Results 
The amount of PRL released by decidual cells during 3 days in in vitro 
culture in RPMI -1640 medium only or containing either oestradiol or 
progesterone or both is shown in Fig. 4.5. A -C. There was no 
significant effect on PRL production by decidual cells treated with 
either oestradiol or progesterone alone relative to non -hormonal control 
during in vitro culture for 3 days. However, a significant increase of 
PRL production occurred when 100 nM progesterone was combined 
with 10 nM oestradiol (p <0.05) on day 1, and (P <0.01) on day 2 and 3 in in 
vitro culture. Furthermore, on day 2 and 3, the cultured cells treated 
with 100 nM progesterone and i nM oestradiol produced significantly 
(P <0.05) more PRL than either non -hormonal control or single steroid 
treated cells. Additionally, PRL production level was maintained over 3 
days in vitro culture in the presence of 100 nM progesterone with either 
1 or 10 nM oestradiol. However, there was no effect of addition of 1 nM 
progesterone with either 1 or 10 nM oestradiol. 
4.2.4. Discussion 
The isopycnic centrifugation of collagenase- and hyaluronidase- 
dispersed decidual tissue through Percoll purification resulted in the 
enrichment of a cell population banded at the density between 1.019- 
1.033, which synthesized and released PRL during in vitro culture. 
This result confirmed the previous report that when cells from the 
individual fractions of the Percoll gradient were cultured only those 
cells with the density between 1.017 -1.045 secreted detectable amounts of 
PRL (Markoff et al., 1983a). The results from immunocytochemistry 
and in situ hybridization further confirmed that the Percoll gradient 
indeed separated out PRL producing cells, suggesting a reliable method 
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Fig. 4.5. The amount of decidual PRL released by the cultured term 
decidual cells in vitro during a 3 day incubation period (A -C) treated 
without or with 1 or 10 n.M oestradiol and 1 or 100 nM progesterone, 
either alone or in various combination as shown in the Fig 4.5. The 
amounts of decidual PRL accumulated in the medium removed from 
cultures that were prepared from the same sample of decidua and 
received the same treatment in vitro (n =3 replicates per treatment) 
were averaged to provide a single representative value for an individual 
patient (n =1). These means were then combined to provide an overall 
mean ± s.e.m. for each day of culture in the various treatment groups. 
On day 1, tissues received 10 nM oestradiol and 100 nM progesterone 
released significantly more (p <0.05) PRL than the control group or the 
groups received either oestradiol or progesterone alone. On day 2 and 3, 
tissue received 1 nM oestradiol and 100 nM progesterone or 10 nM 
oestradiol and 100 nM progesterone released significantly more (p <0.05, 
p<0.01) PRL than the control group or the groups received either 
oestradiol or progesterone alone. 
94 
of dispersing and separating PRL producing cells from term decidua 
used in this study. Much more consistent results (lower standard 
deviation) were obtained in the cell culture system than those of organ 
culture (Chapter 4, Part I) 
The results presented here demonstrated that PRL production could be 
stimulated and maintained by the treatment of a combination of 
oestradiol and progesterone. The role of progesterone was defined as 
an initiator and stimulator of decidualization and, in turn, this had 
effect on PRL production in normal menstrual cycle (Maslar et al., 
1986; Maslar and Ansbacher, 1988; Casslen et al., 1990). However, the 
mechanism of maintaining decidualization and of steroid action on 
PRL production during pregnancy remains unclear. A single study 
(Daly et al., 1983b) demonstrated that progesterone alone stimulated 
PRL production by term decidua, and suggested that progesterone acted 
as stimulator for PRL production throughout pregnancy. However, the 
present results in either early (Part I) or term pregnancy (Part II) 
showed that progesterone alone in vitro was incapable of stimulating 
and maintaining PRL production, in agreement with other studies 
(Markoff et al., 1983a; Rosenberg and Bhatnagar, 1984; Ren and 
Braunstein, 1990). The lack of effect of progesterone alone on PRL 
production was unlikely to be due to the concentration used since the 
dose of progesterone used in this study covered the maximal 
physiological range. Progesterone certainly played an important role 
on PRL production during pregnancy since withdrawal of progesterone 
in vivo using the anti progesterone mefipristone caused de- 
decidualization of decidual cells, with a dramatic decrement of PRL 
production (Chapter 4, Part I). This suggests that progesterone is not a 
direct regulator of PRL production and further supports the concept 
that, through decidualization in which other factors might be required, 
progesterone has an indirect effect on PRL production during 
pregnancy. 
The role of oestrogen was less clear. Previous work has suggested that 
depending on the dose used in culture, oestrogen alone may stimulate 
(Rosenberg and Bhatnagar, 1984), have no effect (Irwin et al., 1989), or 
inhibit slightly (Daly et al., 1983b) PRL production. When combined 
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with progesterone, oestradiol was shown to exert negative (Daly et al., 
1983a), neutral (Huang et al., 1987), or positive (Randolph et al., 1990; 
Casslen et al., 1990) effects on PRL production. The cellular 
hetergeneity of decidua tissue and the interaction between different type 
of cells, especially contaminated by trophoblast may contribute, in part, 
to the discrepancy in the steroid action of oestrogen on PRL production 
among different studies. 
The present study has shown that oestradiol alone could not stimulate 
PRL production or even slightly inhibited PRL production after 3 days 
in in vitro culture. When applied together with 1 nM progesterone, 
oestradiol still had no effect on PRL production even when the 
concentration of oestradiol was increased 10 fold. In contrast 100 nM 
progesterone combined with either 1 nM or 10 nM oestradiol acted to 
stimulate and maintain PRL production over 3 days of culture in vitro, 
which indicated that the ratio of progesterone to oestrogen might be 
crucial for steroid action. This result is supported by the clinical 
evidence that abnormal progesterone or oestradiol levels during the 
luteal phase, resulted in a decreased ability of the endometrium to 
produce PRL which in turn was linked insufficient decidualization 
(Daly et al., 1981; 1983a). 
The enhancement of progesterone - stimulated function by concurrent 
oestradiol treatment observed in this study is consistent with the known 
up- regulation of progesterone receptors by oestrogen both in vivo 
(Lubbert et al., 1982) and in vitro (Eckert and Katzenellenbogen, 1981). 
Since PRL production depends on decidualization, the study from in 
vitro decidaual cell culture has shown that concurrent oestrogen 
treatment could enhance of progesterone induced decidualization 
(Irwin et al., 1989). In addition, oestrogen was clearly the major 
stimulator of cell growth and proliferation in uterus (Pavlik and 
Katzenellenbgen, 1978), which is a direct prerequisite for 
decidualization (Bell, 1983) and oestrogen priming was important for 
subsequent protein secretion by decidua (Seppala et al., 1988). All of 
these results support the concept that oestrogen might be indirectly 
involved in the control of decidualization and as a consequence, PRL 
production by decidua. 
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Summary: these studies clearly showed that neither oestradiol or 
progesterone alone maintained PRL production and suggested that 
oestradiol and progesterone acted synergistically to maintain 
decidualization and the consequent production of PRL by decidual cells. 
In the next chapter, studies on the cellular distribution of oestradiol 
and progesterone receptor are reported in the context of decidualization 
and PRL production. 
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CHAPrER 5 
Immunolocalization of Oestrogen and Progesterone Receptors 
in the Human Decidua in Relation to Prolactin Production 
5.1. Introduction 
In the previous Chapter (Chapter 4) it was shown that progesterone 
and oestrogen acted synergistically to maintain PRL production in 
either early or term pregnancy (Chapter 5). It has been well 
documented that steroid hormones can only act after binding to their 
specific receptors in the target tissue (Gorski and Gannon, 1976). 
Decidual steroid receptors must therefore play a vital role in mediation 
of the responses of decidua to steroids. 
The changes in receptor content and receptor distribution using 
biochemical binding assay have been reported during human 
pregnancy. The results showed a progressive decrease in progesterone 
and oestrogen binding to undetectable level by term (Padayachi et al., 
1987). However, because of the heterogeneity of uterine cells, it has been 
exceedingly difficult to accurately determine the relative receptor 
contents of individual cell types, and the intracellular distribution of 
receptors using biochemical assays. In addition, no information is 
available to define the exact receptor status of various intrauterine 
tissue in relation to PRL production during pregnancy. 
Immunocytochemistry allows direct localization of steroid receptors 
within individual cells and an evaluation of the receptors within a 
complex association of cell types in decidua parietalis and capsularis. 
Thus, the following studies were carried out to determine, firstly, the 
status of steroid receptors in decidua parietalis and capsularis; 
secondly, the changes in the pattern of intracellular receptor 
distribution and receptor content throughout the pregnancy; finally, the 
relationship among steroids, steroid receptors and PRL production in 
both decidua parietalis and decidua capsularis by examining the PRL 
and progesterone production from decidua parietalis and capsularis 
and double immunostaining PRL and progesterone on same sections. 
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5.2 Materials and methods 
5.2.1. Development of method for freezing tissue 
Decidua samples from early pregnancy were obtained by curettage 
during therapeutic abortions and term pregnancy tissue was collected 
in the labour ward immediately after delivery. Both early and term 
tissue were frozen as describe in Method 3. In each group, tissues from 
3 different patients were collected both in early and term pregnancy. In 
early pregnancy, both decidua capsularis and parietalis were 
examined for oestrogen and progesterone receptors. 
Previous studies have reported a loss of steroid receptor or apparent 
translocation of steroid receptors during tissue preparation (West et al., 
1987). Since this can be avoided by using frozen sections, all 
immunocytochemistry of steroid receptors was performed on frozen 
sections. 
In order to obtain good morphology of the tissue section, different 
freezing methods were tried: 
1. A piece of tissue no more than 4 mm3 was placed in an aluminium 
foil and immersed in either a dry ice or liquid nitrogen bath until 
frozen, then stored in liquid nitrogen before performing 
immunocytochemistry. Even though tissue was small in size, and 
quickly frozen, the formation of ice crystals which disrupted the tissue 
and cell structure could not be prevented. This yielded heavy 
background staining and caused difficulty in detecting the specific 
staining (Plate 5.1. A). 
2. Tissue (4 mm3) was placed in aluminium foil, and immersed in 
cooled isopentane /liquid nitrogen bath for 2 min, then stored at -70 °C 
until sectioned. When the tissue block was sectioned on a crystat at - 
20°C, tissue was soft because of isopentane in the tissue which became 
liquid since the freezing point of isopentane is - 150 °C. Therefore, it was 
impossible to cut the sections without destroying the tissue morphology. 
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3. Tissue (4 mm3) was placed in a small plastic container, filled with 
Tissue -Tek O.C.T. mounting medium (Miles, Diagnostic Division, 
Elkhart, IN 46515, USA), and quickly frozen in a precooled 
isopentane/liquid nitrogen bath. The frozen tissue mounted in the 
medium was stored in -70 °C freezer until processing for 
immunocytochemistry. When the tissue was frozen by this method, the 
immunostaining results were greatly improved (Plate 5.1. B). 
Therefore, this method of freezing tissue, was adopted for the steroid 
receptor study described in this chapter. 
5.2.2. Oestrogen receptor immunostaining 
Oestrogen receptor immunostaining was performed according to the 
method described by manufacturer (ER immunostaining kit from 
Abbott Laboratories; Diagnostics Division, North Chicago, IL 60064, 
USA) using the peroxidase anti -peroxidase (PAP) technique and 
described as follows. After each treatment, the slides were rinsed twice 
in PBS for 10 min at room temperature expect for step 3. 
1. Frozen tissue was sectioned at 5 p.m on a crystat at -20 °C, and 
sections were lifted onto gelatin coated slides and then 
immediately in 3.7% formaldehyde in PBS for 10 min at room 
temperature; 
2. Fixed sections were then transferred to cold methanol at -20 °C for 4 
min, followed by cold acetone at -20 °C for 2 min; 
3. Normal goat serum included in the kit was added as blocking 
reagent to each specimen and incubated for 30 min at RT; 
4. After removing the excess blocking reagent, the specimens from 
either early or term pregnancy were treated with the primary rat 
monoclonal oestrogen receptor antibody (0.1 µg/ml) for 16 h at 4 °C; 
5. The sections were then incubated with goat anti -rat immunoglobulin 
(1 gg/ml) for 30 min; 
6. Finally, the sections were treated with a rat anti -goat 
gammaglobulin peroxidase- anti- peroxidase complex (0.1 µg /ml) for 
30 min at RT. 
100 
5.2.3. Progesterone receptor immunostaining 
Indirect and PAP immunostaining techniques for progesterone 
receptor were compared. As the indirect immunostaining method gave 
much less background, the subsequent experiment was undertaken 
using this method. 
5.2.3.1. Preparation of PAF fixative (pH 7.3) 
Based on the method recommended by Stefanini and Perrot -Applanat 
(Stefanini et al., 1967; Perrot- Applanat et al., 1985), the buffered picric 
acid -formaldehyde (PAF) fixative was used to fix the tissue for 
progesterone receptor immunostaining. To prepare PAF fixative, 20g 
of paraformaldehyde was added to 150 ml of a double -filtered, saturated 
aqueous solution of picric acid. The solution was heated at 60 °C and 
made alkaline with drops of a 2.52 % (w /v) sodium hydroxide in water to 
dissociate the paraformaldehyde into formaldehyde. Thus a clear 
solution was obtained, which was filtered in a cylinder, allowed to cool, 
and then made up to 1,000 ml with a 0.15 M phosphate buffer. 
5.2.3.2. Progesterone receptor immunostaining procedure 
1. Frozen sections (51.1m) were lifted onto gelatin coated slides, and 
fixed in PAF for 15 min at -20 °C; 
2. Fixed sections were then transferred to PBS at 4 °C for 40 min before 
proceeding; 
3. Pretreated with 0.5% (v /v) H2O2 in PBS for 15 min, followed by 
rinsing in PBS twice for 10 min at RT; 
4. Incubated with 20% (v /v) normal rabbit serum and 5% (w /v) BSA in 
PBS with 0.15 NaC1 for 30 min at RT; 
5. After blotting off the excess normal rabbit serum, the sections were 
then incubated with 5 gg /ml mouse anti -progesterone receptor 
monoclonal antibody (Transbio; 6 Rue Thiers, 75116 Paris, France) 
for 30 min for staining progesterone receptor in early pregnancy 
tissue, and 10 µg /m1 for 24 h at 4 °C for staining progesterone 
receptor in term decidua; 
6. Rinsed in PBS twice for 10 min; 
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7. Blocked by normal rabbit serum again for 10 min; 
8. Treated with rabbit peroxidase conjugated anti -mouse IgG (1:20 
diluted in 20% (v /v) normal rabbit serum) for 30 min at RT. 
The immunoprecipitate for the specific antigens (i.e. ER and PR) was 
visualized by incubation with DAB, which formed a brown reaction 
product. Sections were lightly couterstained with hematoxylin to 
facilitate the identification of cellular elements and mounted. 
Negative control serial sections, involving substitution of rat or mouse 
antibody, were performed for each tissue sample. 
5.2.4. PRL and progesterone double immunostaining 
PRL and progesterone receptor double immunostaining was performed 
on frozen sections fixed with PAF for 15 min at -20 °C. The 
immunocytochemical localization of progesterone receptor in early 
decidua parietalis was accomplished by the method described above. 
The first antigen (progesterone receptor) was visualized by using DAB 
as the reaction product (brown colour). The sections were then 
immersed in 1 N HC1 for 1 h to elute tissue -bound antibodies. The 
sections were then blocked by normal swine serum (1:4 diluted in PBS 
with 5% (w /v) BSA before being exposed to the rabbit anti human PRL; 
(1:500 diluted in 20% (v /v) normal swine serum with 5% (w /v) BSA) for 
30 min at RT. After rinsing in PBS twice for 10 min, biotinylated swine 
immunoglobulin raised against rabbit immunoglobulin and AB 
complex were sequentially applied to the sections as described for single 
antigen localization, followed by rinsing in PBS twice for 10 min after 
each treatment. The peroxidatic activity of the immunolocally bound 
AB complex was revealed by incubation in the medium containing 0.1% 
(v /v) H2O2 and 0.3% (w /v) 4- C1- 1- napthol (Sigma) in 0.05 M Tris/HC1 
buffer, pH 7.6 (blue colour). The sections stained 
immunocytochemically in this manner for two antigens were 
examined without any counterstaining. 
The specificity control consisted of substituting normal mouse serum 
and normal rabbit serum for the specific antisera. 
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5.2.5. Tissue culture and radioimmunoassay 
Organ culture was performed as described in Chapter 4. The culture 
medium was changed daily for 4 -5 days with the spent medium from 
each day being frozen and stored at -20 °C before assaying for PRL using 
a two -site immunoradiometric assay (IRMA) as described in Chapter 3, 
and assaying for progesterone using non -extraction 
radioimmunoassay described in detail as follows: 
A specific non -extraction radioimmunoassay was used for measuring 
progesterone in culture medium according to the method described 
previously (McNeilly and Fraser, 1987). Briefly, duplicate 50 µl of 
samples /standards, diluted as required, were added to 100 p.1 assay 
buffer ( 0.1% (w /v) gelatin in phosphate citrate buffer, pH 6.0 with 0.1% 
(w /v) thiomersal). All tubes apart from NSB then received 100 µl of 
sheep anti -progesterone (S 361), with subsequent addition of 100 .tl 
[125I]- labelled progesterone (12,000 -15,000 c.p.m. /100 µl) to all tubes. 
After incubation at room temperature for 3 h, 100 µl normal sheep 
serum (1:3200) and 100 µl Donkey anti -sheep serum (1:64) were added to 
all tubes except for total counts and the tubes were then incubated at 
4 °C overnight. With addition of 1 ml of 0.9% saline including 4% 
PEG /0.2% (v /v) Triton -X , tubes were then centrifuged for 30 min at 
2,500 rpm at 4 °C. The supernatant was discarded and the tubes were 
then counted in Multigrammer counter. 
The reference standard ranging between 7.8 -1000 pg /0.1 ml was Preg -4- 
ene 3, 20 -dione ( Catalogue No. P0130, Sigma Chemical Co. Ltd). The 
antibody S361 was used at an initial concentration of 1:10,000. The 
detection limit was 7.8 pg /tube. The intra- and interassay coefficients of 
variation were 5.0% and 18 %, respectively. 
5.2.6. Analysis of data 
The changes in PRL and progesterone during organ culture were 
analysed using paired Student's t test in same group on different days. 
The changes of different groups on the same day were analysed using 
unpaired Student's t -test. 
103 
5.3. Results 
5.3.1. Oestrogen receptor immunostaining 
In early decidua parietalis, the nuclei of all of the glandular cells were 
positively stained for oestrogen receptor, while only a few weakly 
stained nuclei of decidual cells could be identified (Plate 5.1. C). In 
decidua capsularis, most of decidualized cells contained oestrogen 
receptor, and the intensity of staining was much stronger in decidua 
capsularis than that in decidua parietalis (Plate 5.1. E). The specific 
staining was always localized in cell nuclei in early decidua, whereas 
no specific staining in either cytoplasm or nuclei could be identified in 
term decidua. No nuclear staining occurred in the control preparation, 
i.e. when a normal non -immunized rat serum was used in place of the 
anti oestrogen receptor antibody. Term decidual cells did not show any 
detectable staining of oestrogen receptor in this immunostaining 
system. 
5.3.2. Progesterone receptor 
Both decidualized cells in decidual capsularis and parietalis of early 
pregnancy were stained for progesterone receptor and the staining 
intensity in decidua capsularis was slightly stronger than that in 
decidua parietalis (Plate 5.1. F and B). However, no specific 
progesterone receptor immunostaining was identified in glandular cell 
of decidual parietalis (Plate 5.1. D). All specific immunostaining was 
localized in nuclei in early pregnancy decidua. In contrast, the specific 
progesterone receptor staining was only localized in the cell cytoplasm 
and not in the nucleus in term pregnancy decidua on either frozen 
sections (Plate 5.1. I) or dispersed term decidual cells. Indeed, this 
immunostaining was very faint even using a longer incubation time 
and a higher concentration of primary antibody. The preparation of 
term dispersed decidual cells for immunocytochemistry was exactly 
same as described in Chapter 4. None of the control sections produced 







Progesterone and oestrogen receptor distribution in human early and 
term pregnancy decidua analysed by immunocytochemical method 
using monoclonal antibodies to human progesterone and oestrogen 
receptors. 
(5.1.A) Immunolocalization of progesterone receptor in decidua 
parietalis of early pregnancy. The decidua was frozen in the 
liquid nitrogen immediately after collection. Note the destroyed 
integrity of the tissue and very heavy background staining. 
(5.1.B) Immunolocalization of progesterone receptor in decidua 
parietalis of early pregnancy. The decidua was frozen 
according to Method 3 of freezing tissue described in the 
Materials and Methods. Note the morphology of the decidua 
was much more improved. Progesterone receptor was only 
localized in the nuclei of the decidual cells without any 
background staining. 
(5.1.C) Immunolocalization of oestrogen receptor in decidua parietalis 
of early pregnancy Immunoreactive oestrogen receptor is only 
present in the nuclei of epithelial and decidual cells. Much 
more intense staining is noted in the glandular epithelia than 
that of decidual cells. 
(5.1.D) Immunolocalization of progesterone receptor in decidua 
parietalis of early pregnancy. Note the progesterone receptor 
staining is absent in the nuclei of glandular epithelia in 
contrast to the strong staining localized in the decidual cells. 
(5.1.E) Immunolocalization of oestrogen receptor in decidua capsularis 
of early pregnancy. Note decidual cells in decidua capsularis 
contain higher lever of oestrogen receptor than that in decidua 
parietalis shown in 5.1.C. 
(5.1.F) Immunolocalization of progesterone receptor in decidua 
capsularis of early pregnancy. Note the nuclear staining in the 
Continued.... 
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decidual cells in decidua capsularis is slightly stronger than 
that in decidua parietalis as shown in 5.1. B and D. 
(5.1.G) Immunolocalization of oestrogen receptor in decidua parietalis 
of early pregnancy. Note the nuclei of smooth muscle of blood 
vessels contained oestrogen receptor. 
(5.1.H) Immunolocalization of progesterone receptor in decidua 
parietalis of early pregnancy. Note the nuclei of smooth muscle 
of blood vessels contained progesterone receptor. 
(5.1.I) Immunolocalization of progesterone receptor in decidua of term 
pregnancy. Note progesterone receptor is specifically localized 
in the cytoplasm in contrast to the absence of the progesterone 
receptor staining in the nuclei of term decidual cells, 
suggesting that the nuclei of term decidual cells do not contain 
progesterone receptor. 
(5.1.J) Double immunolocalization of progesterone receptor and PRL on 
the same section of decidua parietalis from early pregnancy. 
Note progesterone receptor is only identified in the nuclei, while 
PRL is present in the cytoplasm of decidual cells. The positive 
PRL staining is predominantly associated with these cells 
containing progesterone receptor in the nuclei. 
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Day in culture 
Fig. 5.1. Comparison of progesterone and PRL production in decidua 
parietalis and capsularis. Tissue was collected from women between 
days 42 and 56 of pregnancy after therapeutic abortion and cultured in 
vitro for 4 to 5 days. The amount of progesterone and PRL accumulated 
in the cultured medium removed from cultures that were prepared 
from the same sample of decidua (n =4 replicates per treatment) were 
averaged to provide a single representative value for an individual 
patient (n =1). These means were then combined to provide an overall 
mean ± s.e.m. for each day of culture in decidua parietalis and 
capsularis. Note the decidua capsularis produced significantly more 
progesterone (P <0.05) than that in decidua parietalis over each day in 
vitro culture (A). PRL production in vitro in decidua parietalis declines 
dramatically (P <0.05) in contrast to the maintenance of the PRL level in 
decidua capsularis upon in vitro culture (B). 
1 2 3 4 
2 3 4 5 
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The presence of nuclear staining of oestrogen (Plate 5.1.G) and 
progesterone receptor (Plate 5.1.H) in spiral arteries of the early human 
decidua was observed, yet there was no evidence of receptor staining in 
endothelial cells lining blood vessels. 
5.3.3. Progesterone and PRL double immunostaining 
This study was only executed in early decidua parietalis. Most decidual 
cells were positive for progesterone receptor in the nucleus, and for 
PRL in the cytoplasm (Plate 5.1. J). Control sections showed no specific 
staining. 
5.3.4. PRL and progesterone production by decidua in early pregnancy 
Progesterone production by decidua parietalis and capsularis on each 
day for 4 days incubation is shown in Fig. 5.1.A. Decidua capsularis 
produced significantly (P<0.05) more progesterone than decidua 
parietalis on each day of incubation. 
Decidua PRL production by decidua parietalis during the 5 days of 
organ culture in vitro decreased significantly (P <0.05) on each day. In 
contrast, for decidua capsularis there was a maintenance in decidual 
PRL production during the 5 day organ culture (Fig.5.1.B). 
5.4. Discussion 
This is the first study carried out examining steroid receptor 
distribution in the different regions of early pregnancy decidua. It 
clearly shows that most decidual cells in either decidua parietalis or 
capsularis contain progesterone receptors. This provides direct 
evidence that both decidua capsularis and parietalis are under 
progesterone control. This suggests that the failure of mefipristone in 
vivo to cause de- decidualization and subsequent inhibition of PRL 
production in decidua capsularis was not related to the absence of 
progesterone receptors. Other factors from trophoblast attached to 
decidua capsularis play an important role in maintaining 
decidualization. 
109 
Progesterone receptor shifted from epithelial cells to stromal cells, 
caused either by accumulation of oestrone and oestradiol in the stroma 
cells (Press et al., 1988) or cumulative activity of progesterone (Garcia et 
al., 1988). This occurred in the late luteal phase (Press et al., 1988; 
Garcia et al., 1988), but continued in early pregnancy as demonstrated 
in the present study, in which no specific progesterone receptor 
staining was localized in glandular cells. This shift of progesterone 
receptor to stromal cells coincided with the start of decidualization of 
stromal cells and PRL production in the late luteal phase. In addition, 
during pregnancy progesterone mainly acted on stromal cells to 
maintain dedidualization in decidua with increased PRL gene 
expression (Chapter 4). The results from the present study show for the 
first time that decidual cells staining positively for PRL always 
contained progesterone receptor (Plate 5.1. J). These results further 
indicated that progesterone was a fundamental factor involved in 
stromal cell decidualization through which expression of PRL gene 
was promoted. The depletion of progesterone receptor in the glandular 
epithelium may parallel its declining functional importance in this cell 
populations during early pregnancy. Stroma, which becomes 
decidualized, would logically require receptors to support its further 
growth and differentiation. 
Decidual cells are a main target for progesterone during pregnancy 
and progesterone has been shown to down -regulate the oestrogen 
receptor (Tseng and Gurpide, 1975; West et al., 1987; Brenner et al., 
1990). In addition, treatment with mefipristone in vivo resulted in a 
large increase in the number of oestrogen receptors in decidua of 
rhesus macaques during pregnancy (Haluska et al., 1990). Thus the 
low level of oestrogen receptor in the nuclei of decidual cells in decidua 
parietalis may be due to an inhibitory action of progesterone acting 
through the nuclear receptors demonstrated in these cells. The much 
stronger oestrogen receptor staining in the nuclei of glandular cells 
may be maintained because there is low or no progesterone receptor 
present in these cells and thus progesterone would not affect the 
expression of oestrogen receptor in these cells. However, it remains to 
be shown whether the high level of oestrogen receptor in glandular 
cells contributes to a biological effect. In contrast, more intense 
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staining of oestrogen and progesterone receptor could be identified in 
decidual cells of decidua capsularis. This may be correlated with the 
oestrogen produced by trophoblast in decidua capsularis, since it was 
well established that syncytio -trophoblast produces not only 
progesterone but also oestrogen. The high local concentration of 
oestrogen in decidua capsularis could up- regulate its own receptor and 
the progesterone receptor (Kreitmann- Gimbal et al., 1979; Kreitmann- 
Gimbal et al., 1980; West et al., 1987), which would, therefore, enhance 
progesterone action in decidua capsularis to maintain PRL production. 
In the present study, decidua capsularis released significantly more 
progesterone than decidua parietalis which presumably related to the 
presence of trophoblast cells in capsularis. However, it is unlikely that 
this endogenous production of progesterone alone can explain the 
difference in the release of PRL between decidua capsularis and 
parietalis, as the addition of progesterone alone in vitro could not 
stimulate PRL secretion in either early or term decidua ( Markoff et al., 
1983a; Ren and Braunstein, 1990; Chapter .4). It is possible that 
oestrogen or other factors from trophoblast, together with progesterone 
participated in modulation of PRL production. This view was further 
confirmed in the study of term decidual cells in culture in which 
oestrogen in combination with progesterone modulated PRL production 
(Chapter 4). 
The existence of oestrogen and progesterone receptors in the nuclei of 
smooth muscles of blood vessels in human decidua, in agreement with 
previous study (Perrot -Applanat et al., 1988), may relate to a steroid - 
mediated regulation of uterine blood flow during pregnancy. During 
pregnancy, blood flow undergoes dramatic increases in order to 
support fetal growth and homoeostasis (Nuwayhid, 1979; Resnik, 1986). 
The present immunocytochemistry results imply that sex steroids 
modulate uterine blood flow through a direct effect on uterine arterial 
walls. 
A striking observation made in the present study was that in term 
decidual cells progesterone receptor was localized in the cell cytoplasm 
and not in the nucleus. This is the first report that by using 
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immunocytochemical technique progesterone receptor was localised in 
the cytoplasm. Immunocytochemistry of frozen sections most likely 
revealed antigen in their native localizations, because tissue was 
processed under low temperature and there was, no dehydration 
through alcohol and xylene which could potentially damage the 
receptor antigens involved before fixation. It is, therefore, unlikely that 
nuclear progesterone receptor was translocated into cytoplasm during 
the preparation of the tissue. Furthermore, progesterone receptors 
were also present in cytoplasm of the dispersed term decidual cells and 
the staining for term decidua was performed under same condition as 
early decidua. Many studies have proved that both unoccupied and 
steroid -occupied forms of oestrogen and progesterone receptors reside 
in the nucleus even under conditions of low circulating steroids (Press 
and Greene, 1984; King and Greene, 1984; Press and Greene, 1988a). 
Thus, whether this discrepancy of intracellular localization of 
progesterone receptor in decidual cells between early and term 
pregnancy resulted from localization of dissimilar forms of steroid 
receptors remains to be identified. Nevertheless, this cytoplasmic form 
of progesterone receptor appeared to be functional since progesterone 
combined with oestrogen could stimulate and maintain PRL production 
in cultured term decidual cells (Chapter 4). This occurred in spite of 
the present results in which the oestrogen receptor could not be 
localized in term decidua. This might relate to the lower concentration 
of anti oestrogen receptor antibody (0.1 µg /ml) used in this study being 
insufficient to detect a very low level of oestrogen receptor. 
It was suggested by biochemical assay (Padayachi et al., 1987) and 
confirmed in this study that with advancing of gestation, decreases in 
oestrogen and progesterone receptors became more marked. This was 
presumed to be due to the down -regulating effect of increased 
progesterone throughout pregnancy on both steroid receptors as seen in 
the luteal phase of menstrual cycle and in patients treated with the 
combined oral contraceptive pill (Illingworth et al., 1971). 
Combining the previous studies from other groups and the serial 
investigations of steroids and their receptors in this thesis, several 
assumptions can be drawn: progesterone was required for induction 
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and maintenance of decidualization in the human endometrium, thus 
switching on PRL production (Daly et al., 1983a; Maslar and 
Ansbacher, 1986) in the normal menstrual cycle. This extended 
throughout pregnancy, since there was increased expression of PRL 
mRNA within cells as decidualization progressed in pregnancy 
(Chapter 4 and 5). Moreover, the double progesterone and PRL 
immunostaining results further support the concept discussed above, 
that specific PRL staining was only associated with the cells which 
contained progesterone receptors. Furthermore, progesterone was only 
capable of inducing and maintaining decidualization in oestrogen - 
primed tissue since in the present study progesterone could modulate 
PRL production only when used together with oestrogen in vitro. As 
progesterone receptors are oestrogen- dependent, there may be an 
indirect association between oestrogen and progesterone receptors at 
receptor level. This mechanism may be involved in controlling PRL 
production between decidua parietalis and capsularis and cultured 
term decidual cells treated by steroids, with the combination of 
oestrogen and progesterone produced by trophoblast in decidua 
capsularis or added in culture medium, maintaining progesterone 
receptors and modulating PRL production. 
Apart from steroids, other potential factors from trophoblast, e.g. 
placenta derived releasing factor (Handwerger et al., 1987a), IGF -1 
(Thraifill et al., 1988) serving as mediators of the effects of sex steroids 
(Brenner et al., 1990) or as direct regulators, may also play a role in the 
differentiation of decidual cells and maintenance of PRL production. 
In summary, these data suggest that while progesterone induced and 
maintained PRL production via its receptor mechanism as result of 
decidualization, oestrogen may modulate progesterone function at 
receptor level, thus being indirectly involved in modulating PRL 
production. This interplay between progesterone and oestrogen 
modulated PRL production in vivo throughout pregnancy. Whether or 
not other releasing factors from trophoblast are involved in this process 
is open to further study. 
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CHAPTER 6 
Local Control of Decidual Prolactin Production by Non-steroid 
Factors 
6.1. Introduction 
Earlier observations in Chapter 4 have shown that sex steroids may be 
the potential modulators for decidual PRL production. However, the 
maintenance of the decidualization during pregnancy is poorly 
understood, and it has been suggested that in normal pregnancy 
blastocyst- induced decidualization probably augments that initiated by 
sex steroids of the cycle (Finn, 1977). The next step in the present study 
was to investigate whether factors from feto- placental unit were 
directly involved in decidualization and PRL production during human 
pregnancy. In addition, little was known about the intracellular 
mechanisms involved in the control of release of PRL from human 
decidua tissue. The aims of the following studies were to investigate, 
firstly, the potential PRL releasing activity associated with the placenta 
and secondly, the intracellular signal transduction factors affecting 
decidual PRL production. Thus the effects on decidual PRL production 
of cAMP and TPA were assessed to determine the potential input of the 
adenylate cyclase and phosphoinositol second messenger pathways in 
the control of PRL synthesis and release. 
6.2. Materials and Methods. 
Early pregnancy tissues between 7 -11 weeks of gestation from 
therapeutic abortions were received fresh in the theatre where they 
were isolated into decidua and placenta and put into a sterile bottle 
containing RPMI -1640 medium supplemented with 5 p.g /ml 
gentamycin and 2 µg /ml amphotericin B for transporting to the 
laboratory. The term decidua and placenta from uncomplicated 
pregnancies between 37 -40 weeks were obtained in the labour ward and 
then transferred to the laboratory in the same way. The organ culture 
and cell culture were performed exactly as described in Chapter 4. 
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6.2.1. Experimental design 
In all these studies the putative releasing or inhibiting substances were 
tested for their ability to alter the production of PRL from both early and 
term decidua maintained in organ cultures as described in Chapter 4. 
6.2.1.1. Early or term placenta conditioned medium (PCM) 
To prepare placental conditioned medium, human early or term 
placenta cut into 5 mm3 was incubated overnight in RPMI -1640 
medium (1g placenta/ 15 ml medium) The medium defined as PCM 
was then collected by discarding the placenta tissue and stored at -20 °C 
until used in the culture system. 
Both early and term pregnancy decidua were included in the 
experiments using organ culture and the acute response (1 h) and 
chronic response (24 h) of decidual PRL secretion to 10 %, 30 %, 50% 
PCM respectively were then tested. 
To test the acute response, after preincubation of decidua tissue in 
control medium (RPMI -1640 medium supplemented with 5% charcoal 
stripped calf serum, 50 µg /ml gentamycin and 2 µg /ml amphotericin B) 
for 1 h, the medium was changed to control medium or medium 
containing 10 %, 30 %, or 50% PCM prepared from early or term 
placenta for an additional 1 h. The acute effect of PCM was tested on 
different decidua from early (n =4) and term (n =7) pregnancies. The 
spent medium from both the preincubation and 1 h incubation was 
collected and stored at -20 °C until assayed for PRL as described in 
Chapter 4. 
To test the chronic response of decidua to PCM, decidua from either 
early (n =5) or term (n =3) pregnancies was treated with variable 
concentrations of PCM. After 24 h incubation, the experiment was 
terminated by collecting medium and the spent medium was stored at - 
200C for measurement of PRL. All experiments were carried out with 4 
replicates per treatment. 
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6.2.1.2. Human chorionic gonadotropin (hCG) 
Early or term decidua explants in in vitro culture were exposed to hCG 
(Intervet UK Ltd., Science Park, Milton Road, Cambridge CB4 4FP, UK) 
at the concentrations of 0.1, 1 or 10 U /ml medium for 3 days with the 
medium changed daily. Decidua from 6 early and 9 term pregnancies 
was included in this study with 4 replicates for each treatment from 
each tissue. The acute response (1 h) of decidual PRL secretion to hCG 
was only tested in term decidua from 4 patients. 
In addition, term dispersed decidual cells from 3 different tissues were 
examined for the chronic response of decidual PRL secretion to hCG at 
the same concentrations as above for 3 days. Both organ and cell 
culture were performed as described in chapter 4. The cells were plated 
at the density of 0.5- 1x106 /ml with the medium renewed daily. 
6.2.1.3. cAMP 
Term decidual cells from 5 different tissues were prepared as described 
in Chapter 4 and plated at a density of 2x106 /ml. After 48 h incubation, 
the medium was removed and the cells washed in serum -free RPMI- 
1640 medium twice and incubated for additional 2 h in serum -free 
medium. At the end of 2 h incubation, 0.2 ml of medium was aspirated 
from each well, replaced with control medium (serum -free) alone or 
medium containing dibutyryl cAMP (Sigma, Lot No 89F- 7180), which 
was dissolved directly into medium immediately prior to each 
experiment at the concentrations of 0.1 mM, 1 mM, or 5 mM. 
Incubation was continued for 0.5 h and 1 h. Each treatment had 4 
replicates. 
At the end of each experiment, the medium was removed and to 
determine PRL cell content the cells were washed twice with PBS, then 
resuspended in 0.1 %(v /v) Triton X -100 (500 µl per well) for 15 min with 
or without being freeze -thawed three times. The cell suspensions were 
then centrifuged for 0.5 h at 2600 x g. The cell suspensions and media 
were frozen at -20 °C until PRL was measured by radioimmunoassay as 
described in chapter 4. 
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6.2.1.4. Phorbol ester 12- 0- tetradecanoyl phorbol 13- acetate (TPA) 
Term decidual cells from 3 different tissues were prepared and plated 
at the density of 0.5- 1x106 /ml, then exposed to TPA (Sigma chemical 
Co., UK) at 10-6 to 10-12 M (triplicate per treatment) for 3 days. Medium 
was changed daily and the media were stored in -20 °C for later assay of 
PRL. 
In one set of experiments, the effect of oestrogen and progesterone, 
alone or together, on the PRL response to TPA was examined. The cells 
were exposed to sex steroids alone for the first 48 h after cells were 
plated. On the third day of culture cells were exposed to the sex steroids 
in the presence or absence of TPA. The cells were then incubated for 
another 3 days with media contained steroids and TPA replaced daily. 
Decidual PRL levels were measured in the collected cultured medium. 
6.2.2. Statistical analysis 
Four replicates of each treatment from one tissue were averaged to one 
mean (n =1) and then an overall mean calculated for each treatment 
from the different tissue depending on the experiments. Statistical 
analysis was performed using analysis of variance. Contrasts between 
different groups were performed using Duncan's multiple range test. 
6.3. Results 
6.3.1. The effect of PCM 
Term decidua explants exposed for 1 h to the medium containing 10 %, 
30 %, and 50% PCM released 39 %, 83 %, and 152% more PRL, 
respectively, than explants exposed to control medium alone. (Fig. 6.1. 
A). This increase was only significant (p <0.05) after the addition of 50% 
PCM. 
In contrast, there was no acute stimulation of PRL release from 
decidua when the early decidua was incubated with 10 %, 30% or 50% 
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Fig. 6.1. The effect of placenta conditioned medium (PCM) on the 
release of decidual PRL from term decidua. Four replicate cultures of 
decidual explants were exposed to the culture medium (control) or 
medium containing 10 %, 30% and 50% PCM. The results are 
expressed as the mean ± s.e.m. The top panel (A; n =7) shows the acute 
response of decidual PRL to PCM. After 1 h preincubation in the 
medium without supplement of PCM, decidual explants were 
incubated at various doses of PCM for additional 1 h. The decidua 
explants released 39 %, 83% and 152% more PRL in response to 10 %, 
30% and 50% PCM. This increase was only significant (P <0.05) after 
the addition of 50% PCM. The bottom panel (B; n =3) shows the amount 
of PRL released by term decidua exposed to 10 %, 30% and 50% PCM for 
24 h. In each instance, there is no significant increase (P >0.05) in the 
amounts of PRL released by PCM treated decidua compared with that 
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Fig. 6.2. The effect of PCM on the release of PRL from early pregnancy 
decidua. Four replicate cultures of decidual explants were exposed to 
either the control medium or medium containing 10 %, 30% and 50% 
PCM. The results are expressed as the mean ± s.e.m. Exposure of 
early decidua to PCM either for 1 h (A; n =4) or 24 h (B; n =5), had no 
significant effect on the amount of PRL released by early decidua. 
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PCM for 1 h (Fig. 6.2. A). In addition, chronic exposure of either early 
or term decidua to PCM for 24 h had no significant effect (p >0.05 in each 
instance) on release of PRL, although there was a trend for an increase 
in PRL release in both experiments (Fig. 6.1.B and Fig. 6.2.B). 
6.3.2. The effect of hCG 
The lack of effect of hCG on decidual PRL production is shown in Fig. 
6.3. PRL levels in early (Fig. 6.3.A), or term (Fig. 6.3.B) decidua 
explants or dispersed term decidual cells (Fig. 6.3. C) incubated in the 
medium supplemented with hCG (0.1, 1 or 10 IU /m/) failed to differ 
from those of the matched control decidua (p >0.05) on any of the 3 days 
of in vitro explant culture at any concentration tested. No significant 
effect (p >0.05) on the acute release of PRL from decidua was observed 
when term decidua was treated by the variable concentrations of hCG 
(Fig. 6.3. D). 
6.3.3. The effect of dibutyryl cAMP (dbcAMP) 
Fig. 6.4 depicts the effect of the addition of dbcAMP to the cultured 
medium on decidual PRL secretion. The difference in PRL production 
did not achieve significance (p >0.05) on cultured term decidual cells 
treated by dbcAMP at any concentration of 0.1, 1 or 5 mM compared 
with their controls. Furthermore PRL production by term decidual 
cells in culture was not significantly affected by treatment with 
dbcAMP in vitro for 0.5 h and 1 h (Fig. 6.4. A and B). The PRL 
concentration in the cell suspensions was undetectable ( <50 mU /106 
cells). 
6.3.4. The effect of TPA 
The effect of TPA on the release of PRL from human term decidual cells 
in culture is shown in Fig. 6.5. A (Day 1), B (Day 2) and C (Day 3). 
Triplicate cultures of decidual cells from 3 different tissue were exposed 
to control medium or medium containing TPA at different 
concentrations. On each day of the 3 days in in vitro culture, TPA at the 
concentrations of 10-8 to 10-5 M inhibited the PRL production 
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Fig. 6.3. The effect of hCG on the release of PRL from early and term 
decidua. Four replicate cultures of decidual explants were exposed to 
either the control medium or medium containing 0.1 -10 IU /ml hCG. 
The results are expressed as the mean ± s.e.m. hCG had no effect on 
decidual PRL release in either early pregnancy (A; n =6) or term 
pregnancy (B; n =8) during a 3 day in vitro organ culture. The same 
negative effect of hCG on decidual PRL production was observed in the 
cultured term decidual cells (C; n =3) during a 3 day in vitro organ 
culture. When term decidua explants were exposed to hCG for 1 h (D; 
n=4), again, no any change in the amount of decidual PRL measured in 
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Fig. 6.4. The effect of dbcAMP on the release of PRL from term decidual 
cells. Four replicate cultures of term decidual cells were exposed to 
either the control medium or medium containing 0.1 -5 mM dbc.l4:P. 
The results are expressed as the mean ± s.e.m. The amount of PRL 
released by the term decidual cells exposed to dbc.AlI" for either 0.5 h 
(A; n =4) or 1 h (B; n =4) was not significantly different from that exposed 
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Fig. 6.5. The effect of TPA on the release of PRL from term decidual 
cells during a 3 day in vitro culture. Triplicate cultures of term 
decidual cells were exposed to either the control medium or medium 
containing TPA at the concentrations between 10-5 -10-9 M. On each of 
the three days (A -C; n =3) of in vitro culture, TPA at concentrations of 
10-$ to 10-5 M inhibited the PRL production significantly (P <0.05 on day 
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Fig. 6.6. The effect of oestradiol, progesterone and TPA on decidual 
PRL production from term decidual cells during a 3 day in vitro culture 
observed in one patient. 1 or 10 nM oestradiol and 100 nM progesterone, 
alone or in combination, were added to the culture medium when the 
cells were plated. After attachment of cells, the medium were changed 
and the cells were exposed to oestradiol and progesterone in presence or 
absence of TPA. The sex steroids failed to prevent TPA -induced 
suppression of decidual PRL production. 
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significantly (p<0.05 on day 1, p<0.01 on day 2 and 3) in a time and dose - 
dependent manner with maximal inhibition at the concentration of 10-5 
M on day 3. 
The addition of oestradiol at either 1 or 10 nM together with 
progesterone at 100 nM failed to prevent the TPA -induced reduction in 
PRL production (Fig. 6.6.). 
6.4. Discussion 
6.4.1. Control of PRL production associated with placenta 
Previous studies have suggested that factors from utero -feto- placental 
unit act locally to regulate PRL production from the decidua 
(Handwerger et al., 1987a; Thraikill et al., 1988; Thraikill et al., 1989). 
The present results support the concept that the placenta may be 
important in regulation of decidual PRL secretion during pregnancy, 
since there was an acute increase in PRL released by the term decidua 
exposed to term placental conditioned medium for 1 h. The results 
from this study, in agreement with a previous study (Handwerger et 
al., 1983), confirmed that the placenta released a factor(s) that 
stimulated the release of PRL. However, this PRL releasing activity 
associated with the placenta was reduced or absent when the term 
decidua was exposed to placental conditioned medium for 24 h. This 
contrasts with previous reports in which a factor derived from placenta 
induced a biphasic stimulation, i.e. acute and chronic stimulation of 
PRL secretion and synthesis (Golander et al., 1988). 
An earlier purification study suggested that the PRL releasing factor(s) 
was heat (56 °C for 30 min) and pH (3.0 -10.0) stable, unaffected by lipid 
extraction, sensitive to proteolytic digestion and appeared to be a single 
protein on sodium dodecyl sulfate- polyacrylamide gel electrophoresis 
with an apparent molecular weight of 23.5 K (Handwerger et al., 
1987a). However, the nature of this placentally derived factor has still 
not been determined. 
It was of interest to note that neither acute nor chronic release of PRL 
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from decidua was affected in the early pregnancy decidua incubated 
with early placental conditioned medium for either 1 h or 24 h. Because 
both early and term experiments were performed under exactly the 
same conditions, the failure of stimulation of PRL release from early 
pregnancy decidua indicated that this PRL releasing factor(s) probably 
did not participate in the regulation of PRL production in early 
pregnancy. The dynamic pattern of the placentally derived releasing 
factor in modulating PRL secretion throughout human pregnancy still 
needs to be defined. 
Human chorionic gonadotropin (hCG) is the major protein produced by 
the langhans cells of the cytotrophoblast in the large quantities during 
pregnancy. It was logical to inquire whether this major placental 
protein was involved in regulating PRL release and synthesis from 
decidua. Thus extensive experiments were carried out in this study to 
examine the effect of hCG on PRL production by decidua. Neither early 
nor term decidual explants responsed to hCG in terms of PRL 
production, this being further confirmed in term decidual cell culture. 
A single study from Rosenberg and Bhathagar (1984) demonstrated that 
HCG at a specific dose (104 mIU /ml) stimulated PRL production in in 
vitro organ culture of term decidua. However, this result was disputed 
by other reports in which either hCG given repeatedly in anovulatory 
monkeys (Ying et al., 1988) or added to culture medium in vitro 
(Handwerger et al., 1983) failed to induce or stimulate PRL production, 
consistent with the present study. As the hCG levels range between 
4,000- 11,000 IU per litre in the second and third trimesters of 
pregnancy, the concentration of hCG tested in the present study covered 
the physiological ranges in the serum of pregnancy. The present 
results do not support any role for hCG in regulating PRL production 
during pregnancy. 
6.4.2. Intracellualr signalling factors regulating decidual PRL 
production 
Unlike steroid hormones which bind to specific hormone receptors in 
the cytoplasm or nucleus and then directly activate transcriptional 
enhancers located in DNA sequences, all water soluble signalling 
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molecules including protein hormones bind to specific receptor proteins 
on the surface of the target cells and convert this extracellular event 
into signals inside cells. Hormone release in most endocrine tissues 
appears to be triggered by the G- protein linked receptor mechanism, 
which activate or inactivate adenylate cyclase, thereby altering the 
intracellular cAMP concentration, or phospholipase -C which 
generates either insitol triphosphate (Ins P3) to increase Ca +2 
concentration, or diacylglycerol (DAG) to activate protein kinase C 
(Alberts et al., 1989). 
Extensive studies have shown that the regulation of synthesis and 
release of decidual PRL differs from pituitary PRL, but failure of a 
number of hormones to affect PRL secretion from decidual cells could 
be explained by a lack of the corresponding receptors in the decidual 
cell. The intracellular messenger system controlling PRL production 
is not well defined at present. The current finding has demonstrated 
that dibutyryl cAMP, an analogue of cAMP, in the concentration 
between 0.1 to 5 mM had no effect on PRL secretion of decidual cells in 
either 0.5 h or 1 h in vitro exposure to cAMP. These results are in 
apparent contradiction with previous reports (Handwerger et al., 1987b) 
in which an increase in intracellular cAMP inhibited the releasable 
PRL. 
Another second messenger system investigated in this study is protein 
kinase C. The activation of protein kinase C can be achieved by 
diacylglycerol or phorbol esters (TPA). It was clearly shown in this 
study that TPA incubated with decidual cells in vitro for 3 days 
inhibited PRL production significantly in a time and dose dependent 
manner. The time course of TPA inhibition in decidual PRL is 
consistent with a role for protein kinase -C in altering PRL synthesis. 
The inhibitory effect of TPA on decidual PRL existed even in the 
presence of sex steroids, which indicated that the effect of TPA was to 
negate the positive effect of oestradiol and progesterone on decidual PRL 
synthesis. To our knowledge, this represents the first report of a long- 
term action of TPA on decidual PRL production. A similar inhibitory 
effect of TPA in a long term action on PRL synthesis has been reported 
in the human B- lymphoblastoid cell line IM -9 -P3 which represents 
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another ectopic source of human PRL (Gellersen et al., 1989b). This 
PRL resembles decidual PRL according to its similar molecular size of 
PRL mRNA (Gellersen et al., 1989a), identical 5' untranslated gene 
structure (DiMattia et al., 1990), very low intracellular storage and the 
unresponsiveness to many secretagogues controlling pituitary PRL 
secretion (Gellersen et al., 1989b). 
Although decidual PRL has chemical and biological properties 
identical to those of pituitary PRL, the regulation of release of PRL from 
decidua is distinct from that of pituitary PRL, even at the second 
messenger level. PRL secretion in the pituitary is stimulated by the 
protein kinase C signal transduction mechanism at the level of a 
readily releasable intracellular PRL pool as well as at the level of gene 
transcription and protein synthesis (Oshorne and Tashjian, 1981; 
Maurer, 1982; Murdoch et al., 1985). However, the opposite, inhibitory 
effect of activation of protein kinase C signal pathway on decidual PRL 
production was observed in the present study. In addition, activation of 
the adenylate cyclase -cAMP system had no effect on decidual PRL 
secretion, again in contrast to its stimulative effect on the pituitary PRL 
release (Tam and Dannies, 1981; Maurer, 1982). Marked differences in 
control of PRL secretion between pituitary and decidua might be 
associated with the different intracellular storage amount and sites, in 
that decidual PRL has a very small intracellular pool confirmed in the 
present study and no particular subcellular storage site (Handwerger 
et al., 1984), while pituitary PRL is stored in large secretory granules. 
Taken together, the present results support the concept that complex 
regulatory mechanisms for decidual PRL production might exist, 
operating at the local level associated with placenta, but hCG appeared 
to be not involved in the control of PRL production by decidua. In terms 
of the intracellular transduction signal system, unlike the pituitary 
PRL, an increase of intracellular cAMP had no effect on release of 
decidual PRL, whereas the activation of protein kinase C by chronic 
exposure to TPA inhibited the production of PRL. 
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CHAPTER 7 
Effect of Dopamine on Decidual Prolactin Production before 
and after Transfection of Decidual Cells with Dopamine D2 
Receptor 
Part I. Localization of Dopamine D2 Receptor Gene Expression in 
Human Decidua 
7.1.1. Introduction 
It has been well- established that dopamine is a major physiological 
inhibitor of PRL secretion that directly acts on the pituitary gland. In 
addition, dopamine receptors have been localized on the plasma 
membrane of pituitary cells, and there is a good correlation between the 
relative binding affinities of dopamine and the inhibition of PRL 
secretion (Caron et al., 1978). Thus it is likely that dopaminergic 
inhibitory effect on pituitary PRL is mediated through dopamine 
receptors. In contrast, dopamine or its agonist, bromocriptine, failed to 
affect PRL secretion by human decidua (Golander et al., 1979; Ben - 
Jonathan et al., 1980). It is not clear whether this is due to a failure of 
dopamine to affect PRL after binding to its receptor, or because no 
dopamine receptor is present in the decidual cells. In view of the major 
difference in dopaminergic control of PRL release in decidua compared 
to the pituitary, the effect of the dopamine agonist, bromocriptine, on 
PRL production by human term pregnancy decidual cells in culture 
was reexamined in the presence and absence of oestradiol and 
progesterone shown previously (Chapter 4) to influence decidual PRL 
production. The potential presence of dopamine receptors in human 
decidual cells was then examined by in situ hybridization, Northern 
blot analysis and polymerase chain reaction (PCR). Finally, decidual 
cells in culture were transfected with a dopamine D2 receptor construct 
to increase expression of dopamine receptor and determine whether 
dopamine could then act to control decidual PRL production. 
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7.1.2. Materials and methods 
7.1.2.1. Collection of human decidua, rat and sheep pituitaries 
Human term placentae with membranes between 37 -40 weeks of 
gestation from uncomplicated pregnancies were obtained in the labour 
ward where decidua was stripped from chorion, rapidly frozen and 
stored in liquid nitrogen for later extraction of RNA. Dispersed term 
decidua cells prepared as described in Chapter 4 were used for the in 
situ hybridization study. After attachment of cells to the slides the cells 
were washed twice with RPMI -1640 medium and then stored at -70 °C. 
Both rat and sheep pituitaries known to express dopamine receptor 
shown by in situ hybridization (Peters et al., 1991) were used as positive 
controls for in situ hybridization and PCR. Female adult rats were 
maintained in an individual cage in a room with controlled light (14 h 
of light, 10 h of darkness) and temperature (22 -24 °C) and fed on Purine 
rat chow and tap water ad libitum. They were killed by decapitation, 
the pituitaries removed within 1 min, washed in cold PBS before they 
were frozen in dry ice and stored in -70 °C freezer until use. Sheep 
pituitaries were removed within 2 min after they were killed with an 
overdose of sodium pentobarbitone and processed as for the rat 
pituitaries. Sheep pituitaries were used as a positive control for 
Northern blot analysis. 
7.1.2.2. Treatment of decidual cells with bromocriptine 
Decidual cells from 4 term pregnancy tissues were treated with 
bromocriptine at the doses 1x10-6, 1x10-7, 1x10-8, and 1x10-9M for 3 days 
during in vitro culture. Each treatment had 4 replicates. At the end of 
experiment, the cultured medium was collected and stored at -20 °C 
until assayed for PRL. 
In a second set of experiments, oestrogen at 1 nM and 10 nM and 
progesterone at 1 nM and 100 nM were added separately or in 
combination to the culture medium when cells were plated. After 48 h 
incubation, the cells were then treated with bromocriptine at 10-6 M in 
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the continued presence of the same concentration of oestradiol and 
progesterone. 
7.1.2.3. In situ hybridization using ribo-probes 
A. Preparation of ribo- probes 
The plasmid containing rat dopamine D2 receptor cDNA cloned in the 
E. coRI site of pBluescript was generously provided by Dr. K. Eidne, 
MRC Reproductive Biology Unit. The clone contained a 1.5 kilobase 
insert that coded from the third cytoplasmic loop to the 3' poly A tail of 
dopamine D2 receptor (Fig. 7.1.) and was used for constructing ribo- 
probes for the in situ hybridization study. The plasmid dopamine D2 
receptor cDNA was prepared using a Miniprep kit (Pharmacia LKB, 
Biotechnology; see Appendix 9). After purification the plasmid was 
linearized by restriction enzymes (Xba 1 and Kpn 1), which cleaved 
downstream from inserted sequences, with respect to the T7 and the T3 
promoters, forming the DNA template (see Appendix 10 for restriction 
enzyme procedure). T7 (antisense) or T3 (sense) RNA transcripts were 
synthesized and labelled with [36S] UTP in vitro using the mCAP 
transcription kit (see Appendix 11 for ribo -probe labelling method) to a 
specific activity 1 -2 x 106 c.p.m. /µl. The antisense probe hybridized to 
the cellular mRNA and the sense riboprobe acted as a negative control. 
The radioactive ribo- probes were then hydrolysised for 70 min at 60 °C to 
produce a shorter probe (100 -120 bp) to facilitate penetration of the probe 
into the tissue. 
B. In situ hybridization procedure 
Frozen sections of rat pituitary (5 gm) were cut at -20 °C on a crystat, 
and floated on to the precleaned poly -L- lysine coated slides. The slides 
with cultured decidual cells were removed from the -70 °C freezer and 
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Fig. 7.1. Schematic representation of the predicted dopamine D2 -B 
receptor structure encoded by the clone pZ19.12 cDNA. The amino acid 
sequence is shown in one -letter code and the protein is displayed in the 
seven -transmembrane domain configuration. The potential N- 
glycosylation sites in the amino -terminal extracelllular domain are 
represented by asterisks. The shaded sequence shows the difference 
between dopamine D2 A and D2 B receptors. 
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fixed in freshly -made 4% paraformaldehyde for 5 min and washed 
twice in PBS for 10 min. The slides were then acetylated by washing 
briefly in 0.1 M triethanolamine/HC1 buffer, pH8.0 (TEA buffer) and 
then immersed in 0.5% (v /v) acetic anhydride in TEA buffer for 20 min, 
followed by washing in 2XSSC twice for 10 min. All procedures were 
carried out at room temperature. 
Prehybridization using the prehybridization buffer defined in Chapter 2 
was carried out at 56 °C for 1 h. In the meantime, ribo- probes previously 
labelled were denatured at 60 °C in waterbath for 3 min and transferred 
to ice for 5 min and then diluted in hybridization buffer (see Chapter 2) 
at an appropriate concentration (1x106 c.p.m. /slide). The hybridization 
was conducted at 56 °C for 18 h followed by immersion of the slides in 
4XSSC to remove the coverslips. The sections were then treated with 
RNAse (20 µg /m1) at 37 °C in RNAse buffer (0.5 M NaCl, 100 mM 
Tris/HC1, pH 8.0, 1 mM EDTA), followed by a 30 min wash in RNAse 
buffer at 37 °C. 
The remaining wash steps were carried out either as that described in 
Chapter 2 (Schedule 3) or as follows: 
1. The sections were rinsed in 2XSSC at 60 °C for 30 min; 
2. Followed by 0.1XSSC at 60 °C for 30 min; 
3. Finally, washed with 0.1XSSC at RT for 3 min. 
All the washes were carried out with 2 mM DTT in each dish except the 
last step and with gently stirring. The dehydration, autoradiography 
and development of autoradiography were performed as described 
previously in Chapter 2. 
7.1.2.4. Northern blot analysis 
RNA extraction and separation were undertaken as described in 
Chapter 2. However, different hybridization buffers and wash steps 
were examined as following: 
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A. Hybridization buffers 
a. Buffer 1 
Stock Solution Final concentration 
20XSSPE 5XSSPE 
Formamide 5% (v /v) 
100X Denhard's 5X 
10% (w /v) SDS 0.5% (w /v) 
10 mg /ml testis DNA 5 p.g /ml 
b. Buffer 2 
Stock Solution Final concentration 
1M Sodium phosphate buffer 0.5M 
0.5M EDTA (pH 8.0) 1 mM 
BSA 1% (w /v) 
10% SDS 7% (w /v) 
Formamide 15% (v /v) 
After BSA was dissolved in aqueous components, SDS and formamide 
were added to the solution. 
Dopamine D2 receptor cDNA probes were constructed from a clone 
containing the full length of the dopamine D2 receptor (2.5 kilobase) and 
labelled with [32P] by the random primer method (Appendix 3). After 
prehybridization overnight, the membrane with transferred RNA was 
hybridized for 24 h in 20 ml of hybridization buffer containing 1 x 106 
c.p.m. /ml alkali denatured [32P] cDNA probes. 
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B. Washes 
a.Wash step 1 
1. The membrane was washed with 3XSSC with 0.1% (w /v) SDS at 65 °C 
for 20 min; 
2. Followed by 1XSSC with 0.1% (w/v) SDS at 65 °C for 10 min. 
b. Wash step 2 
1. The membrane was briefly rinsed twice with 10 ml of prewarmed 
2XSSC; 
2. Then followed by washing with 30 ml of 2XSSC for 5, 10, and 30 min 
respectively at 65 °C, renewed with fresh 2XSSC each time. 
The development of film were carried out as described in Chapter 2, 
after exposing 1, 7 and 14 days. 
7.1.2.5. Reverse transcriptase polymerase chain reaction (RT -PCR) 
Term decidual cells showed the specific hybridization signals of 
dopamine D2 receptor mRNA by in situ hybridization, while this 
finding was not confirmed by Northern blot analysis. Therefore, PCR 
was used to cross -check whether decidual cells indeed contained 
dopamine D2 receptors. 
A. Primers 
Three pairs of rat and one pair of human dopamine D2 receptor 
primers were tested. The primers against the different regions of 
dopamine D2 receptor cDNA sequence were selected by the Genejock 
programme written by Dr. Phil Taylor, MRC Reproductive Biology Unit, 
for the Apple Macintosh computer and synthesized in 391 DNA 
Synthesezet (Applied Biosystems, PCR -MATE) and deprotected as 
presented in Appendix 12. 
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Met Asp Pro Leu Asn Leu Ser Trp Tyr Asp Asp Asp Leu Glu Arg Gln Asn 17 
1 ATG GAT CCA CTG AAC CTG TCC TGG TAC GAT GAC GAT CTG GAG AGG CAG AAC 
Trp Ser Arg Pro Phe Asn Gly Ser Glu Gly Lys Ala Asp Arg Pro His Tyr 34 
52 TGG AGC CGG CCC TTC AAT GGG TCA GAA GGG AAG GCA GAC AGG CCC CAC TAC 
Asn Tyr Tyr Ala Met Leu Leu Thr Leu Leu Ile Phe Ile Ile Val Phe Gly 51 
103 AAC TAC TAT GCC ATG CTG CTC ACC CTC CTC ATC TTT ATC ATC GTC TTT GGC 
Asn Val Leu Val Cys Met Ala Val Ser Arg Glu Lys Ala Leu Gln Thr Thr 68 
154 AAT GTG CTG GTG TGC ATG GCT GTA TCC CGA GAG AAG GCT TTG CAG ACC ACC 
Thr Asn Tyr Leu Ile Val Ser Leu Ala Val Ala Asp Leu Leu Val Ala Thr 85 
205 ACC AAC TAC TTG ATA GTC AGC CTT GCT GTG GCT GAT CTT CTG GTG GCC ACA 
Leu Val Met Pro Trp Val Val Tyr Leu Glu Val Val Gly Glu Trp Lys Phe 102 
256 CTG GTA ATG CCG TGG GTT GTC TAC CTG GAG GTG GTG GGT GAG TGG AAA TTC(oligos,13 /8) 
Ser Arg Ile His Cys Asp Ile Phe Val Thr Leu Asp Val Met Met Cys Thr 119 
307 AG¡,, AGG ATT CAC TGT GAC ATC TTT GTC ACT CTG GAT GTC ATG ATG TGC ACA 
Ala Ser Ile Leu Asn Leu Cys Ala Ile Ser Ile Asp Arg Tyr Thr Ala Val 136 
358 GCA AGC ATC CTG AAC CTG TGT GCC ATC AGC ATT GAC AGG TAC ACA GCT GTG 
Ala Met Pro Met Leu Tyr Asn Thr Arg Tyr Ser Ser Lys Arg Arg Val Thr 153 
409 GCA ATG CCC ATG CTG TAT AAC ACA CGC TAC AGC TCC AAG CGC CGA GTT ACT 
Val Met Ile Ala Ile Val Trp Val Leu Ser Phe Thr Ile Ser Cys Pro Leu 170 
460 GTC ATG ATT GCC ATT GTC TGG GTC CTG TCC TTC ACC ATC TCC TGC CCA CTCz(oligo,14) 
Leu Phe Gly Leu Asn Asn Thr Asp Gln Asn Glu Cys Ile Ile Ala Asn Pro 187 
511 CTC TTC GGl{ CTC AAC AAT ACA GAC CAG AAT GAG TGT ATC ATT GCC AAC CCT 
Ala Phe Val Val Tyr Ser Ser Ile Val Ser Phe Tyr Val Pro Phe Ile Val 204 
562 GCC TTT GTG GTC TAC TCC TCC ATT GTC TCA TTC TAC GTG CCC TTC ATC GTC 
Thr Leu Leu Val Tyr Ile Lys Ile Tyr Ile Val Leu Arg Lys Arg Arg Lys 221 
613 ACT CTG CTG GTC TAT ATC AAA ATC TAC ATC GTC CTC CGG AAG CGC CGG AAG 
Arg Val Asn Thr Lys Arg Ser Ser Arg Ala Phe Arg Ala Asn Leu Lys Thr 238 
664 CGG GTC AAC ACC AAG CGC AGC AGT CGA GCT TTC AGA GCC AAC CTG AAG ACA 
Pro Leu Lys Gly Asn Cys Thr His Pro Glu Asp Met Lys Leu Cys Thr Val 255 
715 CCA CTC AAG GGC AAC TGT ACC CAC CCT GAG GAC ATG AAA CTC TGC ACC GTT 
Ile Met Lys Ser Asn Gly Ser Phe Pro Val Asn Arg Arg Arg Met Asp Ala 272 
766 ATC ATG AAG TCT AAT GGG AGT TTC CCA GTG AAC AGG CGG AGA ATG GAT GCT 
Ala Arg Arg Ala Gln Glu Leu Glu Met Glu Met Leu Ser Ser Thr Ser Pro 289 
817 GCC CGC CGA GCT CAG GAG CTG GAA ATG GAG ATG CTG TCA AGC ACC AGT CCC 
Pro Glu Arg Thr Arg Tyr Ser Pro Ile Pro Pro Ser His His Gln Leu Thr 306 
868 CCA GAG AGG ACC CGG TAT AGC CCC ATC CCT CCC AST CAC CAC CAG CTC ACT(oligo,1) 
Leu Pro Asp Pro Ser His His Gly Leu His Ser Asn Pro Asp Ser Pro Ala 323 
919 ,çTC CCT GAT CCA TCC CAC CAC GGC CTA CAT AGC AAC CCT GAC AGT CCT GCC 
Lys Pro Glu Lys Asn Gly His Ala Lys Ile Val Asn Pro Arg Ile Ala Lys 340 
970 AAA CCA GAG AAG AAT GGG CAC GCC AAG ATT GTC AAT CCC AGG ATT GCC AAG 
Phe Phe Glu Ile Gln Thr Met Pro Asn Gly Lys Thr Arg Thr Ser Leu Lys 357 
1021 TTC TTT GAG ATC CAG ACC ATG CCC AAT GGC AAA ACC CGG ACC TCC CTT AAG 
Thr Met Ser Arg Arg Lys Leu Ser Gln Gln Lys Glu Lys Lys Ala Thr Gln 374 
1072 ACG ATG AGC CGC AGA AAG CTC TCC CAG CAG AAG GAG AAG AAA GCC ACT CAG 
Met Leu Ala Ile Val Leu Gly Val Phe Ile Ile Cys Trp Leu Pro Phe Phe 391 
1123 ATG CTT GCC ATT GTT CTC GGT GTG TTC ATC ATC TGC TGG CTG CCC TTC TTC 
Ile Thr His Ile Leu Asn Ile His Cys Asp Cys Asn Ile Pro Pro Val Leu 408 
1174 ATC ACG CAC ATC CTG AAT ATA CAC TGT GAT TGC AAC ATC CCA CCA GTC CTC 
Tyr Ser Ala Phe Thr Trp Leu Gly Tyr Val Asn Ser Ala Val Asn Pro Ile 425 
1225 TAC AGC GCC TTC ACA TGG CTG GGC TAT GTC AAC AGT GCC GTC AAC CCC ATC 
Ile Tyr Thr Thr Phe Asn Ile Glu Phe Arg Lys Ala Phe Met Lys Ile Leu 442 
1276 ATC TAC ACC ACC TTC AAC ATC GAG TTC CGC AAG GCC TTC ATG AAG ATC TTG 
His Cys Stop 444 
Fig. 7.2. The amino acid and nucleotide sequences of rat dopamine D2- 
B receptor. The sequence of the different oligonucleotides used for PCR 
are shown by the underlined sequences. The inserted amino acid 
sequence (AA 242 to 270) of the dopamine D2 -B receptor is shown in the 
italic regions 
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Met Asp Pro Leu Asn Leu Ser Trp Tyr Asp Asp Asp Leu Glu Arg Gln Asn 17 
29 ATG GAT CCA CTG AAT CTG TCC TGG TAT GAT GAT GAT CTG GAG AGG CAG AAC 
Trp Ser Arg Pro Phe Asn Gly Ser Asp Gly Lys Ala Asp Arg Pro His Tyr 34 
81 TOG AGC CGG CCC TTC AAC GGG TCA GAC GGG AAG GCG GAC AGA CCC CAC TAC 
Asn Tyr Tyr Ala Thr Leu Leu Thr Leu Leu Ile Ala Val Ile Val Phe Gly 51 
132 AAC TAC TAT GCC ACA CTG CTC ACC CTG CTC ATC GCT GTC ATC GTC TTC GGC 
Asn Val Leu Val Cys Met Ala Val Ser Arg Glu Lys Ala Leu Gln Thr Thr 68 
183 AAC GTG CTG GTG TGC ATG GCT GTG TCC CGC GAG AAG GCG CTG CAG ACC ACC 
Thr Asn Tyr Leu Ile Val Ser Leu Ala Val Ala Asp Leu Leu Val Ala Thr 85 
234 ACC AAC TAC CTG ATC GTC AGC CTC GCA GTG GCC GAC CTC CTC GTC GCC ACA 
Leu Val Met Pro Trp Val Val Tyr Leu Glu Val Val Gly Glu Trp Lys Phe 102 
285 CTG GTC ATG CCC TGG GTT GTC TAC CTG GAG GTG GTA GGT GAG TGG AAA TTC(oligo,8) 
Ser Arg Ile His Cys Asp Ile Phe Val Thr Leu Asp Val Met Met Cys Thr 119 
336 per AGG ATT CAC TGT GAC ATC TTC GTC ACT CTG GAC GTC ATG ATG TGC ACG 
Ala Ser Ile Leu Asn Leu Cys Ala Ile Ser Ile Asp Arg Tyr Thr Ala Val 136 
387 GCG AGC ATC CTG AAC TTG TGT GCC ATC AGC ATC GAC AGG TAC ACA GCT GTG 
Ala Met Pro Met Leu Tyr Asn Thr Arg Tyr Ser Ser Lys Arg Arg Val Thr 153 
438 GCC ATG CCC ATG CTG TAC AAT ACG CGC TAC AGC TCC AAG CGC CGG GTC ACC 
Val Met Ile Ser Ile Val Trp Val Leu Ser Phe Thr Ile Ser Cys Pro Leu 170 
489 GTC ATG ATC TCC ATC GTC TGG GTC CTG TCC TTC ACC ATC TCC TGC CCA CTC 
Leu Phe Gly Leu Asn Asn Ala Asp Gln Asn Glu Cys Ile Ile Ala Asn Pro 187 
540 CTC TTC GGA CTC AAT AAC GCA GAC CAG AAC GAG TGC ATC ATT GCC AAC CCG 
Ala Phe Val Val Tyr Ser Ser Ile Val Ser Phe Tyr Val Pro Phe Ile Val 204 
591 GCC TTC GTG GTC TAC TCC TCC ATC GTC TCC TTC TAC GTG CCC TTC ATT GTC 
Thr Leu Leu Val Tyr Ile Lys Ile Tyr Ile Val Leu Arg Arg Arg Arg Lys 221 
642 ACC CTG CTG GTC TAT ATC AAG ATC TAC ATT GTC CTC CGC AGA CGC CGC AAG 
Arg Val Asn Thr Lys Arg Ser Ser Arg Ala Phe Arg Ala His Leu Arg Ala 238 
693 CGA GTC AAC ACC AAA CGC AGC AGC CGA GCT TTC AGG GCC CAC CTG AGG GCT 
Pro Leu Lys Gly Asn Cys Thr His Pro Glu Asp Met Lys Leu Cys Thr Val 255 
744 CCA CTA AAG GGC AAC TGT ACT CAC CCC GAG GAC ATG AAA CTC TGC ACC GTT 
Ile Met Lys Ser Asn Gly Ser Phe Pro Val Asn Arg Arg Arg Val Glu Ala 272 
795 ATC ATG AAG TCT AAT GGG AGT TTC CCA GTG AAC AGG CGG AGA GTG GAG GCT 
Ala Arg Arg Ala Gln Glu Leu Glu Met Glu Met Leu Ser Ser Thr Ser Pro 289 
846 GCC CGG CGA GCC CAG GAG CTG GAG ATG GAG ATG CTC TCC AGC ACC AGC CCA 
Pro Glu Arg Thr Arg Tyr Ser Pro Ile Pro Pro Ser His His Gln Leu Thr 306 
897. CCC GAG AGG ACC CGG TAC AGC CCC ATC CCA CCC AGC CAC CAC CAG CTC; ACT(oligo,l) 
Leu Pro Asp Pro Ser His His Gly Leu His Ser Thr Pro Asp Ser Pro Ala 323 
948 LTC CCC GAC CCG TCC CAC CAT GGT CTC CAC AGC ACT CCC GAC AGC CCC GCC 
Lys Pro Glu Lys Asn Gly His Ala Lys Asp His Pro Lys Ile Ala Lys Ile 340 
999 AAA CCA GAG AAG AAT GGG CAT GCC AAA GAC CAC CCC AAG ATT GCC AAG ATC 
Phe Glu Ile Gln Thr Met Pro Asn Gly Lys Thr Arg Thr Ser Leu Lys Thr 357 
1050 TTT GAG ATC CAG ACC ATG CCC AAT GGC AAA ACC CGG ACC TCC CTC AAG ACC 
Met Ser Arg Arg Lys Leu Ser Gln Gln Lys Glu Lys Lys Ala Thr Gln Met 374 
1101 ATG AGC CGT AGG AAG CTC TCC CAG CAG AAG GAG AAG AAA GCC ACT CAG ATG 
Leu Ala Ile Val Leu Gly Val Phe Ile Ile Cys Trp Leu Pro Phe Phe Ile 391 
1152 CTC GCC ATT GTT CTC GGC GTG TTC ATC ATC TGC TGG CTG CCC TTC TTC ATC 
Thr His Ile Leu Asn Ile His Cys Asp Cys Asn Ile Pro Pro Val Leu Tyr 408 
1203 ACA CAC ATC CTG AAC ATA CAC TGT GAC TGC AAC ATC CCG CCT GTC CTG TAC 
Ser Ala Phe Thr Trp Leu Gly Tyr Val Asn Ser Ala Val Asn Pro Ile Ile 425 
1254 AGC GCC TTC ACG TGG CTG GGC TAT GTC AAC AGC GCC GTG AAC CCC ATC ATC 
Tyr Thr Thr Phe Asn Ile Glu Phe Arg Lys Ala Phe Leu Lys Ile Leu His 442 
1305 TAC ACC ACC TTC AAC ATT GAG TTC CGC AAG GCC TTC CTG AAG ATC CTC CAC 
cys stop 443 
Fig. 7.3. The amino acid and nucleotide sequences of human dopamine 
D2 -B receptor. The sequence of the different oligonucleotides used for 
PCR are shown by the underlined sequences. The inserted amino acid 
sequence (AA 242 to 270) of the dopamine D2 -B receptor is shown in the 
italic regions. 
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The sequences of the primers against rat and human pituitary 
dopamine D2 receptor cDNA are shown in Fig. 7.2. and Fig. 7.3. 
B. RT -PCR protocol 
Total RNA from early and term decidua was extracted as previously 
described. Rat pituitary poly -A- RNA, kindly supplied by Ms J. 
Zabavnik, MRC Reproductive Biology Unit, was used as a positive 
control. 
All the reagents except the reverse transcriptase and RNAse inhibitor 
were included in the GeneAmp DNA Amplication Reagent Kit and 
purchased from Perkin Elmer Cetus (Perkin Elmer Cetus, 761 Main 
Ave., Norwalk, CT 06859). AMV reverse transcriptase and RNAse 
inhibitor were purchased from Promega Corporation (Promega 
Corporation, 2800 Woods Hollow Road, Madison, W153711 -5399, USA). 
RT -PCR DNA amplification was carried out in 20 gl reaction mixtures 
containing 3 µg of decidua RNA (early or term pregnancy) or 1µg of rat 
pituitary poly -A -RNA, in 50 mM KC1, 10 mM Tris/HCl (pH 8.4), 1.5 mM 
MgC12, 0.1% gelatin, each primer at 1.5 µg, each dNTP (dATP, dCTP, 
dTTP, dGTP) at 10 mM, Ampli Taq polymerase at 9 units, RNAse 
inhibitor at 15 units and 8 unit reverse transcriptase. The samples 
were then overlaid with 1 drop (40 µl) of mineral oil to prevent 
condensation and subjected to 30 cycles of amplification. In two 
experiments, the products from the first 30 cycles of PCR were recycled 
with fresh reaction mixtures for additional 30 cycles to ensure adequate 
amplification. 
After reverse transcription from RNA to DNA was completed at 42 °C 
for 40 min, the samples were then heated to 94 °C over 3 min to 
inactivate the reverse transcriptase and additional 1.5 min at 93 °C to 
denature the double strand DNA. After cooling to 55 °C over 1 min to 
anneal the primers with sample the sample was then heated to 72 °C in 
2 min to activate the polymerase and extend the annealed primers. 
Cycling was terminated after a final extension at 72 °C for 7 min to 
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ensure that final extension was complete. Reaction was stopped by 
chilling to 4 °C. 
Thermal cycling was performed in a programmable Thermal Reactor 
(Hybaid, Hook & Tucker Instruments LTD, UK). Each amplified 
sample was checked on a 0.8% agarose gel stained with ethidium 
bromide and visualized on UV transilluminator. 
7.1.3. Results 
7.1.3.1. The effect of bromocriptine on decidual cells 
The amount of PRL produced by the decidual cells treated with 
bromocriptine at 1x10-6, 1x10-7, 1x10-8, and 1x10-9M for 3 days were not 
statistically different from that secreted by control decidual cells 
(Fig.7.4.). Addition of oestradiol and progesterone did not alter the lack 
of effect of bromocriptine in decidual PRL production (Fig. 7.5.). 
7.1.3.2. In situ hybridization 
Radiolabelled antisense probes to dopamine D2 receptor gave the 
specific hybridization signals, albeit at low level, over the cytoplasm of 
the decidual cells (Plate 7.1. A). This pattern of hybridization was 
identical when different washing steps were tested. Furthermore, 
reproducible results were obtained in different tissues from 3 patients. 
In contrast, sense dopamine D2 receptor probe radiolabelled at a 
similar specific activity and used under identical concentrations and 
conditions, showed only a few sliver grains scattered over the decidual 
cells (Plate 7.1. B). 
Specific hybridization was observed in the anterior and intermediate rat 
pituitary, when antisense probes were hybridized to rat pituitary. In 
the rat pituitary, the intermediate lobe displayed a high level of 
expression of dopamine D2 receptor and a relatively lower expression 
occurred in anterior pituitary lobe. However no silver grains above the 
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Fig. 7.4. The effect of bromocriptine on decidual PRL production from 
untransfected term decidual cells during a 3 day period of in vitro 
culture. Four replicate cultures of decidual cells from 4 different tissue 
were exposed to either the control medium or medium containing 10-6 to 
10-8 M bromocriptine. The results are expressed as the mean ± S.E.M. 
Bromocriptine at any concentration tested had no effect on decidual 
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Oestradiol 1 1 1 1 10 10 10 10 (nM) 
Progesterone 1 1 100 100 1 1 100 100 (nM) 
Bromocriptine 0 -6 0 -6 0 -6 0 -6 (LogM) 
Fig. 7.5. The effect of oestradiol, progesterone and bromocriptine on 
decidual PRL production from term decidual cells during a 3 day in 
vitro culture observed in two patients. 1 or 10 nM oestradiol and 1 or 100 
nM progesterone, alone or in combination, were added to the culture 
medium when the cells were plated. After attachment of the cells, the 
medinrn were changed and the cells were exposed to oestradiol and 
progesterone in presence or absence of bromocriptine (10-6 M). The 
presence of oestradiol and progesterone did not alter the lack of effect of 
bromocriptine on decidual PRL production. 
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Plate 7.1. In situ localization of dopamine D2 receptor mRNA in 
untransfected and transfected human decidual cells. The scale bar is 
20 µm. 
(7.1. A) Light field micrographs of untransfected human decidual cells 
after in situ hybridization with antisense riboprobe of dopamine 
D2 receptor showing the specific hybridization signals over the 
cytoplasm of the decidual cells. 
(7.1. B) Light field micrographs of untransfected human decidual cells 
after in situ hybridization with sense riboprobe showing only 
non -specific labelling of the decidual cells. 
(7.1. C) Light field micrographs of transfected human decidual cells 
after in situ hybridization with antisense riboprobe showing 
dramatically increased dopamine D2 receptor mRNA expressed 
in the transfected cells, which was diminished in the 
transfected decidual cells when hybridized to the sense probe 
(7.1.D). 
(7.1.E) Dark field micrographs of transfected human decidual cells 
after in situ hybridization with antisense riboprobe shown 
dramatically increased dopamine D2 receptor mRNA expressed 
in the transfected decidual cells. 
(7.1. F) Dark field photomicrographs of dopamine D2 receptor mRNA in 
rat pituitary after hybridization with the antisense riboprobe. 
There were intense hybridization signals in the intermediate 
lobe and specific labelling signals over the anterior lobe. The 
posterior lobe showed only non -specific background 
hybridization. 
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7.1.F). Sense probes showed only background hybridization signals in 
rat pituitary. 
7.1.3.3. Northern blot analysis 
No specific signal was observed on Northern blot analysis of human 
decidua mRNA from early or term decidua when using hybridization 
buffer 1 and wash buffer 1. Use of a low stringency hybridization buffer 
(buffer 2) and wash condition (step 2) also did not yield a specific signal. 
In contrast, a specific band of hybridization at 2.5 kb was observed on 
Northern blot analysis of sheep pituitary mRNA (Plate 7.2.) confirming 
that the probe and conditions were adequate to detect dopamine D2 
receptor raRNA. 
7.1.3.4. RT-PCR 
One pair of rat primers (oligo 1 and 14) produced the amplified products 
with a molecular sizes of 400 bp, which could not be distinguished from 
degraded RNA on the 0.8% agarose gel (Plate 7.3.(1) from the top). A 
further two pairs of primers to rat dopamine D2 receptor (oligo 1 and 8, 
oligo 1 and 13) which gave an amplified products of about 600 bp were 
then used but no specific amplified product was identified from 
decidual mRNA although rat pituitary mRNA was amplified 
successfully (Plate 7.3.(2)). Both 5'primers exactly matched the human 
dopamine D2 receptor cDNA sequence, but there were mismatches of 
two nucleotides in 3'primer oligo (oligo 1) which might resulte in the 
failure of amplification of decidual mRNA. 
In the final attempt to amplify decidual dopamine D2 receptor mRNA, a 
3'primer corresponding exactly to the human pituitary dopamine D2 
cDNA sequence was used. Again, no specific amplified product with 
the expected molecular size in human decidua was observed, while the 
specific amplified product was identified in the mRNA from rat 
pituitaty (Plate 7.3.(3 and 4)). 
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1 2 3 4 5 6 7 8 
Plate 7.2. The autoradiographic detection of dopamine D2 receptor 
mRNA in ovine and human early or term decidua by Northern blot 
analysis. The specific hybridization only occurred in the ovine pituitary 
(lane 1 and 5) and was absent in both early (lane 2 and 6) and term (lane 
3, 4, 7 and 8) decidua. The total RNA loaded in the lanes 1 to 4 was 20 
µglane and was 40 µg/lane in the lanes 5 to 8. 
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Plate 7.3. (The first photograph from the top) Reverse transcriptase PCR 
analysis of the dopamine D2 receptor mRNA in rat pituitary and 
human decidua. RT -PCR was performed on the poly -A RNA of rat 
pituitary or total RNA of human decidua using rat dopamine D2 
receptor primers 1 and 14. Amplified products were run on a 0.8% 
agarose gel, stained with ethidium bromide and visualized on W 
transilluminator. Note the amplified products (about 400bp) were not 
separated from the degraded primers and RNA. 
Lane 1. no template (negative control); Lane 2 and 3. term pregnancy 
decidua; Lane 4. early pregnancy decidua; Lane 5. pZ19.12 cDNA clone 
(positive control). Lane 6. rat pituitary poly -A RNA (positive control). 
Plate 7.3. (The second photograph) Reverse transcriptase PCR analysis 
of the dopamine D2 receptor mRNA in rat pituitary and human decidua 
performed under the same conditions as above., but using rat primers 1 
and 8 (lane 2 to 7), and 1 and 13 (lane 8 to 13). Note that the amplified 
products were separated from the degraded RNA on the 0.8% agarose 
gel. No specific products were amplified from early or term decidua 
samples. 
Lanes 1 and 14. DNA markers; Lanes 2 and 13. RNA prepared from 
RAG cells (negative 10 12. pregnancy 
decidua; Lanes 4 and 11. early pregnancy decidua; Lanes 6 and 8. 
pZ19.12 cDNA clone (positive control). Lanes 7 and 9. rat pituitary poly - 
A RNA (positive control). 
Plate 7.3. (The third and fouth photographs taken after running gel for 
1.5 and 2.5 h, respectively) Reverse transcriptase PCR analysis of the 
dopamine D2 receptor mRNA in rat pituitary and human decidua 
performed under the same conditions as above, but using human 
dopamine D2 receptor primers 1 and 8. Note the specific amplified 
products were only observed in the lanes of rat pituitary samples. The 
human decidua from either early or term pregnancy had no specific 
bands shown on the gel. 
Lanes land 8. DNA markers; Lane 2. no template (negative control); 
Lanes 3 and 5. term pregnancy decidua; Lane 4. early pregnancy 
decidua; Lane 6. rat pituitary poly -A RNA (positive control); Lane 7. 
pZ19.12 cDNA clone (positive control). 
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7.1.4. Discussion 
The present result is consistent with previous reports that the secretion 
of decidual PRL was not under dopamine control (Golander et al., 1979; 
Ben -Jonathan and Munsick, 1980). Furthermore, this study extends the 
previous study by showing that, even under appropriate environment of 
sex steroids, bromocriptine still did not affect PRL production by 
decidua. However, the mechanism of the failure of dopamine effect on 
decidual PRL production remains unclear. The presént study is the 
first to examine the dopamine D2 receptor gene expression in human 
decidua, which is a perquisite for dopamine action. Based on the 
theory that before the synthesis of a particular protein can begin, the 
corresponding mRNA molecules must be produced by DNA 
transcription, the expression of dopamine D2 receptor mRNA was 
evaluated in this study by in situ hybridization, Northern blot analysis 
and RT -PCR. 
In situ hybridization was the first method employed in this study 
because of its great sensitivity and precise identification of the class of 
cells. It did indeed show that specific hybridization occurred in the 
cytoplasm of the decidual cells which had the characteristics of 
differentiated decidual cells, i.e. the size of the cells was four times 
bigger than that of other type of cells and contained enlarged nuclei. 
Moreover, the hybridization signals were reproducibly obtained from 
the tissue of the different patients and under variable hybridization and 
wash conditions. Furthermore, hybridization to sense probes showed 
only background staining. The stringency of the wash condition was 
adjusted by varying the salt concentrations in washing buffer. Poorly 
matched hybrids are only stable at high salt concentration, whereas in 
0.1X SSC, only sequences which are well matched will remain. 
Additionally, posthybridization treatment with RNAse will destroy any 
unhybridized probes. Using these conditions in the present study a 
signal indicating dopamine D2 receptor in decidual cells remained. 
Thus the result suggest the existence of dopamine D2 receptor in 
human decidua. 
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To double check the existence of dopamine D2 receptor in decidual cells 
Northern blot analysis of decidual mRNA was carried out. Under 
whatever hybridization conditions assessed in this study, no specific 
labelled band was observed. This technique requires homogenization of 
tissue and extraction of RNA, which might result in a loss of sensitivity 
if the target contained only a low level of the specific RNA to be detected 
(Shivers et al., 1986). With in situ hybridization, 10 to 100 molecules can 
be detected in a single cell, while the level of detection for Northern blot 
is about 105 to 106 target sequence molecules (Kawasaki, 1990). The 
negative results from Northern blot analysis therefore do not exclude 
the possibility of existence of dopamine D2 receptor gene expression in 
human decidua, albeit at a low level. 
As a final attempt to determine whether the decidua indeed expressed 
dopamine D2 receptors, another powerful tool, RT -PCR, for detecting 
RNA molecules was utilized. As PCR is so sensitive, a single copy of 
the gene has been amplified (Innis and Gelfand, 1990). Another 
advantage for PCR is its specificity, in that the two oligoprimers 
complementary to the target DNA fragment are able to hybridize to 
opposite strands of the target sequence and are oriented so that the DNA 
synthesis by the polymerase proceeds across the region between the 
primers. In addition, the amplified products are also complementary 
to and capable of binding primers and each successive cycle doubles the 
amount of the specific DNA in the region between the two primers. The 
result is an exponential accumulation of the specific target fragment. 
Under the RT -PCR conditions used in this study, again, no detectable 
dopamine D2 receptor amplified product could be visualized on the gel 
by using the primers either derived from the sequence of the rat or 
human dopamine D2 receptor. The system and primers were shown to 
amplify rat pituitary mRNA confirming that the failure to amplify 
decidual mRNA was not due to an inadequacy of the method. 
It is therefore concluded that human decidua does not contain a 
dopamine D2 receptor identical to that in rat or human pituitaries. 
However, whether the decidua processes a similar structure to 
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dopamine D2 receptor or the different subtypes of dopamine D2 receptor, 
as suggested by in situ hybridization, needs to be further investigated. 
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Part H. Dopamine effect on decidual cells transfected with dopamine 
D2 receptor 
7.2.1. Introduction 
Since dopamine D2 receptor was not conclusively localized in the 
human decidual cells (Part I, Chapter 7), the lack of dopamine effect on 
decidual PRL production may be due to an absence of dopamine D2 
receptor in human decidual cells. The next question is to ask if the 
dopamine D2 receptor is introduced into decidual cells, would they then 
response to dopamine? Therefore, the aim of the following study was to 
investigate the influence of bromocriptine on decidual cells transfected 
with dopamine D2 receptor gene. 
7.2.2. Materials and methods 
A previous study in the MRC Reproductive Biology Unit (Zabavnik et al., 
1991) had successfully transfected a human kidney cell line with a rat 
dopamine D2 receptor construct using the Lipofectin, (N[1 -(2,3- 
dioleyloxy)Propyl]-N,N,N-triethyl- ammonium) (DOMT) mediated 
transfection procedure. Therefore this procedure and construct were 
used in this study. 
The transfection procedure was performed on human term decidual 
cells dispersed as described in Chapter 4. A full length dopamine D2 
receptor cDNA clone kindly supplied by Dr. K. Eidne was used for 
transfection. The process of making purified DNA is detailed in 
Appendix 9. 
Lipofecting reagent used as DNA delivery reagent was purchased from 
Bethes Research Laboratories (Bethes Research Laboratories, Life 
Technologies, Inc., Maryland, USA). The transfection procedure was 
accomplished according to the method description supplied by 
manufacture with slight modification as described in the following: 
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7.2.2.1. Formation of lipid -DNA complex 
1 µg DNA and 30 µg Lipofectin for each well of 24 -well plates were 
diluted separately to prevent precipitation in 250 pl RPMI -1640 medium 
in polystyrene tubes and then combined and allowed to stand for 15 min 
at room temperature. RPMI -1640 medium used for transfection was 
serum -free to overcome the effect of any inhibitory component present 
in the serum. 
7.2.2.2. Transfection procedure 
Dispersed term decidual cells were plated in 24 -well plates at a density 
1x106 cells /well in 1 ml of RPMI -1640 medium supplemental with 10% 
fetal calf serum, 25 u/ml penicillin, 25 p.g /ml streptomycin, 50 µg /ml 
gentamycin and 5 µg /ml amphotericin B. The cells were then 
incubated in a humified, 95% air:5% CO2 environment at 37 °C until 
they were 50 -60% confluent. The decidual cells were then washed twice 
with 0.5 ml/well RPMI -1640 medium. After addition of 0.5 ml RPMI- 
1640 medium to each well, 0.5 ml lipid -DNA complex was dropwise and 
uniformly added to each well. For control wells, 250 µl lipid with 750 pi 
RPMI -1640 medium was introduced only. After incubation at 37 °C in a 
humidified atmosphere of 95% air:5% CO2 overnight, the medium was 
replaced with 1 ml of fresh RPMI -1640 medium supplemented with 20% 
fetal calf serum, with subsequent incubation for 1 day. The medium 
were then aspirated and the cells were treated with bromocriptine 
(1x10-6, 1x10-7, 1x10-8, and 1x10-9 M) for an additional 24 h. The 
experiments were terminated by collecting the medium which, along 
with the medium from the cultured normal decidual cells was stored in 
-20 °C prior to radioimmunoassay PRL as described previously. Tissues 
from 4 different patients were used in this study, and each treatment 
was run at 4 replicates. 
Prior to the treatment of the cells with bromocriptine, two wells from 
either control or transfected cells were harvested by trypsinization for 
in situ hybridization to examine the dopamine D2 receptor mRNA 
expression. After detachment from the wells, the cells were 
transferred to the chamber slides and incubated overnight for 
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reattachment of cells to the slides. The cultured cell slides were stored 
at -70 °C after they were washed twice with PBS before processing for in 
situ hybridization. 
7.2.2.3. Statistical analysis 
The significance of the differences between different treatment was 
tested by analysis of variance. Contrasts between different groups were 
performed using Duncan's multiple range test. 
7.2.3. Results 
7.2.3.1. The expression of dopamine D2 receptor mRNA in decidual cell 
A large concentration of dopamine D2 receptor mRNA was found in 
transfected decidual cells which indicated that the inserted clone of 
dopamine D2 gene was highly transcribed in the transfected decidual 
cells (Plate 7.1. C and E). No specific labelling signals were localized 
when the transfected decidual cells hybridized to sense probe (Plate 7.1. 
D). This result was reproducible in the decidual cells from the different 
patients. 
7.2.3.2. The effect of bromocriptine on transfected decidual cells 
Even after decidual cells expressed much higher level of dopamine D2 
receptor mRNA than that of controls, bromocriptine at any 
concentrations tested had no effect on decidual PRL secretion 24 h of in 
vitro culture (Fig. 7.6.). 
7.2.4. Discussion 
Previous studies have determined beyond doubt that dopamine and its 
agonist, such as bromocriptine, were able to inhibit PRL secretion from 
the pituitary both in vivo and in vitro in all species tested (Macleod et al., 
1974; Birge et al., 1970). Dopamine exerts its action through a 
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Fig. 7.6. The effect of bromocriptine on decidual PRL production of term 
decidual cells transfected with rat dopamine D2 receptor construct. 
Upon 1 day in vitro culture, there was no effect of bromocriptine at the 
concentrations 10-6 to 10-8 M on decidual PRL production from the 
transfected decidual cells. 
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been localized by in situ hybridization as well as PCR in both rat, 
human (Meador- woodruff et al., 1989; Toso et al., 1989) and ship 
pituitaries (present study). 
Dopaminergic signalling is transduced by two physiologically distinct 
plasma membrane receptors known D1 and D2 receptor (Kebabian and 
Calne, 1979). The D1 receptor was proposed to couple to adenylate 
cylcase and stimulate its activity, while D2 receptor had an inhibitory 
effect on this enzyme, and in turn decreased cAMP level inside cells to 
inhibit PRL production in pituitary, possibly by affecting K+ channels 
(Ben- Jonathan, 1985; Ingram et al., 1985). 
In contrast, dopamine or its agonist, bromocriptine, was not involved in 
the regulation of decidual PRL production (Golander et al., 1979; Ben - 
Jonathan et al., 1980). This was further confirmed by the present study 
showing that bromocriptine did not either stimulate or inhibit decidual 
PRL production with or without oestradiol and/or progesterone in the 
culture system. The present study represents the first report on 
examining the mechanism of failure of dopaminergic agonist to affect 
decidual PRL production. As discussed in part I, dopamine D2 receptor 
was not decidual cells, strongly 
suggesting the conclusion that failure of dopaminergic agonist effect on 
decidual PRL production resulted from a lack of its receptor on decidual 
cells. However, even after dopamine D2 receptor was induced at a high 
level of expression in decidual cell by transfection with the dopamine 
receptor construct, bromocriptine still had no effect on decidual PRL 
production. 
However, some caution must be taken over these results. Signal 
transduction of the D2 receptor in the pituitary is mediated through G- 
proteins and at least two different G proteins, referred to as Gi and Go, 
are involved (Senogles et al., 1987; Elazar et al., 1989). Thus lack of the 
appropriate G protein to couple with the transfected dopamine D2 
receptor might contribute to the failure of bromocriptine effect on PRL 
production by tranfected decidual cells. Apart from G proteins, the 
second messenger system and machinery associated with cell 
signalling, are needed to produce measurable responses after the 
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ligand activation of the receptors. Moreover, it is uncertain at present 
time if the failure to show an inhibitory response to bromocriptine by 
transfected decidual cells is not due to the unstable transfection, since 
bromocriptine treatment on transfected decidual cells was only for 24 h. 
In some cases longer exposure time of pituitary cells to bromocriptine 
was needed before a measurable inhibitory response on PRL production 
could be observed (Ben- Jonathan et al., 1980), although an effect of 
bromocriptine on pituitary PRL production within 24 h is usually 
clearly observed. Since inhibition of pituitary PRL secretion by 
dopamine or its agonist was mediated through cAMP second message 
system (Ben- Jonathan, 1985) and cAMP was not involved in PRL 
production in the decidua (Chapter 6), there was no link between 
dopamine D2 receptor expressed in the transfected decidual cells and 
PRL regulation, which might result in the failure of bromocriptine to 
affect PRL production in transfected cells. 
In conclusion: the present study, for the first time, revealed that the 
absence of dopaminergic inhibition of decidual PRL production might 
be due to the lack of dopamine receptors in decidual cells. However, no 
measurable response to bromocriptine by the decidual cells transfected 
with dopamine D2 receptor was observed. This may be due to the lack of 




8.1. Identification of the cellular origin of decidual PRL 
In early 1970's, large quantities of PRL were found in amniotic fluid 
through gestation (Tyson et al., 1972). Previous studies, either upon in 
vitro culture of pregnant and non -pregnant decidua (Maslar and 
Riddick, 1979; Maslar et al., 1980) or via identification of PRL mRNA in 
decidua by Northern blot (Clements et al., 1983) and in vitro translation 
(Taii et al., 1984), strongly suggested that the high concentration of PRL 
in amniotic fluid during human pregnancy was produced by decidua. 
This PRL appeared to be identical to pituitary PRL according to its 
chromatographic (Frame et al., 1979a), biological, immunological 
(Tornita et al., 1982a; 1982b) and binding properties (Golander et al., 
1978). However, PRL secretion by decidua seems to be regulated quite 
differently from that in pituitary gland. Although the factors 
controlling PRL production have been extensively studied in pituitary 
tissue, much less is known about its regulation in decidual tissue. In 
order to investigate the control of decidual PRL production during 
human pregnancy, firstly, identification of the exact cellular origin of 
decidual PRL was carried out in this thesis (Chapter 2), since it is 
extremely important in further determination of relevant regulators of 
decidual PRL. 
Several groups gave attempted to isolate these PRL -producing cells by a 
number of different methods. DeZeigler and Gurpide (1982) obtained an 
enriched PRL -producing cellular population from term decidua by 
enzymic digestion and selective attachment to plastic culture dishes. 
By employing isopycnic centrifugation, Markoff et al (1982a) has 
purified PRL -producing cells from term pregnancy. Similarly, 
Bravermen et al. (1984) have isolated PRL -producing cells, confirmed by 
immunocytochemical staining of PRL, from early and mid pregnancy 
decidua. Results from these studies showed that PRL -producing cells 
were morphologically similar to decidual cells, but the exact cell type 
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which was responsible for PRL production in decidua had not been 
conclusively localized. 
While these studies suggested that only decidua in utero- placental unit 
was the source of PRL in amniotic fluid, PRL has also been localized by 
immunocytochemistry in the amnion (Healy et al., 1977), chorion 
(Frame et al., 1979b), trophoblast (Al- Timimi and Fox, 1986) and 
decidua from pregnant and non -pregnant women (Meuris et al., 1980). 
As immunocytochemistry can not distinguish between the site of 
synthesis and binding sites, it is not clear whether this PRL is 
synthesized in these PRL immunopositive cells or whether it is 
sequestered from the extra cellular space. In addition, the role of 
decidual PRL in utero -feto- placental unit is still obscure. Thus a 
positive identification of the site of synthesis of PRL together with a 
precise localization of the cell types which accumulate PRL should 
provide evidence for the potential sites of action of decidual PRL. 
In situ hybridization enables the precise localization and identification 
of individual cells that contain the specific nucleic acid sequence. 
When used together with immunocytochemistry, both mRNA 
transcribed from the gene itself and the gene product translated from 
RNA can be co- localized in a particular cell type, which will give strong 
evidence for the site of synthesis. By developing an in situ hybridization 
method using a human pituitary PRL cDNA probe, together with 
immunocytochemistry to co- localize PRL mRNA and PRL in the studies 
reported in this thesis, decidual cells in the utero- placental unit were 
identified conclusively, for the first time, as the only source of PRL 
synthesis. 
The use of a human pituitary PRL cDNA probe for in situ hybridization 
was validated by Northern blot analysis, showing that the probe 
hybridized to a single RNA species. It appeared that the decidual PRL 
mRNA was bigger than that of pituitary. This was confirmed by the 
recent reports that the decidual PRL mRNA is about 150 nucleotides 
longer than the human pituitary transcript attributed to differences in 
the 5' untranslated regulatory region of the gene (Gellersen et al., 
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1989a; Hiraoka et al., 1991), further implying usage of a different 
transcription initiation site from that in the pituitary gene. 
The results in Chapter 2 strongly suggest that only decidualized cells 
are capable of PRL biosynthesis. As PRL was also localized by 
immunocytochemistry in the amnion and placenta, but without co- 
localization of its mRNA, this finding indicated that cells of fetal origin, 
namely amnion and trophoblast, might be the potential target of PRL 
action. PRL receptors have also been identified in these tissue 
(McCoshen et al., 1982b; Healy et al., 1982; 1985; Herington et al., 1980), 
which is a mandatory prerequisite for any biological action of protein 
hormones. A number of studies have shown decidual PRL may be 
involved in maintaining amniotic fluid volume (Tyson et al., 1984), 
regulating fetal lung maturity (Hamosh and Hamosh, 1977; Grosso et 
al., 1980) and controlling parturition (Horrobin, 1973; Tyson et al., 1985). 
This study was the first to identify decidual cells as the unique source of 
PRL in utero -placental unit by co- localization of PRL mRNA and its 
protein product using in situ hybridization and immunocytochemistry. 
The positive immunostaining in amnion and trophoblast indicated that 
decidual PRL play an important paracrine role within feto- placental 
unit. 
8.2. The effect of oestrogen and progesterone on decidual PRL 
production 
It is clear now that the high level of PRL in amniotic fluid is specifically 
produced by decidual cells. Decidual cells are differentiated from the 
stromal cells of the endometrium starting from luteal phase and 
continuing during pregnancy, mainly under the control of oestrogen 
and progesterone. In other words, the decidual cells are one of main 
targets of oestrogen and progesterone within uterus. Therefore, it 
would be logical to ask what is the potential role of oestrogen and 
progesterone on decidual PRL production. 
Previous studies have suggested that the decidualization of the stromal 
cells in the endometrium is essential for the initiation of PRL 
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production (Maslar and Riddick, 1979; Daly et al., 1983a). Studies 
examining the potential effects of progesterone and oestrogen on PRL 
production of decidualized cells in normal menstrual cycle indicated 
that sex steroids, specially progesterone, were important regulators of 
decidual PRL production (Maslar et al., 1986). However, few studies 
have been performed on pregnant decidua, i.e. the control of oestrogen 
and progesterone on decidual PRL synthesis and release throughout 
pregnancy remains uncertain. Furthermore, many studies have not 
distinguished between regulation of de novo synthesis and secretion of 
PRL. Unlike pituitary, decidual PRL is not packaged into secretory 
granules (Handwerger et al., 1984), so it is important to examine the 
regulation of PRL at the level of synthesis. 
Decidual cells continue to undergo further decidualization throughout 
pregnancy principally under the control of oestrogen and progesterone. 
To reveal the relationship between decidualization and PRL production, 
will give a clue as to how progesterone and oestrogen modify decidual 
PRL production during pregnancy. In Chapter 3 the relationship 
between the ability of the decidua to produce PRL at the different stages 
of pregnancy, the degree of decidualization of decidual cells in vivo, the 
PRL mRNA level determined by in situ hybridization and Northern blot, 
PRL content inside the decidual cells determined by 
immunocytochemistry, PRL output in amniotic fluid measured by 
radioimmunoassay was investigated. The results clearly showed that 
decidual PRL production is entirely dependent on decidualization in 
vivo (Chapter 3). 
This study confirmed previous studies in the normal menstrual cycle 
that the capacity of the endometrium to produce PRL in vitro increased 
when decidualization spread throughout the endometrium (Maslar and 
Riddick, 1979; Maslar et al., 1980). However, the present results have 
extended these previous studies by demonstrating that decidualization, 
indicated by the enlargement of the cell size continued throughout the 
pregnancy, and had a close correlation with the PRL mRNA level. 
Thus, as decidualization progressed, more PRL gene was expressed in 
decidual cells, further confirmed by Northern blot analysis. Thus the 
ability of individual decidual cells to make PRL was magnified. 
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However, it is still not clear how decidualization activates decidual PRL 
gene expression. The results from immunocytochemistry to reveal 
gene product (PRL) contained inside decidual cells corresponded well 
with the result of in situ hybridization and Northern blot. As the 
decidualization spread over the decidua throughout pregnancy, the 
proportion of positive in situ and immunostaining cells in sections 
increased dramatically which was very obvious from early to mid 
pregnancy. 
This is the first study using an in vivo model to examine decidual PRL 
regulatory mechanism at the level of both synthesis and secretion 
(Chapter 3). The results demonstrated that PRL gene expression in 
human decidual paralleled the degree of decidualization in vivo. 
Further study were carried out to examine the effect of the factors 
involved in decidualization on controlling PRL production in human 
decidua. 
Progesterone is an essential factor for induction of decidualization, thus 
switching on decidual PRL production (Daly et al., 1983a) in the normal 
menstrual cycle. However, it is not clear how important the effects of 
progesterone on decidual PRL production are during early pregnancy. 
By blocking the action of progesterone with the antiprogesterone RU 486 
in vivo, the potential role of progesterone on PRL production was 
investigated in decidua parietalis, free of trophoblast, and decidua 
capsularis, with attached trophoblast (Chapter 4). 
The results show for the first time that withdrawal of progesterone 
action in vivo resulted in suppression of decidual PRL production, with 
associated morphological de- decidualization in decidual parietalis. 
These results supported the concept that PRL production by decidual 
cells occurred as a consequence of decidualization which was induced 
by progesterone. However, no such effect occurred on decidua 
capsularis with trophoblast attached, which indicated that decidual 
PRL production was not only dependent on progesterone, but also 
potentially on factors derived from trophoblast (Handwerger et al., 
1987a). In addition, secretion of PRL by decidual capsularis did not 
decline over the 5 days in in vitro culture in contrast to decidua 
161 
parietalis. This result implies that the trophoblast tissue attached to 
the capsularis may produce a factor(s), steroids or non -steroids, to 
maintain decidualization, and hence, PRL production, regardless of 
progesterone withdrawal. 
In spite of the apparent dependence of PRL secretion on progesterone in 
vivo, it is of surprising that addition of progesterone in vitro could not 
stimulate PRL secretion (Chapter 4), confirming previous reports on 
PRL production by decidua in vitro from early human pregnancy 
(Bischof et al., 1986; Ren and Braunstein, 1990). It is well known that 
oestrogen priming is necessary for demonstration of progestational 
effect (Tamaya et al., 1985), and this may explain the absence of an 
effect of progesterone on decidual PRL secretion in vitro as oestradiol 
was not added to the cultured decidua. Thus the effect of progesterone 
may only be facilitative, maintaining decidual differentiation and PRL 
is only associated with the presence of progesterone- dependent 
differentiated decidual cells. 
Decidualization in the human, in contrast to animals, is a spontaneous 
phenomena that occurs under the control of ovarian steroid hormones 
(Dallenbach- Hellweg, 1988). During pregnancy, syncytio -trophoblast 
cells synthesize not only progesterone but also oestrogen. To determine 
whether both sex steroids are required for the modulation of PRL 
release, the pattern of PRL produced by term decidual cells in vitro 
treated with or without progesterone and oestrogen, either alone or in 
combination, was investigated. The results demonstrated that PRL 
production was stimulated and maintained by the treatment of decidual 
cells with a combination of oestradiol and progesterone. Either 
progesterone or oestradiol alone in vitro was incapable of stimulating 
and maintaining PRL secretion from decidua. These results, again, 
suggest that progesterone is not a direct regulator of decidual PRL 
production and, further, support the hypothesis that, through 
decidualization, in which oestrogen is required, progesterone has an 
indirect effect on decidual PRL production. 
The enhancement of progesterone- stimulated function by concurrent 
oestradiol treatment observed in this study is comparable with the 
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known synergistic action of oestrogen and progesterone on 
decidualization of the endometrium (Irwin et al., 1989). This is 
presumably related to the known up- regulation of progesterone 
receptors by oestrogen both in vivo (Lubbert et al., 1982) and in vitro 
(Eckert and Katzenellenbogen, 1981). Moreover, oestrogen is clearly the 
major stimulator of cell growth and proliferation of stromal cells (Pavik 
and Katzenellenbogen, 1978), which is a direct prerequisite for 
decidualization (Bell, 1983). Thus, oestrogen might be indirectly 
involved in the control of decidualization and, together with 
progesterone, act synergistically to maintain decidualization and the 
consequent PRL production by decidualized cells which was further 
confirmed by studies of the immunolocalization of oestradiol and 
progesterone receptors (Chapter 4 and 5). 
It has been well established that steroid hormones can only act after 
binding to their specific receptors in the target (Gorski and Gannon, 
1976). Decidual steroid receptors must therefore play a vital role in 
mediation of the decidual response to steroids. However, at present, no 
information is available to define the exact receptor status of decidua in 
relation to PRL production during pregnancy. As 
immunocytochemistry allows direct localization of steroid receptors 
and an evaluation of the receptors within a complex association of cell 
types in decidua parietalis and capsularis, the steroid receptor status in 
different regions of early pregnancy decidua, intracellular steroid 
receptor distribution and steroid receptor content throughout 
pregnancy in relation to PRL production were examined (Chapter 5). 
The results clearly show that most decidual cells in either decidua 
capsularis or parietalis contain progesterone receptor. This confirmed 
a previous study that early pregnant decidua was characterized by a 
large concentration of progesterone receptors determined by binding 
assay (Levy et al., 1980) and provides direct evidence that both decidua 
parietalis and capsularis are under the control of progesterone. This 
corresponded to its main role in decidual cells to support their further 
growth and differentiation during pregnancy. These results give more 
direct evidence that failure of RU 486 to cause de- decidualization in 
decidua capsularis is not related to the alteration of the progesterone 
163 
receptor, but due to the factors derived from trophoblast which attached 
to decidua capsularis to maintain decidualization. 
In contrast to the progesterone receptor, oestrogen receptor in decidua 
parietalis were mainly localized in glandular epithelia, while few 
decidual cells contained oestrogen receptor which may result from the 
down -regulation of oestrogen receptor by high local concentration of 
progesterone, as the decidual cells are a main target for progesterone 
during pregnancy. However, it remains to be shown whether the high 
level of oestrogen receptor in glandular cells contributes to a biological 
effect. 
More intense staining of oestrogen and progesterone receptors was 
found in the decidual cells of decidua capsularis. This may be due to 
the high local concentration of oestrogen produced by the attached 
trophoblast which could up- regulates its own receptor and the 
progesterone receptor ( Keitmann- Gimgal et al., 1979; Kreitmann- 
Gimgal et al., 1980; West et al., 1987). This would, therefore, enhance 
progesterone action in decidua capsularis to maintain PRL production 
as observed in Chapter 4. 
Thus the difference between decidua capsularis and parietalis in 
producing PRL upon in vitro culture might result from oestrogen or 
other factors together with progesterone produced by attached 
trophoblast which participated in modulation of PRL production. This 
view was further confirmed in the study of term decidual cells in 
culture in which oestrogen in combination with progesterone modified 
PRL production (Chapter 4). 
A striking observation made in this study was that in term decidual 
cells, progesterone receptor was localized in the cytoplasm, but not in 
nuclei. As steroid receptor immunocytochemistry was performed on 
frozen sections and under the same conditions as that of early 
pregnancy decidual staining, it is unlikely this cytoplasm staining was 
due to any artifacts. Recently, a new view of the mechanism of steroid 
action has been proposed based on the immunocytochemistry: both 
unoccupied and steroid -occupied receptors reside in nuclei even under 
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the environment of low steroid concentration (Welshon et al., 1984). 
Thus, whether this discrepancy in the intracellular localization of 
progesterone receptor in decidual cells resulted from localization of 
dissimilar forms of steroid receptors remained to be identified. 
Nerveless, this cytoplasmic form of progesterone receptor appeared to 
be functional since progesterone combined with oestrogen could 
stimulate PRL production in term decidual cells (Chapter 4). 
Combing the previous studies from other groups and the serial 
investigations of steroids and their receptors in this thesis (Chapter 
2,3,4 and 5), several assumptions can be drawn: progesterone was 
required for induction and maintenance of decidualization in the 
human endometrium, thus switching on PRL production (Daly et al., 
1983a; Maslar et al., 1986) in the normal menstrual cycle. This 
extended to pregnancy, since PRL gene expression was increased as 
decidualization progressed in pregnancy (Chapter 3). Moreover, the 
results of co- localization of progesterone receptor and PRL by double 
immunostaining (Chapter 5) further supports the concept discussed 
above, that PRL was only associated with the cells which contained 
progesterone receptors. Additionally It was shown that progesterone 
was only capable of inducing and maintaining decidualization in 
oestrogen -primed tissue since progesterone could modulate PRL 
production only when used together with oestrogen. As progesterone 
receptors are oestrogen- dependent, there may be an indirect association 
between oestrogen and progesterone at receptor level. This mechanism 
may be involved in controlling PRL production, with the combination of 
oestrogen and progesterone produced by trophoblast in decidua 
capsularis or added in culture medium, maintaining progesterone 
receptors and modulating PRL production. 
8.3. The effect of non -steroid factors and dopamine on decidual PRL 
production 
It was suggested that in normal pregnancy blastocyst- induced 
decidualization probably augments that initiated by sex steroids (Fin, 
1977). This was further confirmed in studies in this thesis where as 
gestation advanced, decidualization progressed throughout pregnancy 
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(Chapter 3) with increasing expression of PRL mRNA in fully 
decidualized cells. In Chapter 4, it has been demonstrated that a 
factor(s) from trophoblast in decidua capsularis could maintain 
decidualization, with consequent maintenance of PRL production. The 
potential regulatory effect associated with placenta was then examined. 
The results in Chapter 6 support the concept that the placenta may be 
important in regulation of decidual PRL secretion, since significantly 
more PRL was released by term decidua exposed to placental 
conditioned medium, consistent with previous studies (Handwerger et 
al., 1983). However, the present study extends previous studies by 
demonstrating that neither acute nor chronic PRL- releasing activity 
was observed in early pregnancy incubated with early placental 
conditioned medium for either 1 h or 24 h, which indicated PRL 
releasing factor(s) was not involving in regulation of PRL production in 
early pregnancy. 
Human chorionic gonadotrophin (hCG), a major protein from placenta, 
tested within physiological doses, failed to induce either an acute or a 
chronic response of decidual PRL production. This result, in 
agreement with other studies (Handwerger et al., 1983; Ying et al., 
1988), did not support any role of hCG in regulation PRL production 
during pregnancy. 
Since a number of physiological inhibitors and stimulators of pituitary 
PRL synthesis and release, such as TRH and dopamine, failed to affect 
PRL secretion from decidual cells, the second messenger system in 
decidua was investigated to determine whether the same intracellular 
signalling system was involved in controlling PRL production in both 
tissues. The inhibition of PRL secretion from pituitary lactotrophos by 
dopamine is linked to adenylate cyclase. The activity of this enzyme is 
reduced by the interaction of dopamine with D2 receptors, resulting in a 
decreased level cAMP (Ben- Jonathan, 1985). The stimulatory effect of 
TRH on PRL secretion and synthesis mediated through protein kinase 
C activation (Sutton and Martin, 1982). These two intracellular 
signalling factors, cAMP and protein kinase C, were chosen to be 
examined in this study (Chapter 6). 
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The current finding demonstrated that dibutyryl cAMP, an analogue of 
cAMP, in concentrations between 0.1 to 5 mM had no effect on decidual 
PRL production in either 0.5 h or 1 h exposure. However, activation of 
protein kinase C, achieved by TPA acting as functional analogue of 
diacyiglycerol, competing for same receptor on the enzyme (Sharkey et 
al., 1984), inhibited decidual PRL production significantly in a time and 
dose dependent manner. This occurred even in the presence of 
oestrogen and progesterone indicating that the effect of TPA was to 
negate the positive effect of oestrogen and progesterone. This 
represents the first report of a long -term action of TPA on decidual PRL 
production. Gellersen et al. (1989) has reported a similar effect of TPA 
on reducing PRL mRNA synthesis in human IM -9 -P3 cell line, which 
shares characteristics of decidual cells, with regard to its very small 
intracellular PRL pool, their unresponsiveness to many secretagogues 
controlling PRL secretion, and probably similar PRL gene structure in 
5' untranslated region (DiMattia et al., 1990; Hiraoka et al., 1991). 
The results in Chapter 6 support the concept that a local regulatory 
mechanism for decidual PRL production might exist, which is related 
to the placenta, but not hCG. The regulation of PRL secretion from 
decidua is distinct from that of pituitary PRL, even at the second 
messenger level. The adenylclase system (dbcAMP) failed to affect, 
while TPA inhibited PRL production by term decidual cells. 
In the pituitary, dopamine, a major physiological inhibitor of PRL 
production, acts through the dopamine D2 receptor. However, it not 
clear wether the failure of dopamine to affect PRL production in 
decidua occurs after binding to its receptor or because no dopamine 
receptor is present on the decidual cells. In the studies reported in 
Chapter 7, in situ hybridization, Northern blot and PCR were employed 
to investigate whether or not dopamine D2 receptor is present or absent 
on decidual cells. Although in situ hybridization appeared to indicate 
the presence of dopamine D2 receptors, albeit at a low level, on decidual 
cells, Northern blot and PCR of decidual mRNA with primers to both 
the rat and human dopamine D2 receptor sequence failed to confirm the 
presence of dopamine D2 receptors. 
167 
Thus, human decidual cells do not appear to contain a dopamine D2 
receptor identical to that in rat or human pituitary. However, whether 
the decidual cells process a structure similar to the dopamine D2 
receptor or the different subtypes of dopamine D2 receptor, as suggested 
by in situ hybridization, needs further investigation. 
Since dopamine D2 receptor was not conclusively localized in human 
decidual cells, the lack of dopamine effect on decidual PRL production, 
as shown by previous studies (Golander et al., 1979; Ben -Jonathan et 
al., 1980) and confirmed in this study (Chapter 7), may be due to the 
absence of dopamine D2 receptor in human decidual cells. Then the 
next step (Chapter 7) was performed to investigate whether the 
introduction of dopamine D2 receptor into decidual cells would induce 
decidual cells to response to bromocriptine. However, even after the 
dopamine receptor was introduced and expressed at a high level of its 
mRNA in decidual cells by transfection with a dopamine receptor 
construct, bromocriptine still had no effect on decidual PRL production. 
No measurable response to bromocriptine by decidual cells transfected 
with dopamine D2 receptor suggests that the machinery associated 
with cell signalling, such as relevant G- protein, second messenger 
system, is not functional. 
8.4. The comparision of the regulatory systems involved in the synthesis 
and release of decidua and pituitary PRL 
The marked difference of the regulatory systems involved in decidua 
and pituitary PRL synthesis and release have been demonstrated in 
previous (Golander et al., 1979; Handwerger et al., 1983; Rosenberg 
Bhatnagar, 1984) and present studies, the mechanism of which, 
however, remains poorly understood. Unlike pituitary gland, little 
hormone is stored in the decidual cells (Golander et al., 1978; Markoff et 
al., 1983a), further confirmed in this study (Chapter6). In addition, 
decidual PRL is non -specifically bound to cellular components, while 
pituitary PRL is packaged into secretory granules (Handwerger et al., 
1984). Furthermore, no chromogramin, a major protein component of 
secretory vesicles, was localized in the decidual cells by 
immunocytochemical techniques, in contrast again to the strong 
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positive staining in pituitary cells (Handwerger and Capel, 1985). 
These results suggest important differences in the peptide processing 
and secretory system in two tissues. 
Decidual cells do not possess the cell surface ganglioside A2B5 and 3G5, 
which are all features shared by anterior pituitary and other endocrine 
cells that synthesis and release protein hormone (Handwerger and 
Capel, 1985). The decidual cells thus appear to represent a unique 
protein hormone -secreting cells. Furthermore, the lack of the 
respective receptors, such as dopamine D2 receptor as demonstrated in 
Chapter 7 or different intracellular cell signalling systems might also 
be attributed to this regulatory difference in these two tissue. 
However, the main difference, as revealed recently, resides in the 
different gene regulatory region between decidua and pituitary PRL. In 
contrast to the PRL protein coding sequence in decidua identical to that 
in pituitary, as evidenced by in vitro translation system (Takahashi et 
al. 1984), recent studies have revealed that decidual PRL mRNA was 
approximately 150 nucleotides longer than the transcript from pituitary 
(Gellersen et al., 1989a; Chapter 2), which might result from the 
elongation of the 5'untranslated region of the PRL gene. It has been 
suggested that PRL gene in decidua contained a placenta- specific 
promoter and decidual PRL mRNA was encoded by six exons including 
a placenta- specific exon (DiMattia et al., 1990; Hiraoka et al., 1991). In 
addition, Pit -1, interacting with cis -acting elements located in the PRL 
gene of pituitary to direct the pituitary- specific transcription of the PRL 
gene (Davis, 1990), is not expressed in the human decidua (DiMattia et 
al., 1990; Brook, Davis and McNeilly, unpublished observation, 1991). 
Thus, the mechanism of the different regulators controlling the 
synthesis and secretion of PRL from pituitary and decidua resided in 
the different regulatory structure of the PRL gene, because cis - acting 
elements were responsible for transducing regulatory signals from the 
cell membrane to the pituitary PRL gene located in the immediate 
vicinity of the transcription initiation site associated with Pit-1 response 
elements (Elsholtz et al., 1986; Jackson and Bancroft, 1988). 
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Conclusion: The results reported in this thesis support the concept that 
decidual cells are the only source of PRL in utero -placental unit. The 
major control of decidual PRL release is the rate of PRL synthesis and 
this is related to the degree of decidualization, induced and maintained 
by a synergistic action of oestradiol and progesterone via the respective 
receptors throughout pregnancy. Dopamine is not a controller of 
decidual PRL production. 
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Appendix 1. Preparation of poly- L-lysine coated slides 
Washed slides were further cleaned by the following procedures: 
1. 95% ethanol for 5 min; 
2. 0.5 M HC1 in 95% ethanol for 5 min; 
3. 95% ethanol twice, for 5 min; 
4. The slides were rinsed with distiled water; 
5. Baked at 250 °C for 6 h; 
6. The slides were then immersed in poly -L- lysine (0.1 µg /ml) solution 
for 10 min. After air -drying, the slides were stored in black boxes at 4 °C 
until use. 
Appendix 2. In situ hybridization solution 
A. Solutions 
1. DEPC treated water 
500 µl of 10 % (v /v) DEPC in absolute alcohol were dried in 500 ml bottle 
by N2, then 500 ml distiled water were added to a final concentration of 
0.1% (v /v) DEPC, allowed to stand for 12 h, and then autoclaved. All the 
following solutions were made up with 0.1% (v /v) DEPC treated water. 
2. Phosphate buffered saline (PBS), pH 7.2 (100 mM), 
The followings were added to 800 ml of DEPC treated water 
85.0g NaCl (1.3M) 
10.7g Na2HPO4 (70mM) 
3.9g NaH2PO4 (30mM) 
Made up to 1 litre with DEPC treated water 
3. 4% paraformaldehyde 
4g of paraformaldehyde were dissolved in 100 ml of 10 mM PBS by 
heating to 60 °C with stirring, cooled and filtered. This solution was 
made up fresh each day. 
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4. 20X standard saline citrate (20XSSC) 
175.3g of NaC1 and 88.2g of sodium citrate were dissolved in 800 ml of 
DEPC treated water, adjusted to pH 7.0 with 1N HC1, and made up to 
1L, then autoclaved. 
5. 0.2% Glycine 
200 mg of glycine were dissolved in 100 ml of 10 mM PBS, this solution 
was made up fresh each day. 
6. Proteinase K 
The proteinase K was dissolved in DEPC treated water at a stock 
concentration of 10 mg /ml and stored at -20 °C. 
7. 0.1M Tris/HC1 
Tris base 12.1g 
DEPC treated water 800 ml 
Adjusted to pH 7.5 by concentrated HC1. Made the volume of the 
solution up to 1L. 
8. 1N HC1: made with DEPC treated water and autoclaved. 
9. 50 mM CaC12: made with DEPC treated water and autoclaved. 
10. RNAse buffer: 20 mM Tris/HC1 pH 7.6 containing 1 mM EDTA. 
B. Hybridization buffer 
1. Deionised formamide 
50 ml of formamide were mixed with 5g of mixed -bed ion exchange 
resin (Bio -Rad AG 501 -x8, 20 -50 mesh). The solution was stirred for 
overnight at 4 °C, filtered twice with whatman No.1 filter paper and 
stored at -20 °C. 
2. Denhart's solution (50X) 
To each vial which contained 50 mg each of BSA, Ficoll, and PVP, 5 ml 
of DEPC treated water was added. The solutions was then aliquoted 
and stored at -20 °C. 
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3. Salmon testis denatured DNA (10 mg /ml) 
4. transfer RNA (10 mg /ml) 
20 mg of tRNA was dissolved in 2 ml of DEPC treated water and placed 
on ice for 30 min, then aliquoted to storage volume and stored at -70 °C. 
5. 50% (w /v) dextran sulphate 
1g of dextran sulphate was dissolved in 2 ml of DEPC treated water by 
heating to 37 °C. 
6. 10% (w /v) SDS: made with DEPC treated water. 
7. 1M DTT 
5g DTT was added to 32.4 ml DEPC treated water. 
8. 25X SSPE 
The following reagents were added to 80 ml DEPC treated water: 
NaC1 26.3g 
NaH2PO4 2.98g 
The pH was adjusted to 7.4, then 5 ml of 0.5M EDTA added. The 
solution was made up to 100 ml using DEPC treated water and then 
autoclaved. 
1X SSPE being: 0.18 M NaCl, 10 mM NaH2PO4, pH 7.4 and 1 mM EDTA. 
C. Hybridization buffer formula 
Stock concentration Final concentration 
100% deionized formamide 50% 
25X SSPE 5X 
50X (1% w/v) denhart's 0.1% 
50% (w/v) dextran sulphate 4% 
10 mg/ml tRNA 200 µg/ml 
10 mg/ml stDNA 200 µg/ml 
10% (w/v) SDS 0.1% 
1 M DTT 10 mM 
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Prehybridization buffer was made up using DEPC treated water instead 
of dextran sulphate because it made the buffer too viscous and 
consequently was difficult to remove prior to application of the 
hybridization buffer. 
Appendix 3. cDNA probe labelling by using Random Primer 
labelling method 
cDNA probe was labelled with [35S] dCTP for in situ hybridization and 
with a[32P] dCTP for Northern blot analysis by the method of Feinberg 
and Vogelstein (1983) using a random primed DNA labelling kit 
(Boehringer Mannheim, Lewes, Sussex, UK). 
1. 20 ng hPRL DNA in 10 mM Tris/HC1 buffer was aliquoted to a new 
eppendorf tube and boiled for 10 min to denature the DNA; 
2. The following reagents were added in order: 
1 µl of each dNTP (dTTP, dTTP, dATP) 
2 pi of reaction buffer 
5 p.1 [35S] dCTP or a[32P] dCTP 
1 p.1 Klenow 
Incubated for 1 hour at 37 °C in dryblock in hot lab. 
3. Labelled DNA was separated on a NICK Column (Pharmacia LKB, 
Biotechnology AB, Uppsala, Sweden) by eluting with three times 400 p.1 
of equilibration buffer (10 mM Tris/HC1 and 1 mM EDTA). 
6. Samples were collected into three tubes. 
7. 2 p.1 from each tube was counted directly on a scintillation counter to 
assess specific activity of the probe in counts per min (cpm). 
Appendix 4. Autoradiography 
A. Photographic emulsion 
1.Two vials of Kodak emulsion, which was stored at 4 °C, were warmed 
at 45 °C for 45 min. 
2. Under the safe light in dark room, the melt emulsion was poured into 
a dipping chamber and set back in the 45 °C waterbath. 
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3. Some cleaned blank slides were dipped in to remove bubbles. 
4. Each slide was dipped and withdrew slowly from the emulsion once. 
The bottom edge of the slides was blot on a stack of paper towel. The 
slides were kept vertical, and allowed to stand up in a test tube rack to 
dry for 30 min after the last slide was dipped. 
5. The slides were transferred to a light -tight box for 45 min before 
putting into the black plastic slide boxes containing a tube of drearier. 
6. The slides were allowed to expose at 4 °C for 7 to 14 days. 
B. Developing the emulsion coated slides 
1. The following solutions were cooled on ice to balance the temperature 
to 15 °C. 
1. 350m1 developer (Kodak developer); 
2. 400 ml distiled water (Stopper); 
3. 80 ml fix plus 320 ml distiled water (fix); 
4. 400 ml distiled water. 
2. Under safe light, the slides were taken through: 
1. developer for 4 min; 
2. stopper for 20 seconds; 
3. fix for 10 min; 
4. water for 15 min 
3. The slides were then rinsed in running tap water for at least 15 min. 
Light was on at this point. 
4.The slides were stained with hemotoxylin and eosin within a couple 
of hours. 
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Appendix 5. Preparation of immunocytochemical solutions 
1. 4% neutral buffered formalin was made up with the following 
reagents: 
a) 100 ml of formalin (40% w/v formaldehyde); 
b) 4g of sodium phosphate (monobasic and monohydrate); 
c) 6.5g of sodium phosphate (dibasic and anhydrous); 
The solution was made up to 1L with distiled water. 
2. 4- Chloro- Naphthol -sbstrate solution 
3 mg of 4- Chloro- Naphthol (Sigma) was dissolved in 0.1 ml of absolute 
alcohol with stirring, which was then added to 10 ml of 0.05 M Tris 
buffer, pH 7.6 with 0.1% H2O2. The solution was filtered out before use. 
Appendix 6. Preparation of Northern blot solutions 
1. Solution D 
250g guanidinium thiocyanate (Fluka) was dissolved in 293 ml pure 
water, to which 17.6 ml of 0.75 M sodium citrate pH 7.0 (previously 
prepared in a baked bottle and autoclaved) and 26.4 ml of 10% sarcosyl 
were then added. Before use, 0.36 ml Beta -mercaptoethanol (beta -ME) 
was added to 50 ml of this stock solution. Final solution was 4 M 
guanidinium thiocyanate, 25 mM sodium citrate, 0.5% sarcosyl, 0.1 M 
beta -ME. 
2. Phenol (water saturated) 
100 g highly- purified Phenol (Gibco -BRL) stored at -20 °C was melt in 
waterbath at 65 °C and 250 ml of pure water was then added. After been 
shaken well, it was left overnight at 4 °C to separate. Most of water was 
removed and the solution was stored at 4 °C. 
3. Sodium acetate (2M) 
2 M sodium acetate (Sigma) was adjusted to pH 4.0 by using glacial 
acetic acid, and sterilised by autoclaving. 
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4. Chloroform/isoamyl alcohol 
Chloroform /isoamyl alcohol (Sigma) was mixed in ratio 49:1 
chloroform:isoamyl alcohol at RT. 
5. l0X running buffer 
8.36 g of MOPS, 0.744 g of EDTA and 0.82 g of sodium acetate were 
dissolved in 150 ml of pure water and the pH was adjusted to 7.0 with 
the sterile 5 M NaOH and made up to 200 ml with pure water. The final 
solution was 200 mM MOPS, 10 mM EDTA and 50 mM sodium acetate. 
6. Sample buffer 
The sample buffer was made up by mixing 200 p.1 of 10X running buffer, 
1 ml of deionized formamide and 356 p.1 of 37% formaldehyde 
7. Hybridization buffer (for 100 ml) 
Stock concentration Final concentration 
1 M sodium phosphate, pH 7.2 0.2 M 
0.5 M EDTA 1 mM 
1g BSA 1% 
7g SDS 7% 
100% Formamide 15% 
After BSA was dissolved in the aqueous components, the SDS and 
formamide were added to the solution. 
Appendix 7. Preparation of collagen coated multiwell plates 
10 mg collagen (type I, Sigma) was dissolved in 0.1 M acetic acid at 
room temperature for 3 h. The solution was sterilized through a 0.2 p.m 
filter. The culture well surface was coated by collagen at 6 p.g /cm2 and 
air -dried. Before introducing cells, the plates were rinsed with sterile 
water twice. 
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Appendix 8. Preparation of 40% Percoll Gradient 
40% Percoll (Pharmacia Ltd, Milton Keynes, Bucks, UK) was obtained 
by mixing 9 ml Percoll with 1 ml of 10 x PRMI -1640 Medium (Flow 
Laboratories), which was further diluted by adding 12.5 ml of 1 x PRMI- 
1640 medium. The gradient was established by centrifugation at 13,000 
g for 60 min in a fixed angle rotor. 
Appendix 9. Preparation of plasmid eDNA of dopamine D2 
receptor 
The dopamine D2 receptor cDNA, either full length (2.5 kb) or short 
length (1.5 kb), was cloned into the E. coLi site of plasmid pBluescript 
(Stratatene). The Miniprep Kit (Pharmacia LKB) was used to prepare 
and purify dopamine D2 receptor cDNA from E. coLi. The full length of 
dopamine D2 receptor cDNA was used for constructing the probe for 
Northern blot or used for transfection and the short length of dopamine 
D2 receptor cDNA coding from the third cytoplasmic loop to the 3' poly 
A tail was used for constructing ribo -probe for in situ hybridization. 
A. Alkaline lysis miniprep 
All of the solutions was included in Miniprep Kit (Pharmacia LKB, 
Biotechnology, Molecular Biology Division, S -75182 Uppsala, Sweden) 
except Territic broth. 
1. E.Coli cells, containing dopamine D2 receptor inserts, either full 
length (2.5 kb) or short length (1.5 kb), were grown in 15 ml Territic 
broth in a orbital shaker at 370C (200 rpm/min) for 12 h; 
2. The culture was aliquoted into 1.5 ml eppendorf tube, and 
centrifuged in a microcentrifuge at full speed for 1 min to pellet the 
cells; 
3. After removing the medium by aspiration, 100 µl of solutions I (50 
mM Tris -HC1 (pH 8.0), 50 mM glucose, 10 mM EDTA, 0.15% kathon 
CG/ICP), 200 µl of solution II (0.8 M NaOH, 4% (v /v) Triton X -100) and 
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150 µl of solution III (3 M sodium acetate, pH 4.8), precooled on ice, 
were sequentially added to the tubes. After addition of each solution, 
the tubes were resuspended by votexing and incubated on ice for 5 min; 
4. The tubes were spun in a microcentrifuge at RT for 5 min at full 
speed; 
5. The supernatant was carefully transferred to a clean 
microcentrifuge tube; 
6. 450 µl of isopropanol was added . The solution was mixed by inverting 
and incubated at RT for 10 min; 
7. The DNA was pelleted in a microcentrifuge at RT for 5 min at full 
speed and washed once with 250 µl of isopropanol; 
8. The pellet was freeze -dried for 5 min and redissolved in 50 µl of 
column buffer (10 mM Tris -HC1 (pH 8.0), 1 mM EDTA). DNA was then 
purified by spun columns included in Miniprep Kit (Phamacia LKB). 
The preparation of spun column was performed according to the 
instruction of manufacture (Pharmacia LKB). 
The purified DNA yield was estimated by comparing its fluorescence 
under ultraviolet light on 0.8% agarose gel with that of the three pBR322 
samples. 
Appendix 10. Restriction enzyme digestion 
A. Digestion 
To each eppendorf tube sitting on ice the following solutions 
(Northumbria, Biologicals Limited) were added: 
31 µl plasmid cDNA 
4 µl 10 X buffer H (for anti -sense) or buffer L (for sense) 
5 µl Xba 1 (for anti- sense) or Kpnl(for sense) 
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The tubes were incubated in 37 °C waterbath for 1 h. Then 1.5 µl of 
proteinase K was added to each tube and incubated in 37 °C waterbath 
for 0.5 h. 
B. Extraction of digested plasmid 
By adding DEPC treated water to make the volume in each tube to 100 
µl, DNA was then extracted with 100 p.1 phenol/choloroform twice and 
with 100 p.1 choloroform once, and then redissolved in 100 µl of DEPC 
treated water. 
C. Precipitation 
100 p.1 of DNA solution was added to a new tube which contained 200 p.1 
of absolute alcohol and 20 p.1 of 10.5 M ammonia acetate. After 
precipitated at - 20 °C for overnight, DNA solutions were pelleted in a 
microcentrifuge for 20 min at full speed. The pellet was then 
resuspended in 400 p.1 of 80% ethanol, centrifuged for 10 min at full 
speed. After freezing dry , the pellet was dissolved in 811.1 TE buffer (10 
mM Tris -HC1 (pH 8.0), 1 mM EDTA) and left on ice for 20 min, then 
stored at -70 °C until use. 
The linearized plasmid DNA was checked on a 0.8% agarose gel and 
the yield of the plasmid DNA was estimated by comparison with pBR 
322 standards. 
Appendix 11. Ribo -probe labelling and hydrolysis 
A. Labelling ribo -probe 
T7 (antisense) and T3 (sense) RNA transcripts were synthesized and 
labelled with [35S]UTP in vitro using the mCAP transcription kit 
(Molecular Biology Boehringer Mannheim). 
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The following reagents were added to the tube setting on the ice: 
1 µl RNAse block 
5 µl 5x buffer 
8 µl DNA template (1 µg) 
1 µl rATP 
1 µi rGTP 
1 µl rCTP 
1 µl rUTP (1/50 diluted) 
1 pl 0.75 M DTT 
5 µl [35S]UTP 
1 µi T7 (for antisense) or T3 polymerase (for sense) 
The final volume in each tube was made up to 25 µl with DEPC 
treated water. 
The tubes were incubated at 37 °C for 30 min, and a further 1 pl T7 or T3 
polymerase was added and incubated at 37 °C for 30 min. The solution 
was then treated with 1µl tRNA stock (20 µg) and 1µl RNAse free 
DNAse at 37 °C for 30 min. The volume was made up to 100 µl with 
DEPC treated water, and then extracted twice with 100 pl of buffered 
phenol/chloroform. The DNA was precipitated overnight with 10 pl 
sodium acetate and 220 pl ethanol at -70 °C and pelleted in a 
microcentrifuge at full speed for 10 min at 4 °C. The pellet was washed 
in 250 pl cold 80% ethanol and centrifuged for 10 min. The supernatant 
was then decanted leaving a pellet of labelled RNA in the tube. After 
freezing dry, the pellet was reconstituted in 50 µl DEPC treated water 
and left on ice for 20 min before assessing specific activity of the probe. 
B. Probe Hydrolysis 
The following solutions were incubated at 60 °C for 70 min: 
20 µl labelled probe 
380 pl 50 mM DTT 
380 pl 1 M sodium bicarbonate 
20 µ1 1 M DTT 
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The mixture was divided between two tubes. 114 µl 10.5 M ammonium 
acetate and 400 µl cold absolute alcohol were added to each tube. After 
precipitating at -20 °C overnight, the DNA was pelleted by spinning at at 
full speed for 20 min in a microcentrifuge and washed in 450 pl 100% 
alcohol. The pellets were then freeze -dried briefly, redissolved in 25 µl 
of 50 mM DTT, and left on ice for 20 min before accessing the specific 
activity of the probe. 
Appendix 12. Deprotection of oligos 
The human dopamine D2 receptor 3'primer was synthesized in 391 
DNA Synthesizet (Applied Biosystems, PCR- MATE). On following day, 
the column C containing the synthesized oligonucleotides was removed 
and oligonucleotides was deprotected as follows: 
1. The two ends of the column was tightly connected to sterile 10 ml 
syringes, one of which contained 2 ml of cold ammonia (stored at 4 °C); 
2. Ammonia was pushed through the column several times and then 
left in the column for 30 min before transferred to a 15 ml sterile tube; 
3. The solution, capped and sealed with lab film, was incubated at 55° 
waterbath overnight to deprotect the oligo; 
4. 1 /10 volume of 3 M sodium acetate, pH 7.0 and 2 volume of 100% 
ethanol were added to a 400 p.1 aliquot of deprotected oligo. After 
precipitated at -70 °C for 15 min, the oligo was pelleted by centrifugation 
at full speed for 10 min in a microcentrifuge; 
5. The pellet was washed once with 500 p.1 of 70% ethanol and freeze 
dried; 
6. The freeze dried pellet was then resuspended in 200 p.1 sterile water. 
The concentration of oligonuclei was determined by measuring O.D260 
of 10 p.1 oligo solution in 1 ml distiled water. 
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